{"title": "Publications", "author": null, "url": "https://www.pharmazie.uni-wuerzburg.de/en/forschung/prof-holzgrabe/publications/", "hostname": "uni-wuerzburg.de", "description": null, "sitename": "pharmazie.uni-wuerzburg.de", "date": "2023-08-20", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Publications\nPublications Prof. Dr. Ulrike Holzgrabe\nBroad-spectrum Activity of Macrophage Infectivity Potentiator Inhibitors against Gram-negative Bacteria and Leishmania major\nJ. Iwasaki, D.D. Lorimer, M. Vivoli, E.A. Kibble, C.S. Peacock, J. Abendroth, S.J. Mayclin, D.M. Dranow, P.G. Pierce, D. Fox III, M. Lewis, N.M. Bzdyl, S. Kristensen, T.J.J. Inglis, C.M. Kahler, C.B. Bond, A. Hasenkopf, F. Seufert, J. Schmitz, L. Marshall, A. Scott, I.H. Norville, P.J. Myler, U. Holzgrabe, N. J. Harmer, M. Sarkar-Tyson,, J. Antimicrob. Chemother. 77, 1625-1634 (2022) doi: 10.1093/jac/dkac065\nFingerprint spectra for drug formulations using a DOSY filter: Pros and Cons\nA. Becht, C. Schollmayer, U. Holzgrabe, J. Pharm. Biomed. Anal. 214, 114723 (2022)\nEmerging Antimicrobial Drug Resistance in Africa and Latin America: The Role of Poor-Quality Medicines, Regulatory Action and Bad Prescription Habits, L. H\u00f6llein, E. Kaale, Y.H. Mwalwisi, M.-C. ScHulze, C. Vetye-Maler, U. Holzgrabe, Risk Management and Healthcare Policy, 15, 827-843 (2022)\nTowards a holistic view of tablet quality, an extensive study on paracetamol tablets with nuclear magnetic resonance using similarity calculations, differential NMR and hierarchical cluster analysis.\nJ. Schripsema, R. dos Santos Merlim, L. Gon\u00e7alves Parvan, H. Sant\u2019Ana dos Santos Ribeiro, L.D. Schripsema, S. Aleixo, A. Becht, U. Holzgrabe, D. Dagnino, J. Pharm. Biomed. Anal., 215, 114773 (2022)\nPreface: quantitaitve NMR spectroscopy\nM. Bernstein, U. Holzgrabe, J. Pharm. Biomed. Anal., 215, 114787 (2022)\nGlobale Versorgung mit sicherern Arzneimitteln \u2013 eine Einsch\u00e4tzung. Global supply of safe drugs \u2013 an assessment.\nU. Holzgrabe, Zeitschrift f\u00fcr medizinische Ethik, 68, 307-319 (2022)\nHydrogen-Deuterium (H/D) Exchange Reaction of Acebutolol 3 hydrochloride in D2O and CD3OD Solution\nH. Guesmi., J. Ben Kraim., A. Alatrache, U. Holzgrabe, Pharmazie, 77, 217-223 (2022)\nIsolation and Characterization of Galloylglucoses Effective against Multidrug-Resistant Strains of Escherichia coli and Klebsiella pneumoniae.\nN.E. Masota, K. Ohlsen; C. Schollmayer, L. Meinel, U. Holzgrabe, Molecules 27, 50435 (2022)\nAlternative methods to assess the impurity profile of a monographed API using acarbose as an example\nA. Leistner, U. Holzgrabe, J. Pharm-Biomed. Anal. 221, 115063 (2022)\nCharacterization of binding properties from ephedrine derivatives to human 1 alpha-1-acid glycoprotein\nS. Schmidt, M. Zehe, U. Holzgrabe, C. Sotriffer, Eur. J. Pharma. Sci. 181, 106333 (2022)\nChemometric analysis applied to 1H NMR and FTIR data for a quality parameter distinction of Red Fruit (Pandanus conoideus, Lam.) Oil products\nL. Triyasmono, C. Schollmayer, U. Holzgrabe, Phytochemical Anal. 1-12 (2022)\nAzobenzene derivatives with activity against drug-resistant Candida albicans and Candida auris\nM. Raschig, B. Ram\u00edrez-Zavala, J. Wiest, M. Saedtler, M. Gutmann, U. Holzgrabe, J. Morschh\u00e4user, L. Meinel, Arch. Pharm. 356, e2200463 (2023)\nN-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer\u2019s disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity and antioxidant capacity\nS. Parlar, G. Sayar, A. Hande Tarikogullari, S. Sozer Karada\u011fli, V. Alptuzun, E. Erciyas, U. Holzgrabe, Arch. Pharm. 356, e2200519 (2023)\nSimultaneous determination of the Saponification Value, Acid Value, Ester Value, and Iodine Value in Red Fruit Oil (Pandanus conoideus, Lam.) using 1H NMR spectroscopy and its application for commercial products\nL. Triyasmono, C. Schollmayer, J. Schmitz, E. Hovah, C. Lombo, S. Schmidt, U. Holzgrabe, Food Anal. Methods,16, 155-167 (2023) doi.org/10.1007/s12161-022-02401-4\nMethod development, optimization, and validation of the separation of ketamine enantiomers by capillary electrophoresis using design of experiments\nS. Schmidt, U. Holzgrabe, Chromatographia, 86, 87-95 (2023)\nSimplification of pharmacopoeial methods for related substances of simvastatin and lovastatin by HPLC with hyphentated ultraviolet and charged aerosol detection\nR. Walther, U. Holzgrabe, J. Pharm. Biomed. Anal. 225, 115218 (2023).\nNitrosated active pharmaceutical ingredients \u2013 lessons learnt?\nU. Holzgrabe, J. Pharm. Sci. 112, 1210-1215 (2023)\nQuinolone Amides Against African Trypanosomiasis \u2013 Activity versus Solubility\nJ. Weinmann; L. Kirchner; M. Engstler; L. Meinel; U. Holzgrabe, Eur. J. Med. Chem. 250, 115176 (2023)\nAnalytical Quality by Design approach for robust method development: LC-CAD analysis of non-volatile fatty acids\nR. Walther, J. Krmar, A. Leistner, B. Svrkota, B. Ota\u0161evi\u0107, A. Malenovi\u0107, U. Holzgrabe, A. Proti\u0107, Pharmaceuticals, 16, 478 (2023)\nDevelopment, validation and application of a selective and sensitive LC-MS/MS method for the quantification of daptomycin in a suspension of Mammaliicoccus sciuri in Mueller-Hinton Broth\nL. Kirchner, T. Marciniak, W. Ziebuhr, O. Scherf-Clavel, U. Holzgrabe, J. Pharm. Biomed. Anal.227, 115293 (2023)\nNovel Xanomeline-containing bitopic ligands of muscarinic acetylcholine receptors: design, synthesis and FRET investigation\nC. Matera, M. Kauk, D. Cirillo, M. Maspero, C. Papotto, D. Volpato, U. Holzgrabe, M. De Amici, C. Hoffmann, C. Dallanoce, Molecules, 28, 2407 (2023)\nNature-inspired synthesis of antibacterial glucovanillin derivatives\nN.E. Masota, K. Ohlsen, L. Meinel, U. Holzgrabe, Fitoterapia., Fitoterapia., 167, 105475 (2023)\nFluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei\nN. J. Scheuplein, T. Lohr, M. Vivoli Vega, D. Ankrett, F. Seufert, L. Kirchner, N. J. Harmer, U. Holzgrabe, SLAS Discovery, 28, 211-222 (2023)\nHybridization into a bitopic ligand increased receptor activation for isopilocarpine but not for pilocarpine derivatives\nC. S. Heinz, M. Bermudez, N. Jaiswal, C. Gro\u00dfe, M. Kauk, C. Hoffmann, U. Holzgrabe, J. Nat. Products, 86, 869-881 (2023)\nCombination quantitative 1H NMR spectroscopy and chemometric approaches for the assessment of quality control in commercially available in Red Fruit (Pandanus conoides, Lam.) oil\nL. Triyasmono, C. Schollmayer, U. Holzgrabe, J. Pharm. Biomed. Anal. Open, 1, 100010 (2023)\nAn exploratory study on the effect of mechanical stress on particle formation in monoclonal antibody solutions\nM. Abdel-Tawab, S. Banerjee, R. Kirchner, U. Holzgrabe, M. Schubert-Zsilavecz, A. Seidl, F. Stadler, Arch. Pharm. 356, e2300101 (2023)\nMechanochemical oxidative degradation of thienopyridine containing drugs\nE. F. Krake, L. Backer, B. Andres, W. Baumann, N. Handler, H. Buschmann, U. Holzgrabe, C. Bolm, T. Beweries, ACS Central Science, 9, 1150-1159 (2023)\nAnalysis of Structure\u2013Activity-Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei.\nN. J. Scheuplein, N. M. Bzdyl, T. Lohr, E. A. Kibble, A. Hasenkopf, M. Sarkar-Tyson, U. Holzgrabe. J. Med. Chem. 66, 8876-8895 (2023) https://doi.org/10.1021/acs.jmedchem.3c00458\nMacrophage infectivity potentiator protein, a peptidyl prolyl cis/trans isomerase, essential for Coxiella burnetii growth and pathogenesis\nA. W. Debowski, N. M. Bzdyl, D. R. Thomas, Ni. E. Scott, C. H. Jenkins, J. Iwasaki, E. A. Kibble, C. Ai Khoo, N. J. Scheuplein, P. M. Seibel, T. Lohr, G. Metters, C. S. Bond I. H. Norville, K. A. Stubbs, N. J. Harmer, U. Holzgrabe, H. J. Newton, M. Sarkar-Tyson, PLoS Pathogen, 19, e1011491 (2023)\nIdentification of low-level impurities in drug analysis of carbocisteine by means of liquid chromatography-high resolution mass spectrometryand general unknown comparative screening\nR. Walther, O. Scherf-Clavel, A. Zamponi, M. Kinzig, F. S\u00f6rgel, U. Holzgrabe. J. Chromatography A, 1706, 4642269 (2023)\nThe solvent- and surface-dependent adsorption of the lipopeptide antibiotic daptomycin: The general necessity of adsorption tests\nL. Kirchner, T. Marciniak, W. Ziebuhr, O. Scherf-Clavel, U. Holzgrabe, J. Pharm. Biomed. Anal. 235, 115657 (2023)\n-\nEnantioseparation by Capillary Electrophoresis Using Cyclodextrins in an Amino Acid-based Ionic Liquid Running Buffer\nJ. Wahl, U. Holzgrabe, Chiral Separation: Methods and Protocolls, Methods in Molecular Biology, Chiral separations, 3rdEd. Springer, 1985, 365-371 (2019)\n[doi: 10.1007/978-1-4939-9438-0_20](https://doi.org/10.1007/978-1-4939-9438-0_20)\n-\nDOSY NMR measurements as screening method of potential reactions of API and excipients in drug formulations\nA. Becht, C. Schollmayer, J. Wiest, D. Heller, W. Baumann, H. Bauman, U. Holzgrabe, J. Pharm. Biomed. Anal. 162, 41-46 (2019)\n[doi: 10.1016/j.jpba.2018.09.020](https://doi.org/10.1016/j.jpba.2018.09.020)\n-\nSynthesis, bioactivity and molecular modelinf studies on potential anti-Alzheimer piperidinehydrazide-hydrazones\nS. Parlar, G. Sayar, A.H. Tarikogullari, S.S. Karadagli, V. Alptuzun, E. Erciyas, U. Holzgrabe. Bioorg. Chem. 87, 888-900 (2019)\n[doi: 10.1016/j.bioorg.2018.11.051](https://doi.org/10.1016/j.bioorg.2018.11.051)\n-\nA systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates\nM. Zilker, F. S\u00f6rgel, U. Holzgrabe, J. Pharm. Biomed. Anal. 166, 222-235 (2019)\n[doi: 10.1016/j.jpba.2019.01.016](https://doi.org/10.1016/j.jpba.2019.01.016)\n-\nNuclear Magnetic Resonance Spectroscopy, Application, Identification of Counterfeit Drugs and Herbal Medicine\nU. Holzgrabe. Encyclopedia of Analytical Science, 3rd edition, Volume 7 (2019)\n[doi: 10.1016/B978-0-12-409547-2.14081-8](https://doi.org/10.1016/B978-0-12-409547-2.14081-8)\n-\nZwitterionic-hydrophilic interaction liquid chromatograpy for L-ascorbic acid 2-phosphate magnesium, a raw material in cell therapy\nX. Xu, M. Wozniczka, J. Urlaub, C. Schollmayer, B. Diehl, K. Herman, Ul. Holzgrabe, E. Wynendaele, S. Van Calenbergh, B. de Spiegeleer. J. Pharm. Biomed. Anal. 165, 338-345 (2019)\n[doi: 10.1016/j.jpba.2018.12.010](https://doi.org/10.1016/j.jpba.2018.12.010)\n-\nPurification process and 1H NMR analytical characterization of Mineral Oil Hydrocarbons (PARAFFINS) for Pharmaceutical Use\nJ. Urlaub, J. Norwig, U. Holzgrabe, J. Pharm. Biomed. Anal., 169, 41-48 (2019)\n[doi: 10.1016/j.jpba.2019.01.036](https://doi.org/10.1016/j.jpba.2019.01.036)\nand\n-\nReply to \u201cRequirements for accurate 1H NMR quantification of mineral oil hydrocarbons (paraffins) for pharmaceutical or cosmetic use\u201d\nJ. Urlaub, J. Norwig, U. Holzgrabe, J. Pharm. Biomed. Anal. 171, 235-237 (2019)\n[doi: 10.1016/j.jpba.2019.04.020](https://doi.org/10.1016/j.jpba.2019.04.020)\n-\n\u00df-Lactams and related compounds as antibacterials and \u00df-lactamase inhibitors\nU. Holzgrabe, J. Schmitz, Buchkapitel in Pharmaceutical Biocatalysis (ed. P. Grunwald), Pan Stanford Publishing Pte. Ltd., Singapore\n-\nFluorination of Photoswitchable Muscarinic Agonists Tunes Receptor Pharmacology and Photochromic Properties\nL. Agnetta, M. Bermudez, F. Riefolo, C. Matera, E. Claro, R. Messerer, T. Littmann, G. Wolber, U. Holzgrabe, M. Decker, J. Med. Chem. 62, 3009-3020 (2019)\n[doi: 10.1021/acs.jmedchem.8b01822](https://doi.org/10.1021/acs.jmedchem.8b01822)\n-\nOptical Control of Cardiac Function with a Photoswitchable Muscarinic Agonist\nF. Riefolo, C. Matera, A. Garrido-Charles, A. M. J. Gomila, R. Sortino, L. Agnetta, E. Claro, R. Masgrau, U. Holzgrabe, M. Batlle, M. Decker, E. Guasch, P. Gorostiza, J. Amer. Chem. Soc. 141, 7628-7636 (2019)\n[doi: 10.1021/jacs.9b03505](https://doi.org/doi: 10.1021/jacs.9b03505)\n-\nQuantitative Structure \u2013 Property Relationship modeling of polar analytes lacking UV chromophores to Charged Aerosol Detector Response\nK. Schilling, J. Krmar, N. Maljuri\u0107, A. Proti\u0107, U. Holzgrabe, Anal. Bioanal. Chem. 411, 2945-2959 (2019);\n[doi: 10.1007/s00216-019-01744-y](https://doi.org/10.1007/s00216-019-01744-y)\n-\nA long-time stability study of 50 drug substances representing common drug classes of pharmaceutical use\nM. Zilker, F. S\u00f6rgel, U. Holzgrabe, Drug Testing Anal. 11, 1065-1075 (2019)\n[doi: 10.1002/dta.2593](https://doi.org/10.1002/dta.2593)\n-\nThe contamination of valsartan and other sartans. Part 1 New findings\nF. S\u00f6rgel*, M. Kinzig, M. Abdel-Tawab, C. Bidmon, A. Schreiber, S. Ermel, J. Wohlfart, A. Besa, O. Scherf-Clavel, U. Holzgrabe, J. Pharm. Biomed. Anal., 172, 395-405 (2019)\n[doi: 10.1016/j.jpba.2019.05.022](https://doi.org/10.1016/j.jpba.2019.05.022)\n-\nThe contamination of valsartan and other sartans. Part 2. Untargeted Screening reveals contamination with amides additionally to known nitrosamine imprities\nO. Scherf-Clavel,M. Kinzig, A. Besa, A. Schreiber, C. Bidmon, M. Abdel-Tawab, J. Wohlfart, F. S\u00f6rgel*, U. Holzgrabe, J. Pharm. Biomed. Anal., 172, 278-284 (2019)\n[doi: 10.1016/j.jpba.2019.04.035](https://doi.org/10.1016/j.jpba.2019.04.035)\n-\nNovel population pharmacokinetic approach to explain the differences between cystic fibrosis patients and healthy volunteers via protein binding\nN.R. Shah, J. B Bulitta, M. Kinzig, C. B. Landersdorfer, Y. Jiao, D. S Sutaria, X. Tao, R.R H\u00f6hl, U. Holzgrabe, F. Kees, U. Stephan, F. S\u00f6rgel, Pharmaceutics, 11, 286 (2019)\n- Evaluation of enantiomeric purity of magnesium-L-aspartate dihydrate\nO. Wahl, U. Holzgrabe, J. Pharm. Biomed. Anal. 102, 100-109 (2015)\n[doi:10.1016/j.jpba.2014.08.013](http://dx.doi.org/10.1016/j.jpba.2014.08.013)\n- Simple and rapid high performance liquid chromatography method for the determination of polidocanol as bulk product and in pharmaceutical polymer matrices using charged aerosol detection\nD. Ilko, S. Puhl, L. Meinel, O. Germershaus, U. Holzgrabe, J. Pharm. Biomed. Anal. 104, 17-20 (2015)\n[doi:10.1016/j.jpba.2014.11.012](http://dx.doi.org/10.1016/j.jpba.2014.11.012)\n- Antitrypanosomal activities and structural chemical properties of selected compound classes\nA. Ponte Sucre, H. Bruhn, T. Schirmeister, A. Cecil, C.R. Albert, C. B\u00fcchold, M. Tischer, S. Schlesinger, T. Goebel, A. Fu\u00df, D. Mathein, B. Merget, C. Sotriffer, A. Stich, G. Krohne, M. Engstler, G. Bringmann, U. Holzgrabe, Parasitology Res. 114(2), 501-512 (2015)\n[doi:10.1007/s00436-014-4210-4](http://dx.doi.org/10.1007/s00436-014-4210-4)\n- Rational design of partial agonists for the muscarinic M1 acetylcholine receptor\nX. Chen, J. Kl\u00f6ckner, J. Holze, C. Zimmermann, W.K. Seemann, R. Schrage, A. Bock, K. Mohr, C. Tr\u00e4nkle, U. Holzgrabe*, M. Decker*, J. Med. Chem. 58(2), 560-576 (2015)\n[doi:10.1021/jm500860w](http://dx.doi.org/10.1021/jm500860w)\n- Ionic liquid versus prodrug strategy to address formulation challenges\nA. Balk, T. Widmer, J. Wiest, J.-C. Rybak, P. Matthes, K. M\u00fcller-Buschbaum, A. Sakalis, T. L\u00fchmann, J. Berghausen, U. Holzgrabe, B. Galli, L. Meinel, Pharmaceutical Res. 32, 2154-2167 (2015)\n[doi:10.1007/s11095-014-1607-9](http://dx.doi.org/10.1007/s11095-014-1607-9)\n- Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative\nJ. Glaser, M. Schultheis, H. Moll, B. Hazra, U. Holzgrabe, Molecules 20, 5740-5753 (2015)\n[doi:110.3390/molecules20045740](http://dx.doi.org/10.3390/molecules20045740)\n- Crystal structure of 5,11-Dihydropyrido[2,3-b][1,4]benzodiazepin-6-one\nN.M. Riad, D.P. Zlotos*, U.Holzgrabe*, Acta Crystallographica Section E, 71, o304-o305 (2015)\n[doi:10.1107/S2056989015006817](http://dx.doi.org/10.1107/S2056989015006817)\n- Quantitative 1H NMR analysis of egg yolk, alcohol and total sugar content in egg liqueurs\nM. Hohmann, V. Koospal, C. Bauer-Christoph, N. Christoph, H. Wachter, B. Diehl, U. Holzgrabe, J. Agric. Food Chem., 63, 4112-4119 (2015)\n[doi:10.1021/acs.jafc.5b00940](http://dx.doi.org/10.1021/acs.jafc.5b00940)\n- Profiling a gut microbiota-generated catechin metabolite's fate in human blood cells using a metabolomic approach\nM. M\u00fclek, A. Fekete, J. Wiest, U. Holzgrabe, M. J. M\u00fcller, P. H\u00f6gger, J., J. Pharm. Biomed. Anal., 1145, 71-81 (2015)\n[doi:10.1016/j.jpba.2015.04.042](http://dx.doi.org/10.1016/j.jpba.2015.04.042)\n- Transformation of acidic poorly water soluble drugs into ionic liquids\nA. Balk, J. Wiest, T. Widmer, U. Holzgrabe, B. Galli, L. Meinel, Eur. J. Pharm. Biopharm., 94, 73-82 (2015)\n[doi:10.1016/j.ejpb.2015.04.034](http://dx.doi.org/10.1016/j.ejpb.2015.04.034)\n- Fatty acid composition analysis in polysorbate 80 with high performance liquid chromatography coupled to charged aerosol detection\nD. Ilko, A. Braun, O. Germershausm, L. Meinel, U. Holzgrabe, Eur. J. Pharm. Biopharm., 94, 569-574 (2015)\n[doi:10.1016/j.ejpb.2014.11.018](http://dx.doi.org/10.1016/j.ejpb.2014.11.018)\n- Predicting critical micelle concentration and micelle molecular weight of polysorbate 80 using compendial methods\nA. Braun, D. Ilko, B. Merget, H. Gieseler, O. Germershaus, U. Holzgrabe, L. Meinel, Eur. J. Pharm. Biopharm., 94, 559-568 (2015)\n[doi: 10.1016/j.ejpb.2014.12.015](http://dx.doi.org/10.1016/j.ejpb.2014.12.015)\n- 'Pro et contra' ionic liquid drugs - Challenges and opportunities for pharmaceutical translation\nA. Balk, Holzgrabe, L. Meinel, Eur. J. Pharm. Biopharm., 94, 294-304 (2015)\n[doi: 10.1016/j.ejpb.2015.05.027](http://dx.doi.org/10.1016/j.ejpb.2015.05.027)\n- Impurity Profiling of Ibandronate sodium by HPLC-CAD\nO. Wahl, U. Holzgrabe, J. Pharm. Biomed. Anal., 114, 254-264 (2015)\n[doi: 10.1016/j.jpba.2015.06.002](http://dx.doi.org/10.1016/j.jpba.2015.06.002)\n- Anti-schistosomal Activity of Cinnamic Acid Esters: Eugenyl and Thymyl Cinnamate Induce Cytoplasmic Vacuoles and Death in Schistosomula of Schistosoma mansoni\nJ. Glaser, U. Schurigt, B. M. Suzuki, C. R. Caffrey, U. Holzgrabe, Molecules, 20, 10873-10883 (2015)\n[doi: 10.3390/molecules200610873](http://dx.doi.org/10.3390/molecules200610873)\n- Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics\nE. Kaale, L. H\u00f6llein, U. Holzgrabe, Electrophoresis, 36, 2736-2744 (2015)\n[doi:10.1002/elps.201500025](http://dx.doi.org/10.1002/elps.201500025)\n- Mehr Sicherheit bei der Off-Label-Anwendung in der P\u00e4diatrie\nA. Pospiech, M. Zilker, U. Holzgrabe, P. H\u00f6gger, J. Schreiber, Krankenhauspharmazie, 36, 415-419 (2015)\n- New Griselimycines for the Treatment of Tuberculosis\nU. Holzgrabe, Chemistry & Biology (Preview), 22, 981-982 (2015)\n[doi: 10.1016/j.chembiol.2015.08.002](http://dx.doi.org/10.1016/j.chembiol.2015.08.002)\n- Differentiation of organically and conventionally grown tomatoes by chemometric analysis of combined data from stable proton nuclear magnetic resonance and mid-infrared spectroscopy and stable isotope analysis\nM. Hohmann, Y. Monakhova, S. Erich, N. Christoph, H. Wachter, U. Holzgrabe, J. Agric. Food Chem., 63, 9666-9675 (2015)\n[doi: 10.1021/acs.jafc.5b03853](http://dx.doi.org/10.1021/acs.jafc.5b03853)\nund\nBericht in \"American Chemical Society, Office of Public Affairs - Weekly PressPac\", Greenwire\n- Cinnamic acid bornyl ester derivatives from Valeriana wallichii exhibit antileishmanial in vivo activity in Leishmania major-infected BALB/c mice\nA. Masic, A. M. Valencia Hernandez, S. Hazra, J. Glaser, U. Holzgrabe, B. Hazra, U. Schurigt, PloS One, 10(11):e0142386 (2015)\n[doi: 10.1371/journal.pone.0142386](http://dx.doi.org/10.1371/journal.pone.0142386)\n- Counterfeit drugs studies by NMR\nU. Holzgrabe (\u00dcbersicht, Einladung), Reference Module in Chemistry, Molecular Science and Chemical Engineering, Elsevier, (2016)\n- Focus on PAINS: false friends in the quest for selective anti-protozoal lead structures from nature?\nJ. Glaser, U. Holzgrabe, Med. Chem. Comm., 7, 214-223 (2016)\n[doi: 10.1039/C5MD00481K](http://dx.doi.org/10.1039/C5MD00481K)\n- Micellar electrokinetic chromatography of aminoglycosides\nU. Holzgrabe, S. Schmitt, F. Wienen, J. Wahl, in \"Capillary Electrophoresis - Methods and Protocols\" (Methods in Molecular Biology), Ed. Schmitt-Kopplin, Im Druck (2016)\n- Ionic liquids in Capillary Electrophoreses\nU. Holzgrabe, J. Wahl in \"Capillary Electrophoresis - Methods and Protocols\" (Methods in Molecular Biology), Ed. Schmitt-Kopplin, im Druck (2016)\n- Routine Quality Control of Medicines in Developing Countries: Analytical Challenges, Regulatory Infrastructures and the Prevalence of Counterfeit Medicines in Tanzania\nL. Hoellein, E. Kaale, Y. H. Mwalwisi, M. H. Schulze, U. Holzgrabe, TrAC, 76, 60-70 (2015)\n[doi:10.1016/j.trac.2015.11.009](http://dx.doi.org/10.1016/j.trac.2015.11.009)\n- Tamper-proof tablets for distinction between counterfeit and originator drugs through PEG coating\nD. Ilko, C. Steiger, R. Keller, U. Holzgrabe, L. Meinel, Eur. J. Pharm. Biopharm., 99, 1-6 (2016)\n[doi:10.1016/j.ejpb.2015.11.009](http://dx.doi.org/10.1016/j.ejpb.2015.11.009)\n- Impurity profiling of l-methionine by HPLC on a mixed mode column\nR. K\u00fchnreich, U. Holzgrabe, J. Pharm. Biomed. Anal., 122, 118-125 (2016)\n[doi:10.1016/j.jpba.2016.01.057](http://dx.doi.org/10.1016/j.jpba.2016.01.057)\n- Amino acid analysis for pharmacopoeial purposes\nO. Wahl, U. Holzgrabe, Talanta, 154, 150-163 (2016)\n[doi:10.1016/j.talanta.2016.03.071](http://dx.doi.org/10.1016/j.talanta.2016.03.071)\n- Natur h\u00e4ufig Vorbild\nU. Holzgrabe, G. Hiltensperger, J. Glaser, F. Seufert, L. Meinel, Nachrichten aus der Chemie, 64, 605-609 (2016)\n[doi:10.1002/nadc.20164046023](http://dx.doi.org/10.1002/nadc.20164046023)\n- Comparison of Pantoprazole Concentrations in Simultaneous Cerebrospinal Fluid and Serum Sample\nA. Sigaroudi, C. Stelzer, T. Braun, S. Frechen, S. H\u00fcttner, M. Schr\u00f6ter, M. Kinzig, U. Fuhr, U. Holzgrabe, F. S\u00f6rgel, Pharmacology, 98, 70-72 (2016)\n[doi:10.1016/j.talanta.2016.03.071](http://dx.doi.org/10.1016/j.talanta.2016.03.071)\n- Bistacrine derivatives as new potent antimalarials\nI. Schmidt, G. Pradel, L. Sologub, A. Golzmann, C. J. Ngwa, A. Kucharski, T. Schirmeister, U. Holzgrabe, Bioorg. Med. Chem., 24, 3636-36423 (2016)\n[doi:10.1016/j.bmc.2016.06.003](http://dx.doi.org/10.1016/j.bmc.2016.06.003)\n- Quinolone amides as anti-trypanosomal lead compounds with in vivo activity\nG. Hiltensperger, N. Hecht, M. Kaiser, J. C. Rybak, A. Hoerst, N. Dannenbauer, K. M\u00fcller-Buschbaum, H. Bruhn, H. Esch, L. Lehmann, L. Meinel, U. Holzgrabe, Antimicrob. Agents Chemother., 60, 4442-4452 (2016)\n[doi:10.1128/AAC.01757-15](http://dx.doi.org/10.1128/AAC.01757-15)\n- Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-Coupled Receptor\nA. Bock, M. Bermudez, F. Krebs, C. Matera, B. Chirinda, D. Sydow, C. Dallanoce, U. Holzgrabe, M. De Amici, M. J. Lohse, G. Wolber, K. Mohr, J. Biol. Chem., 291, 16375-16389 (2016)\n[doi:10.1016/j.bmc.2016.06.003](http://dx.doi.org/10.1074/jbc.M116.735431)\n- Indirect enantioseparation of amino acids by CE using automated in-capillary derivatization with ortho-phthalaldehyde and a chiral thiol\nR. K\u00fchnreich, U. Holzgrabe, Chromatographia, 79, 1013-1022 (2016)\n- Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity\nA. Reimer, F. Seufert, M. Weiwad, J. Ebert, N. M. Bzdyl, C. M. Kahler, M. Sarkar-Tyson, U. Holzgrabe, T. Rudel V. Kozjak-Pavlovic, Int. J. Antimicrob. Agents, available online (2016)\n[doi:10.1016/j.ijantimicag.2016.06.020](http://dx.doi.org/10.1016/j.ijantimicag.2016.06.020)\n- Development of a Simple, Rapid and Robust Liquid Chromatographic Method for the Simultaneous Determination of Sulfalene, Sulfadoxine and Pyrimethamine in Tablets\nY. H. Mwalwisi, L. Hoellein, E. Kaale, U. Holzgrabe, J. Pharm. Biomed. Anal., 129, 558-570 (2016)\n[doi:10.1016/j.jpba.2016.07.044](http://dx.doi.org/10.1016/j.jpba.2016.07.044)\n- Development, synthesis and structure-activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei\nF. Seufert, M. Kuhn, M. Hein, M. Weiwad, M. Vivoli, I. H. Norville, M. Sarkar-Tyson, L. E. Marshall, H. Bruhn, N. J. Harmer, C. A. Sotriffer, U. Holzgrabe, Bioorg. Med. Chem., available online\n[doi:10.1016/j.bmc.2016.08.025](http://10.1016/j.bmc.2016.08.025)\n- Impurity profiling of L-asparagine monohydrate by Ion Pair Chromatography Applying Low Wavelength UV detection\nK. Schilling, M. C. Amstalden, L. Meinel, U. Holzgrabe, J. Pharm. Biomed. Anal., 131, 202-207 (2016)\n[doi:10.1016/j.jpba.2016.08.035](http://dx.doi.org/10.1016/j.jpba.2016.08.035)\n- High-performance liquid chromatography evaluation of the enantiomeric purity of amino acids by means of automated precolumn derivatization with ortho-phthalaldehyde and chiral thiols\nR. K\u00fchnreich, U. Holzgrabe, Chirality, 28, 795-804 (2016)\n- Pharmakoikinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin\nF. S\u00f6rgel, R. H\u00f6hl, R. Glaser, C. Stelzer, M. Munz, M. Vormittag, M. Kinzig, J. Bulitta, C. Landersdorfer, A. Junger, M. Crist, M. Wilhelm, U. Holzgrabe, Med. Klin. Intensivmed. Notfmed. (2016)\n[doi: 10.1007/s00063-016-0185-5](http://dx.doi.org/10.1007/s00063-016-0185-5)\n- Oxime Ethers of (E)-11-Isonitrosostrychnine as Highly Potent Glycine Receptor Antagonists\nA. M. Y. Mohsen, Y. M. Mandour, E. Sarukhanyan, U. Breitinger, C. Villmann, M. M. Banoub, H.-G. Breitinger, T. Dandekar, U. Holzgrabe, Christoph Sotriffer, A. A. Jensen, D.P. Zlotos, J. Nat. Prod. 79, 2997-3005 (2016)\n- Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1\nU. Holzgrabe, M. Decker, Expert Opin. Ther. Pat. 27, 121-125 (2016)\n- Design of bitopic ligands of the muscarinic receptor\nU. Holzgrabe, M. Decker, Exp. Opin. Therapeut. Patents, 27, 121-125 (2017)\n[doi: 10.1080/13543776.2017.1272577](http://doi.org/10.1080/13543776.2017.1272577)(Invitation)\n- Counterfeit drugs studied by NMR\nU. Holzgrabe, In: Lindon, J.C., Tranter, G.E. and Koppenaal, D.W. (eds.) Encyclopedia of Spectroscopy and Spectrometry, 3rd Edition, vol 1, pp. 393-395 Oxford: Elsevier (2017)\n- Engineered context-sensitive agonism \u2013 tissue-selective drug signaling through a G protein-coupled receptor\nW.K. Seemann, D. Wenzel, R. Schrage, J. Etscheid, T. B\u00f6defeld, A. Bartol, M. Warnken, P. Sasse, J. Kl\u00f6ckner, U. Holzgrabe, M. DeAmici, E. Schlicker, K. Racke, E. Kostenis, R. Meyer, B.K. Fleischmann, K. Mohr, J. Pharmacol.Exp. Therap. 360, 289-299 (2017)\n[doi: 10.1124/jpet.116.237149 6](http://doi.org/10.1124/jpet.116.237149)\n- Characterization of Complexes between Phenethylamine Enantiomers and \u00df-Cylcodextrin Derivatives by Capillary Electrophoresis \u2013 Determination of Binding Constants and Complex Mobilities\nJ. Wahl, T. Furuishi, E. Yonemochi, L. Meinel, U. Holzgrabe, Electrophoresis, 38, 188-1200 (2017)\n- FRET Studies of Rational Designed Quinolone Based Bitopic Ligands and their Derivatives: A Systematic Approach of Partial Agonism and Allosteric Modulation on the Muscarinic M1 Receptor\nR. Messerer, M. Kauk, D. Volpato, M.C. Alonso Canizal, J. Kloeckner, S. Nuber, C. Hoffmann, U. Holzgrabe, ACS Chem. Biol. 12, 833-843 (2017)\n- A new molecular mechanism to promote protean agonism at a G protein-coupled receptor\nA. De Min, C. Matera, A. Bock, J. Holze, J. Kl\u00f6ckner, M. De Amici, M. Muth, T. Kenakin, U. Holzgrabe, C. Dallanoce, E. Kostenis, R. Schrage, K. Mohr, Mol. Pharmacol. 91, 348-356 (2017)\n- Opening NADPH oxidase inhibitors for in vivo translation\nN. Hecht, N. Terveer, C. Schollmayer, U. Holzgrabe, L. Meinel, Eur. J. Pharmaceutics. Biopharmaceutics. 115, 206-217 (2017)\n- Inter-laboratory Comparison Test as Evaluation of Applicability of an Alternative Edible Oil Analysis by 1H-NMR Spectroscopy\nE. Zailer, U. Holzgrabe, B. W. K. Diehl, J. AOAC Int., accepted manuscript\n- The first photoswitchable dualsteric ligand controlling receptor efficacy\nL. Agnetta, M. Kauk, M. C. A. Canizal, R. Messerer, U. Holzgrabe, C. Hoffmann, M. Decker, Angew. Chem. 129, 1-7 (2017)\n[doi: 10.1002/ange.201701524](http://doi.org/10.1002/ange.201701524)\n- 3-(2-Chloropyridin-3yl)-(1H,3H)-quinazoline-2,4-dione chloroform monosolvate\nN. S. Riad, E. Heller, D. P. Zlotos, U. Holzgrabe (2017) Acta Cryst Sect E., accepted manuscript\n- Novel Bipharmacophoric Inhibitors of the cholinesterases with affinity to the Muscarinic M1 and M2 Receptors\nR. Messerer, C. Dallanoce, C. Matera, S. Wehle, L. Flammini, B. Chirinda, A. Bock, M. Irmen, Tr\u00e4nkle, E. Barocelli, M. Decker, C. Sotriffer, M. De Amici, U. Holzgrabe (2017) MedChemComm, accepted manuscript\n[doi: 10.1039/c7md00149e](http://doi.org/10.1039/c7md00149e)\n- Ugi reaction-derived a-acyl aminocarboxamides bind to PI 3-kinase-related kinases, inhibit HSF1-dependent heat shock response, and induce apoptosis in multiple myeloma cells\nM. Bach, A. Lehmann, D. Br\u00fcnnert, J. T. Vanselow, A. Hartung, R. C. Bargou, Ulrike Holzgrabe, A. Schlosser, M. Chatterjee (2017) J. Med. Chem. online\n[doi: 10.1021/acs.jmedchem.6b01613](https://doi.org/10.1021/acs.jmedchem.6b01613)\n- Crystal structure of cis-4-fluoro-3-(4-methoxyphenyl)-1-oxo-2-phenyl-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid\nA. Lehmann, L. Lechner, K. Radacki, H. Braunschweig, U. Holzgrabe (2017) Acta Cryst Sect E. su5371\n- Current role and future perspectives of multivariate (chemometric) methods in NMR spectroscopic analysis of pharmaceutical products\nY. B. Monakhova, U. Holzgrabec, B. W. K. Diehl (2017) J. Pharm. Biomed. Anal. (im Druck)\n[doi: 10.1016/j.jpba.2017.05.034](http://doi.org/10.1016/j.jpba.2017.05.034)\n- Ligand-specific restriction of extracellular conformational dynamics constrains signaling of the M2 muscarinic receptor\nM. Bermudez, A. Bock, F. Krebs, U. Holzgrabe, K. Mohr, M.J. Lohse, G. Wolber (2017) ACS Chem. Biol, 12, 1743-1748\n[doi: 10.1021/acschembio.7b00275](http://doi.org/10.1021/acschembio.7b00275)\n- Development and Validation of a High-Performance Thin-Layer Chromatography Method for the Determination of Artesunate and Amodiaquine in Tablet Formulations\nY. H. Mwalwisi, S. C. Omolo, L. H\u00f6llein, D. H. Shewijo, U. Holzgrabe, E. Kaale (2017) J Planar Chromatogr. 30, 307-312\n- Development of a Simple, Rapid, and Robust Isocratic Liquid Chromatographic Method for the Determination of Pyrimethamine and its Synthetic Impurities in Bulk Drugs and Pharmaceutical Formulations\nY. H. Mwalwisi, L. H\u00f6llein, E. Kaale, U. Holzgrabe (2017) Chromatographia, 80, 1343-1352\n- Oxidative dehydrogenation of C-C and C-N bonds: A convenient approach to access diverse heteroaromatic compounds\nS. Hati, U. Holzgrabe, S. Sen (2017) Beilstein J. Org. Chem. 13, 1670-1692 (\u00dcbersicht)\n- Novel lead compounds in pre-clinic development against African Sleeping Sickness\nM. Berninger, A. Ponte-Sucre, U. Holzgrabe (2017) MedChemComm 8, 1872-1890\n[doi: 10.1039/C7MD00280G](http://doi.org/doi:)\n- Quantification of bisoprolol and metoprolol in simultaneous human serum and cerebrospinal fluid samples\nA. Sigaroudi, M. Kinzig, O. Wahl, M. Schr\u00f6ter, C. Stelzer, U. Fuhr, U. Holzgrabe, F. S\u00f6rgel (2017) Pharmacology, 101, 29-34\n- Isolation of a novel compound (MIMO2) from the methanolic extract of Moringa oleifera leaves: protective effects against vanadiuminduced cytotoxicity\nO. O. Igado, J. Glaser, M. Ramos-Tirado, E.E. Bankoglu, F.A. Atiba, U. Holzgrabe, H. Stopper, J.O. Olopade, Drug Chem. Toxicol. 41, 249-258 (2018)\n[doi: 10.1080/01480545.2017.1366504](http://doi.org/10.1080/01480545.2017.1366504)\n- A miniaturized peptidyl-prolyl isomerase enzyme assay\nM. Vivoli, J. Renou, A. Chevalier, I. H. Norville, S. Diaz, C. Juli, U. Holzgrabe, P.-Y. Renard, M. Sarkar-Tyson, N. J. Harmer (2017) Analyt. Biochem. 536, 59-68\n- Severe drug-induced liver injury as adverse drug event of antibiotics \u2013 a case report and review of the literature\nM. Munz, H. Grummich, J. Brikmann, M. Wilhelm, U. Holzgrabe, F. S\u00f6rgel (2017) Chemotherapy, 62, 367-373\n- A diversity oriented synthesis of natural product inspired molecular libraries\nJ. Chauhan, T. Luthra, R. Gundla, A. Ferraro, U. Holzgrabe, S. Sen (2017) Org. Biomol. Chem., im Druck\n-\nCapillary Electrophoresis Separation of Phenethylamine Enantiomers using Amino Acid based Ionic Liquids\nJ. Wahl, U. Holzgrabe (2018) J. Pharm. Biomed. Anal., 30, 245-250\n[doi: 10.1016/j.jpba.2017](https://10.1016/j.jpba.2017)\n- 2-Amino-N-(2-chloropyridin-3yl)benzamide\nN. M. Riad, D. P. Zlotos*, U. Holzgrabe,\n[IUCrData](http://iucrdata.iucr.org/x/issues/2017/04/00/)\n- Mapping the pharmaceutical design space by amorphous ionic liquid strategies\nJ. Wiest, M. Saedtler, A. Balk, B. Merget, T. Widmer, H. Bruhn, M. Raccuglia, E. Walid, F. Picard, H. Stopper, W. Dekant, T. L\u00fchmann, C. Sotriffer, B. Galli, U. Holzgrabe, L. Meinel, J. Controlled Release 268, 314-322 (2017)\n[doi: 10.1016/j.jconrel.2017](https://10.1016/j.jconrel.2017)\n- Improving Anti-trypanosomal Activity of Alkamides Isolated from Achillea Fragrantissima\nJ. Skaf, O. Hamarsheh, S. Balasubramanian, T. \u00d6lschl\u00e4ger, U. Holzgrabe, Fitoterapia, 125, 191-198 (2018)\n[doi: 10.1016/j.fitote.2017](https://10.1016/j.fitote.2017)\n- Stability and assessment of amino acids in parenteral nutrition solutions\nN. Unger, U. Holzgrabe, J. Pharm. Biomed. Anal. (invited review), 147, 125-139 (2018)\n[doi: 10.1016/j.jpba.2017.07.064](https://doi.org/10.1016/j.jpba.2017.07.064)\n- Current role and future perspectives of multivariate (chemometric) methods in NMR spectroscopic analysis of pharmaceutical products\nY. B. Monakhova, U. Holzgrabe, B.W.K. Diehl, J. Pharm. Biomed. Anal. 147, 580-589 (2018)\n[doi: 10.1016/j.jpba.2017.05.034](https://doi.org/10.1016/j.jpba.2017.05.034)\n- Quantification of bisoprolol and metoprolol in simultaneous human serum and cerebrospinal fluid samples\nA. Sigaroudi, M. Kinzig, O. Wahl, M. Schr\u00f6ter, C. Stelzer, U. Fuhr, U. Holzgrabe, F. S\u00f6rgel, Pharmacology, 101, 29-34 (2018)\n[doi: 10.1159/000480091](https://doi.org/10.1159/000480091)\n- A novel mechanism of inactivation antibacterial nitro compounds in the human pathogen Staphylococcus aureus by overexpression of a Flavin-dependent nitroreductase\nE. El Hossary, J. Schrenzel, K. Streker, K. F\u00f6rstner, K. Ohlsen, U. Holzgrabe, Anitmicrob. Agents Chemother., 62, e1510-17 (2018)\n[doi: 10.1128/AAC.01510-17](https://doi.org/10.1128/AAC.01510-17)\n- NMR Spectroscopy, Application, identification of counterfeit drugs and herbal medicines\nU. Holzgrabe, Encyclopedia of Analytical Science 3rd Ed. Section Molecular spectrometry, Ed.: P. Worsfold, C. Pool, A. Townshend, M. Miro.\n- Azathioprine induced reversible EBV-associated Hodgkin-like lymphoma after immunosuppressive therapy for autoimmune hepatitis\nM. Munz, D. Pretscher, M. Wilhelm, U. Holzgrabe, F. S\u00f6rgel, J. Birkmann, Int. J. Clin. Pharmacol. Therap. 5, :142-147 (2018)\n[doi: 10.5414/CP203106](https://doi.org/10.5414/CP203106)\n- Impurity profiling of N,N\u2019-ethylenebis-L-cysteine diethyl ester (Bicisate)\nJ. Cleynhens, A. Verbruggen, U. Holzgrabe, O. Wahl, J. Pharm. Biomed. Anal. 150, 132-136 (2018)\ndoi:\n[10.1016/j.jpba.2017.11.078](https://doi.org/10.1016/j.jpba.2017.11.078)\n- The influence of Osmunda regalis root extract on head and neck cancer cell proliferation, invasion and gene expression\nM. Schmidt, J. Skaf; G. Gavril, C. Polednik, J. Roller, M. Kessler; U, Holzgrabe, BMC Complementary Alternative Medicine, 17, 518 (2017)\n[doi: 10.1186/s12906-017-2009-4](https://doi.org/10.1186/s12906-017-2009-4)\n- Capillary Electrophoresis Separation of Phenethylamine Enantiomers using Amino Acid based Ionic Liquids\nJ. Wahl, U. Holzgrabe, J. Pharm. Biomed. Anal. 148, 245-250 (2018)\n[doi: 10.1016/j.jpba.2017.10.010](https://doi.org/10.1016/j.jpba.2017.10.010)\n- A stability-study of expired ampoules manufactured more than 40 years ago\nM. Zilker, F. S\u00f6rgel, U. Holzgrabe, J. Pharm. Biomed. Anal., 150, 318-326 (2018)\n[doi: 10.1016/j.jpba.2017.12.019](https://doi.org/10.1016/j.jpba.2017.12.019)\n- Enhanced fluorescence resonance energy transfer in G protein-coupled receptor probes by nano-coated microscopy coverslips\nB. Schreiber, M. Kauk, H. S. Heil, M. Emmerling, M. Kamp, S. H\u00f6fling, U. Holzgrabe, C. Hoffmann, K. G. Heinze; ACS Photonics, 5, 2225-2233 (2018)\n[doi: 10.1021/acsphotonics.8b00072](https://doi.org/10.1021/acsphotonics.8b00072)\n- Development and Validation of Simplified High-Performance Thin-Layer Chromatography Densitometric methods for the Determination of Sulfalene, Sulfadoxine, and Pyrimethamine\nY. H. Mwalwisi, L. H\u00f6llein, D.H. Shewiyo, U. Holzgrabe, E. Kaale, J. Planar Chromatogr. 31, 290-296 (2018)\n[doi: 10.1556/1006.2018.31.4.4](https://doi.org/10.1556/1006.2018.31.4.4)\n- Fluorine Walk: The Impact of Fluorine in Quinolone Amides on their Activity Against African Sleeping Sickness\nM. Berninger, C. Erk, A. Fu\u00df, J. Skaf, E. Al-Momani, I. Isreal, M. Raschig, P. G\u00fcntzel, S. Samnick, U. Holzgrabe, Eur. J. Med. Chem., 152, 377-391 (2018)\n[doi: 10.1016/j.ejmech.2018.04.005](https://doi.org/10.1016/j.ejmech.2018.04.055)\n- A convenient preparation of carboxy-\u03b3-pyrone derivatives: meconic acid and comenic acid\nP. G\u00fcntzel, L. Forster, C. Schollmayer, U. Holzgrabe, Org. Prep. Proced. Int, 50, 512-516 (2018)\n[doi: 10.1080/00304948.2018.1525990](https://doi.org/10.1080/00304948.2018.1525990)\n- Bioinspired co-crystals of Imatinib providing enhanced kinetic solubility\nM. Reggane; J. Wiest, M. Saedtler, C. Harlacher, M. Gutmann, S. Zottnick P. Piechon, I. Dix, K. Mueller-Buschbaum, U. Holzgrabe, L. Meinel, B. Galli, Eur. J. Pharmaceutics Biopharmaceutics, 128, 290-299 (2018)\n[doi: 10.1016/j.ejpb.2018.05.012](https://doi.org/10.1016/j.ejpb.2018.05.012.)\n- Synthesis and evaluation of antitrypanosomal activity of some thiosemicarbazide derivatives of 1-butyl-6-fluoro-7-morpholino-4-oxo-1,4-dihydroquinoline-3-carboxylic acid\nA. Pyrih, M. Berninger, A. Gzella, R. Lesyk, U. Holzgrabe, Synthetic Communications, 48, 1883-1891 (2018)\n[doi: 10.1080/00397911.2018.1476889](https://doi.org/10.1080/00397911.2018.1476889)\n-\nQuantification of hydrochlorothiazide and ramipril / ramiprilate in blood serum and cerebrospinal fluid: a pharmacokinetic assessment of central nervous system adverse effects\nA. Sigaroudi, M. Kinzig, O. Wahl, C. Stelzer, M. Schroeter, U. Fuhr, U. Holzgrabe, F. S\u00f6rgel, Pharmacology 102, 133-137 (2018)\n[doi: 10.1159/000489999](https://doi.org/10.1159/000489999)\n- Capillary zone electrophoresis for the determination oof amodiaquine and three of its impurities in pharmaceutical formulations.\nJ.P. Mufusama, L. H\u00f6llein, D. Feineis, U. Holzgrabe, G. Bringmann, Electrophoresis, 39(20):2530-2539 (2018)\n[doi: doi.org/10.1002/elps.201800170](https://doi.org/10.1002/elps.201800170)\n- Quality of antimalarial medicines from the Democratic Republic of the Congo: A nationwide survey\nJ-P. Mufusama, K. Ndjoko Ioset, U. Holzgrabe, G. Bringmann, Drug Testing Anal. 10(10):1599-1606 (2018)\n[doi: 10.1002/dta.2420](https://doi.org/10.1002/dta.2420)\n- A new bioactive compound from the marine sponge-derived Streptomyces sp. SBT348 inhibits staphylococcal growth and biofilm formation\nS. Balasubramanian, J. Skaf, U. Holzgrabe, R. Bharti, K. Foerstner, W. Ziebuhr, U. Hentschel, U. R. Abdelmohsen, T.A. Oelschlaeger, Frontier Microbiology, 9 (2018) Article 1473\n[doi: 10.3389/fmicb.2018.01473](https://doi.org/10.3389/fmicb.2018.01473)\n- Characterization of polydisperse macrogols and macrogol-based excipients via HPLC and charged aerosol detection\nChristiane Theiss, U. Holzgrabe, J. Pharm. Biomed. Anal., 25, 212-222 (2018)\n[doi: 10.1016/j.jpba.2018.07.043](https://doi.org/10.1016/j.jpba.2018.07.043)\n-\nFirst population pharmacokinetic report on increased metabolite formation and clearance of fleroxacin in cystic fibrosis patients compared to healthy volunteers\nY. Jiao, T. H. Kim, X. Tao, M. Kinzig, C. B. Landersdorfer, S. K. Drescher, D. S. Sutaria, B. Moya, U. Holzgrabe, F. S\u00f6rgel, J. B. Bulitta, Eur.J. Pharm. Sci. 123, 416-428 (2018)\n[doi: 10.1016/j.ejps.2018.07.054](https://doi.org10.1016/j.ejps.2018.07.054)\n-\nFuture information technology tools for fighting substandard and falsified medicines in low- and middle-income countries\nH. Rasheed, L. H\u00f6llein, U. Holzgrabe, Front. Pharmacol. 9 (2018) Artikel 995\n[doi: 10.3389/fphar.2018.00995](https://doi.org/10.3389/fphar.2018.00995)\n-\nGeometrical and structural dynamics of Imatinib within biorelevant colloids\nJ. Wiest, M. Saedtler, B. B\u00f6ttcher, M. Gr\u00fcne, M. Reggane, B. Galli, U. Holzgrabe, L. Meinel, Mol. Pharmaceutics, 15, 4470-4480 (2018)\n[doi: 10.1021/acs.molpharmaceut.8b00469](https://doi.org/10.1021/acs.molpharmaceut.8b00469)\n-\nInfluence of charged aerosol detector instrument settings on the ultra-high-performance liquid chromatography analysis of fatty acids in polysorbate 80\nK.Schilling, R. Pawellek, K. Lovejoy, T. Muellner, U. Holzgrabe, J. Chromatogr. A1576, 58-66 (2018)\n[doi: 10.1016/j.chroma.2018.09.031](https://Doi.org/10.1016/j.chroma.2018.09.031)\n-\nDetermination of plasma protein binding for sympathomimetic drugs by means of ultrafiltration\nM. Volpp, U. Holzgrabe, Eur. J. Pharm. Sci., 127, 175-184 (2018)\n[doi: 10.1016/j.ejps.2018.10.027](https://doi.org/10.1016/j.ejps.2018.10.027)\n-\nDesigning hybrids targeting the Cholinergic system: a concept to treat Alzheimer\u2019s disease\nD. Volpato, U. Holzgrabe, Molecules, 23, 3230 (2018)\n[doi: 10.3390/molecules23123230](https://doi.org/10.3390/molecules23123230)\n- Control of impurities in L-aspartic acid and L-alanine by high-performance liquid chromatography coupled with a corona charged-aerosol detector\nU. Holzgrabe, C.-J. Nap, S. Almeling. J. Chromatogr. A 1217, 294-301 (2010)\n[doi: 10.1016/j.chroma.2009.11.036](http://dx.doi.org/10.1016/j.chroma.2009.11.036)\n- Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid\nC. B Landersdorfer, C. M. J. Kirkpatrick, M. Kinzig, J. B. Bulitta, U. Holzgrabe, U. Jaehde, A.Reiter, K. G. Naber, M. Rodamer, F. S\u00f6rgel. Br. J. Clin. Pharmacol. 69, 167-178 (2010)\n[doi: 10.1111/j.1365-2125.2009.03564.x](http://dx.doi.org/10.1111/j.1365-2125.2009.03564.x)\n- The role of solvents in the signal separation for quantitative 1H NMR spectroscopy\nT. Beyer, C. Schollmayer, U. Holzgrabe. J. Pharm. Biomed. Anal. 52, 51-58 (2010)\n[doi: 10.1016/j.jpba.2009.12.007](http://dx.doi.org/10.1016/j.jpba.2009.12.007)\n- Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine and butyrylcholine esterases\nV. Alpt\u00fcz\u00fcn, M. Prinz, V. H\u00f6rr, J. Scheiber, K. Radacki, A. Fallarero, P. Vuorela, B. Engels, H. Braunschweig, E. Erciyas, U. Holzgrabe. Bioorg. Med. Chem. 18, 2049-2059 (2010)\n[doi: 10.1016/j.bmc.2010.01.002](http://dx.doi.org/10.1016/j.bmc.2010.01.002)\n- Allosteric Ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunities\nM. de Amici, C. Dallanoce, U. Holzgrabe, C. Tr\u00e4nkle, K. Mohr, Med. Res. Reviews 30, 463-549 (2010)\n[doi: 10.1002/med.20166](http://dx.doi.org/10.1002/med.20166)\n- Use of Evaporative Light Scattering Detection for the Quality Control of Drug Substances: Influence of different Liquid Chromatographic and Evaporative Light Scattering Detector parameters on the appearance of spike peaks\nS. Almeling, U. Holzgrabe, J. Chromatogr. A 1217, 2163-2170 (2010)\n[doi: 10.1016/j.chroma.2010.02.017](http://dx.doi.org/10.1016/j.chroma.2010.02.017)\n- Rational design of dualsteric GPCR ligands: quests and promise\nK. Mohr, C. Tr\u00e4nkle, E. Kostenis, E. Barocelli, M. De Amici, U. Holzgrabe, Br. J. Pharmacol. 159, 997-1008 (2010)\n[doi: 10.1111/j.1476-5381.2009.00601.x](http://dx.doi.org/10.1111/j.1476-5381.2009.00601.x)\n- Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers\nJ. B. Bulitta, C. B. Landersdorfer, J. J. H\u00fcttner, G.L. Drusano, M. Kinzig, U. Holzgrabe, F. S\u00f6rgel, Antimicrob. Agents Chemother. 54, 1275-1282 (2010)\n[doi: 10.1128/AAC.00936-09](http://dx.doi.org/10.1128/AAC.00936-09)\n- The bisnaphthalimides as new active lead compounds against Plasmodium falciparum\nM. Tischer, L. Sologubb, G. Pradel, U. Holzgrabe, Bioorg. Med. Chem. 18(9), 2998-3003 (2010) mit Titelbild\n[doi: 10.1016/j.bmc.2010.03.067](http://dx.doi.org/10.1016/j.bmc.2010.03.067)\n- Convergent, short synthesis of the muscarinic superagonist iperoxo\nJ. Kl\u00f6ckner, J. Schmitz, U. Holzgrabe, Tetrahedron Lett. 51, 3470-3472 (2010)\n[doi: 10.1016/j.tetlet.2010.04.130](http://dx.doi.org/10.1016/j.tetlet.2010.04.130)\n- Composition of OSCS-contaminated Heparin Occurring 2008 in Batches on the German Market\nT. Beyer, M. Matz, D. Brinz, O. R\u00e4dler, B. Wolf, J. Norwig, K. Baumann, S. Alban, U. Holzgrabe, Eur. J. Pharm. Sci. 40(4), 297-304 (2010)\n[doi: 10.1016/j.ejps.2010.04.002](http://dx.doi.org/10.1016/j.ejps.2010.04.002)\n- Magnetic Resonance: Quantitative NMR - Method and Applications. In: Encyclopedia of Spectroscopy and Spectrometry, 2nd Ed.\nU. Holzgrabe (Einladung)\nEd. J.C. Lindon, Elsevier, Kidlington, Oxford; UK, 2331-2339 (2010)\n- 4-{(2E)-(4-Chlorobenzylidene)hydrazinylidene}-1-methyl-1,4-dihydropyridine monohydrate\nA. Aydin, M. Akkurt, V. Alpt\u00fcz\u00fcn, O. B\u00fcy\u00fckg\u00fcng\u00f6r, U. Holzgrabe, K. Radacki, Acta Crystallographica Section E66, o1324-o1325 (2010)\n- Quantitative NMR Spectroscopy in Pharmaceutical Applications\nU. Holzgrabe, Progress in Nuclear Magnetic Resonance Spectroscopy 57, 229-240 (2010)\n[doi: 10.1016/j.pnmrs.2010.05.001](http://dx.doi.org/10.1016/j.pnmrs.2010.05.001)\n- Online monitoring of microwave-enhanced reactions using UV/Vis spectroscopy\nE. Heller, J. Kl\u00f6ckner,W. Lautenschl\u00e4ger, U. Holzgrabe, Eur. J. Org. Chem. 19, 3569-3573 (2010)\n[doi: 10.1002/ejoc.201000441](http://dx.doi.org/10.1002/ejoc.201000441)\n- Comparison of chiral electrophoretic separation methods for phenethylamines and application on impurity analysis\nC. Borst, U. Holzgrabe, J. Pharm. Biomed. Anal. 53(5), 1201-1209 (2010)\n[doi: 10.1016/j.jpba.2010.06.025](http://dx.doi.org/10.1016/j.jpba.2010.06.025)\n- Alternatives to amino acid analysis for the purity control of pharmaceutical grade L-alanine\nU. Holzgrabe, C. J. Nap, T. Beyer, S. Almeling, J. Sep. Sci. 33(16), 2402-2410 (2010)\n[doi: 10.1002/jssc.201000141](http://dx.doi.org/10.1002/jssc.201000141)\n- System suitability criteria and parameters in capillary zone electrophoresis in the European pharmacopoeia\nC. B\u00fcttner-Merz, U. Holzgrabe, Pharmeuropa 22, 257-262 (2010)\n- Nonlinear pharmacokinetics of piperacillin in healthy volunteers - implications for optimal dosage regimens.\nJ. B. Bulitta, M. Kinzig V. Jakob, U. Holzgrabe, F. S\u00f6rgel, N. H. G. Holford, Br. J. Clin. Pharmacol. 70, 682-693 (2010)\n[doi: 10.1111/j.1365-2125.2010.03750.x](http://dx.doi.org/10.1111/j.1365-2125.2010.03750.x)\n- Quantitative NMR spectroscopy of biologically active substances and excipients\nT. Beyer, B. Diehl, U. Holzgrabe (Einladung), Bioanalytical Reviews 2, 1-22 (2011)\n[doi: 10.1007/s12566-010-0016-8](http://dx.doi.org/10.1007/s12566-010-0016-8)\n- N-(3-cyanophenyl)-2-phenylacetamide, an effective inhibitor of the Morbillivirus-induced membrane fusion with low cytotoxicity\nK. Singethan, G. Hiltensperger, S. Kendl, J. Wohlfahrt, P. Plattet, U. Holzgrabe, and J. Schneider-Schaulies, J. Gen. Virol. 91, 2762-2772 (2010)\n[doi: 10.1099/vir.0.025650-0](http://dx.doi.org/10.1099/vir.0.025650-0)\n- Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples\nS. Alban*, S. L\u00fchn, S. Schiemann, T. Beyer, J. Norwig, C. Schilling, O. R\u00e4dler, B. Wolf, M. Matz, K. Baumann*, U. Holzgrabe*, Anal. Bioanal. Chem. 399, 605-620 (2011)\n[doi: 10.1007/s00216-010-4169-7](http://dx.doi.org/10.1007/s00216-010-4169-7)\n- Mode of action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus\nT. M. Menzel, M. Tischer, P. Fran\u00e7ois, J. Nickel, J. Schrenzel, H. Bruhn, A. Albrecht, L. Lehmann, U. Holzgrabe, K. Ohlsen, Antimicrob. Agents Chemother. 55, 311-320 (2011)\n[doi:10.1128/AAC.00586-10](http://dx.doi.org/10.1128/AAC.00586-10)\n- Valeriana wallichii root extracts and fractions with activity against Leishmania spp.\nS. Ghosh, S. Debnath, S. Hazra, A. Hartung, K. Thomale, M. Schultheis, P. Kapkova, U. Schurigt, H. Moll, U. Holzgrabe, B. Hazra, Parasitol. Res. 108, 864-871 (2011)\n[doi: 10.1007/s00436-010-2127-0](http://dx.doi.org/10.1007/s00436-010-2127-0)\n- Pipecolic Acid Derivatives As Small-Molecule Inhibitors of the Legionella MIP Protein\nC. Juli, M. Sippel, J. J\u00e4ger, A. Thiele, M. Weiwad, K. Schweimer, P. R\u00f6sch, M. Steinert, C. A. Sotriffer, and U. Holzgrabe, J. Med. Chem. 54, 277-283 (2011)\n[doi: 10.1021/jm101156y](http://dx.doi.org/10.1021/jm101156y)\n- Fentons oxidation: a tool for the investigation of potential drug metabolites\nE. Kugelmann, C. R. Albert, G. Bringmann, and U. Holzgrabe, J. Pharm. Biomed. Anal. 54, 1047-1058 (2011)\n[doi: 10.1016/j.jpba.2010.12.016](http://dx.doi.org/10.1016/j.jpba.2010.12.016)\n- Analytical challenges in drug counterfeiting and falsificationthe NMR approach\nU. Holzgrabe, and M. Malet-Martino, J. Pharm. Biomed. Anal. 55(4), 679-687 (2011)\n[doi: 10.1016/j.jpba.2010.12.017](http://dx.doi.org/10.1016/j.jpba.2010.12.017)\n- NMR techniques in biomedical and pharmaceutical analysis\nM. Malet-Martino, and U. Holzgrabe, J. Pharm. Biomed. Anal. 55, 1-15 (2011)\n[doi: 10.1016/j.jpba.2010.12.023](http://dx.doi.org/10.1016/j.jpba.2010.12.023)\n- Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers\nJ. B. Bulitta, M. Kinzig, C. B. Landersdorfer, U. Holzgrabe, U. Stephan, F. S\u00f6rgel, Antimicron. Agents Chemother. 55(6), 2927-2936 (2011)\n[doi: 10.1128/AAC.01484-10](http://dx.doi.org/10.1128/AAC.01484-10)\n- Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells\nA. Cecil, C. Rikanovic, K. Ohlsen, C. Liang, J. Bernhardt, T. A. Oelschl\u00e4ger, T. Gulder, G. Bringmann, U. Holzgrabe, M. Unger, T. Dandekar, Genome Biol. 12, R24 (2011)\n[doi: 10.1186/gb-2011-12-3-r24](http://dx.doi.org/10.1186/gb-2011-12-3-r24)\n- Use of collision induced dissociation mass spectrometry sa a rapid technique for the identification of pharmacologically active peptides in compendial testing\nU. Holzgrabe, C.-J. Nap, S. Almeling, Antimicrob. Agents Chemother. 55(5), 957-963 (2011)\n[doi: 10.1016/j.jpba.2011.03.031](http://dx.doi.org/10.1016/j.jpba.2011.03.031)\n- An LC-MS/MS procedure for the quantification of naproxen in human plasma: development, validation, comparison with other methods, and application to a pharmacokinetic study\nP. W. Elsinghorst, M. Kinzig, M. Rodamer, U. Holzgrabe, F. S\u00f6rgel, J. Chromatogr. B 879, 1686-1696 (2011)\n[doi: 10.1016/j.jchromb.2011.04.012](http://dx.doi.org/10.1016/j.jchromb.2011.04.012)\n- Identification and control of impurities in streptomycin sulfate by high-performance liquid chromatography coupled with mass detection and corona charged-aerosol detection\nU. Holzgrabe, C-J. Nap, N. Kunz, S. Almeling, J. Pharm. Biomed. Anal. 56(2), 271-279 (2011)\n[doi:10.1016/j.jpba.2011.05.027](http://dx.doi.org/10.1016/j.jpba.2011.05.027)\n- How to evaluate the separation efficiency of CZE methods?\nC. B\u00fcttner-Merz, U. Holzgrabe, Pharmeuropa Sci. Notes 2011-1, 81-88, (2011)\n- Poor manufacturing practices and the problem of substandard medicines in sub-Saharian Africa\nN. Bah-Traore, L. Hoellein, J. B\u00e4umert, H.G. Schweim, U. Holzgrabe,Scrip Regulatory Affairs, Nov. (2011)\n- Assessment of the performance of an NMR assay for the determination of hydroperoxides in Lipids\nC. Skiera, P. Steliopoulos, U. Holzgrabe, B. Diehl, Magn. Res. Food Sci. 332, Proceedings of the 10th Anniversary of International Conference on the Application of Magnetic Resonance in Food Science, (332), 124-125, (2012)\n[doi: 10.1039/9781849732994-00124](http://dx.doi.org/10.1039/9781849732994-00124)\n- A new synthetic approach to pentacyclic Ring, 6,7,14,15-Tetrahydro[1,5]diazocino[1,2-a:6,5-a]-8-dihydrodiindole\nK. Sripha,* D.P. Zlotos, U. Holzgrabe, and S. Ruchirawat, Heterocycles 83(11), 2627-2633, (2011)\n[doi: 10.3987/COM-11-12340](http://dx.doi.org/10.3987/COM-11-12340)\n- Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions?\nM. Tischer, G. Pradel, K. Ohlsen, U. Holzgrabe, ChemMedChem (Einladung) 7(1), 22-31, (2012)\n[doi: 10.1002/cmdc.201100404](http://dx.doi.org/10.1002/cmdc.201100404)\n- Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation\nD. Karlsson, A. Fallarero, G. Brunhofer, P. Guzik, M. Prinz, U. Holzgrabe, T. Erker, P. Vuorela, Eur. J. Pharm. Sci. 45(1-2), 169-183, (2012)\n[doi: 10.1016/j.ejps.2011.11.004](http://dx.doi.org/10.1016/j.ejps.2011.11.004)\n- Overton\u00b4s rule helps to estimate the penetration of antiinfectives into patients\u00b4 cerebrospinal fluid\nM. Djukic, M. Munz, F. S\u00f6rgel, U. Holzgrabe, H. Eiffert, R. Nau, Antimicrob. Agents Chemother. 56(2), 979-988, (2012)\n[doi: 10.1128/AAC.00437-11](http://dx.doi.org/10.1128/AAC.00437-11)\n- Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.\nG. Hiltensperger, N. Jones, S. Niedermeier, A. Stich, M. Kaiser, J. Jung, S. Puhl, A. Damme, H. Braunschweig, L. Meinel, M. Engstler, U. Holzgrabe, J. Med. Chem. 55, 2538-2548, (2012)\n[doi: 10.1021/jm101439s](http://dx.doi.org/10.1021/jm101439s)\n- Influence of the capillary diameter on the efficiency and sensitivity - a systematic approach\nD. Ilko, U. Holzgrabe, Electrophoresis, 33(11), 1494-1498, (2012)\n[doi: 10.1002/elps.201100575](http://dx.doi.org/10.1002/elps.201100575)\n- Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual binding site acetylcholinesterase inhibitors.\nM. Ignasik, M. Bajda, N. Guzior, M. Prinz, U. Holzgrabe, B. Malawska, Arch. Pharm., 345(7), 509-516, (2012)\n[doi: 10.1002/ardp.201100423](http://dx.doi.org/10.1002/ardp.201100423)\n- M1 muscarinic acetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease\nM. Decker, U. Holzgrabe, MedChemComm, 3, 752-762, (2012)\n[doi: 10.1039/C2MD20025B](http://dx.doi.org/10.1039/C2MD20025B)\n- 1H-NMR spectroscopy as a new tool in the assessment of the oxidative state in edible oils\nC. Skiera, P. Steliopoulos, T. Kuballa, U. Holzgrabe, B. Diehl, JAOCS, 89, 1383-1391, (2012)\n[doi: 10.1007/s11746-012-2051-9](http://dx.doi.org/10.1007/s11746-012-2051-9)\n- Charged aerosol detection in pharmaceutical analysis\nS. Almeling, D. Ilko, U. Holzgrabe, J. Pharm. Biomed. Anal., 69, 50-63, (2012)\n[doi: 10.1016/j.jpba.2012.03.019](http://dx.doi.org/10.1016/j.jpba.2012.03.019)\n- Ficts and Facts of Epinephrine and Norepinephrine Stability in Injectable Solutions.\nL. Hoellein, U. Holzgrabe, Int. J. Pharm., 434, 468-480, (2012)\n[doi: 10.1016/j.ijpharm.2012.05.017](http://dx.doi.org/10.1016/j.ijpharm.2012.05.017)\n- Extracellular allosteric domain rearrangement pilots orthosterically-induced signaling of a seven helical transmembrane receptor through sequential conformational states\nA. Bock, N. Merten, R. Schrage, C. Dallanoce, J. B\u00e4tz, J. Kl\u00f6ckner, J. Schmitz, C. Matera, K. Simon, A. Kebig, L. Peters, A. M\u00fcller, J. Schrobang-Ley, C. Tr\u00e4nkle, C. Hoffmann, M. De Amici, U. Holzgrabe, E. Kostenis, K. Mohr, Nature Commun. (2012)\n[doi: 10.1038/ncomms2028](http://dx.doi.org/10.1038/ncomms2028)\n- Individuelle Noradrenalin-Zubereitungen kommerzieller Fertigarzneimittel (Arterenol\u00ae) - Stabilit\u00e4t, Qualit\u00e4t und Analytik\nL. H\u00f6llein, E. Bennack, U. Holzgrabe, Krankenhauspharmazie 33, 427-31 (2012)\n- Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile.\nC.B. Landersdorfer, J.B. Bulitta, C.M. Kirkpatrick, M. Kinzig, U. Holzgrabe, G.L. Drusano, U. Stephan, F. S\u00f6rgel, Antimicrob. Agents Chemother. 56(11), 5715-5723, (2012)\n[doi: 10.1128/AAC.00937-12](http://dx.doi.org/10.1128/AAC.00937-12)\n- One-pot Ugi/Aza-Michael synthesis of highly substituted 2,5-diketopiperazines with antiproliferative properties\nA. Hartung, F. Seufert, C. Berges, V. Gessner, U. Holzgrabe, Molecules 17, 14685-14699 (2012)\n[doi: 10.3390/molecules171214685](http://dx.doi.org/10.3390/molecules171214685)\n- 1H NMR approach as an alternative to the classical p-anisidine value method.\nC. Skiera, P. Steliopoulos, T. Kuballa, U. Holzgrabe, B. Diehl, Eur. Food Res. Technol. 235, 1101-1105, (2012)\n- Determination of free fatty acids in edible oils by 1H NMR spectroscopy.\nC. Skiera, P. Steliopoulos, T. Kuballa, U. Holzgrabe, B. Diehl, Lipid Technology 24, 279-281 (2012)\n[doi: 10.1002/lite.201200241](http://dx.doi.org/10.1002/lite.201200241)\n- Cyclodextrin-mediated enantioseparation in microemulsion electrokinetic chromatography\nC. Borst, U. Holzgrabe, Methods Mol. Biol. 970, 363-375 (2013), Chiral Separations: Methods and Protocols, Herausgeber: G.K.E. Scriba, 2nd edition, Humana Press, 2013\n[doi: 10.1007/978-1-62703-263-6_23](http://dx.doi.org/10.1007/978-1-62703-263-6_23)\n- Molekulare Allianz - von orthosterischen und allosterischen Liganden zu dualsterischen/bitopischen Agonisten von G-Protein-gekoppelten Rezeptoren\nK. Mohr, J. Schmitz, R. Schrage, C. Tr\u00e4nkle, U. Holzgrabe, Angew. Chem. 125(2), 530-538 (2013),\n[doi: 10.1002/ange.201205315](http://dx.doi.org/10.1002/ange.201205315);\nAngew. Chem. Int. Ed. Engl. 52(2), 508-516 (2013),\n[doi: 10.1002/anie.201205315](http://dx.doi.org/10.1002/anie.201205315)\n- Agonists with supraphysiological efficacy at the muscarinic M2 acetylcholine receptor.\nR. Schrage, W.K. Seemann, J. Kl\u00f6ckner, C. Dallanoce, K. Rack\u00e9, E. Kostenis, M. De Amici, U. Holzgrabe, K. Mohr, Br. J. Pharmacol. 169(2), 357-370 (2013)\n[doi: 10.1111/bph.12003](http://dx.doi.org/10.1111/bph.12003)\n- Possibilities and Limitations of Capillary Electrophoresis in Pharmaceutical Analysis\nC. Borst, F. Belal, U. Holzgrabe, Pharmazie 68, 526-530 (2013)\n[doi: 10.1691/ph.2013.6501](http://dx.doi.org/10.1691/ph.2013.6501)\n- Arzneistoffentwicklung, ein moderner Zehnkampf\nS. Laufer, U. Holzgrabe, D. Steinhilber, Angew. Chem. 125(15), 4164-6168 (2013),\n[doi: 10.1002/ange.201210006](http://dx.doi.org/10.1002/ange.201210006); Angew. Chem. Int. Ed. Engl. 52(15), 4072-4076 (2013) [doi: 10.1002/anie.201210006](http://dx.doi.org/10.1002/anie.201210006)\n- Microwave hydrogenations: Large-size, high pressure microwave reactor\nE. Heller, A. Gutmann, G. Hiltensperger, W. Lautenschlaeger, M.J. Lohse, C. Schad, T. Schirmeister, F. Seufert, D.P. Zlotos, U. Holzgrabe, G.I.T. Laboratory Journal 1-2, 32-33 (2013)\n- 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-\u00df aggregation crossing the blood-brain barrier\nM. Prinz, S. Parlar, G. Bayraktar, V. Alpt\u00fcz\u00fcn, E. Erciyas, A. Fallarero, D. Karlsson, P. Vuorela, M. Burek, C. F\u00f6rster, E. Turunc, G. Armagan, A. Yalcin, C. Schiller, K. Leuner, M. Krug, C.A. Sotriffer, U. Holzgrabe, Eur. J- Pharm. Sci. 49(4), 603-613 (2013)\n[doi: 10.1016/j.ejps.2013.04.024](http://dx.doi.org/10.1016/j.ejps.2013.04.024)\n- Do we need new drugs against human African trypanosomiasis?\nA. Stich, A. Ponte-Sucre, U. Holzgrabe, Lancet Infect. Dis. 13(9), 733-734 (2013)\n[doi: 10.1016/S1473-3099(13)70191-9](http://dx.doi.org/10.1016/S1473-3099(13)70191-9)\n- Pentacyclic triterpenes from Cecropia telenitida with immunomodulatory activity on dendritic cells\nG.L. Montoya Pelaez, J.A. Sierra, F. Alzate, U. Holzgrabe, J.R. Ramirez-Pineda, Rev. bras. farmacogn. 23, 754-761 (2013)\n- Tyrosinase inhibition of isolated compounds obtained from Pachyrhizus erosus\nE. Lukitaningsih, M. Bahi, U. Holzgrabe, Aceh Int. J Sci. Technol. 2, 98-102 (2013)\n[doi: 10.13170/aijst.2.3.1063](https://doi.org/10.13170/aijst.2.3.1063)\n- Bioactive compounds in bengkoang (Pachyrhizus erosus) as antioxidant and tyrosinase inhibiting agents\nE. Lukitaningsih, U. Holzgrabe, Indonesian J. Pharm. 25, 68-75 (2014)\n[doi: 10.14499/indonesianjpharm25iss2pp68](https://doi.org/10.14499/indonesianjpharm25iss2pp68)\n- Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor\nA. Bock, B. Chirinda, F. Krebs, R. Messerer, J. B\u00e4tz, M. Muth, C. Dallanoce, D. Klingenthal, C. Tr\u00e4nkle, C. Hoffmann, M. De Amici, U. Holzgrabe, E. Kostenis, K. Mohr, Nat. Chem. Biol. 10(1), 18-20 (2014)\n[doi: 10.1038/nchembio.1384](http://dx.doi.org/10.1038/nchembio.1384)\n- Quantification of taurine in energy drinks using 1H NMR\nM. Hohmann, C. Felbinger, N. Christoph, H. Wachter, J. Wiest, U. Holzgrabe, J. Pharm. Biomed. Anal. 93, 156-160 (2014)\n[doi: 10.1016/j.jpba.2013.08.046](http://dx.doi.org/10.1016/j.jpba.2013.08.046)\n- Determination of free fatty acids in pharmaceutical lipids by 1H NMR and comparison with the classical acid value\nC. Skiera, P. Steliopoulos, T. Kuballa, B. Diehl, U. Holzgrabe, J. Pharm. Biomed. Anal. 93, 43-50 (2014)\n[doi: 10.1016/j.jpba.2013.04.010](http://dx.doi.org/10.1016/j.jpba.2013.04.010)\n- A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins\nD.W. Begley, D. Fox, D. Jenner, C. Juli, P.G. Pierce, J. Abendroth, M. Muruthi, K. Safford, V. Anderson, K. Atkins, S.R. Barnes, S.O. Moen, A.C. Raymond, R. Stacy, P.J. Myler, B.L. Staker, N.J. Harmer, I.H. Norville, U. Holzgrabe, M. Sarkar-Tyson, T.E. Edwards, D.D. Lorimer, Antimicrob. Agents Chemother. 58(3), 1458-1467 (2014)\n[doi: 10.1128/AAC.01875-13](http://dx.doi.org/10.1128/AAC.01875-13)\n- Antileishmanial lead structures from nature: analysis of structure-activity relationships of a compound library derived from caffeic Acid bornyl ester\nJ. Glaser, M. Schultheis, S. Hazra, B. Hazra, H. Moll, U. Schurigt, U. Holzgrabe, Molecules 19(2), 1394-1410 (2014)\n[doi: 10.3390/molecules19021394](http://dx.doi.org/10.3390/molecules19021394)\n- Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity\nC. Matera, L. Flammini, M. Quadri, V. Vivo, V. Ballabeni, U. Holzgrabe, K. Mohr, M. De Amici, E. Barocelli, Bertoni S, C. Dallanoce,Eur. J. Med. Chem. 75, 222-232 (2014)\n[doi: 10.1016/j.ejmech.2014.01.032](http://dx.doi.org/10.1016/j.ejmech.2014.01.032)\n- Impurity profiling of carbocisteine by HPLC-CAD, qNMR and UV/vis spectroscopy\nO. Wahl, U. Holzgrabe, J. Pharm. Biomed. Anal. 95, 1-10 (2014)\n[doi: 10.1016/j.jpba.2014.02.012](http://dx.doi.org/10.1016/j.jpba.2014.02.012)\n- Acetylcholinesterase Inhibitors with Photoswitchable Inhibition of \u00df-Amyloid Aggregation\nX. Chen, S. Wehle, N. Kuzmanovic, B. Merget, U. Holzgrabe, B. K\u00f6nig, C.A. Sotriffer, M. Decker, ACS Chem. Neurosci. (2014)\n[doi: 10.1021/cn500016p](http://dx.doi.org/10.1021/cn500016p)\n- Identification and quantitation of the ingredients in a counterfeit Vietnamese herbal medicine against rheumatic diseases\nJ. Wiest, C. Schollmayer, G. Gresser, U. Holzgrabe, J. Pharm. Biomed. Anal. 97C, 24-28 (2014)\n[doi: 10.1016/j.jpba.2014.04.013](http://dx.doi.org/10.1016/j.jpba.2014.04.013)\n- New insight into active muscarinic receptors with the novel radioagonist [3H]iperoxo\nR. Schrage, J. Holze, J. Kl\u00f6ckner, A. Balkow, A. S. Klause, A.-L. Schmitz, M. DeAmici, E. Kostenis, C. Tr\u00e4nkle1, U. Holzgrabe2, K. Mohr, Biochem. Pharmacol. 90C, 307-319 (2014)\n[doi: 10.1016/j.bcp.2014.05.012](http://dx.doi.org/10.1016/j.bcp.2014.05.012)\n- A cell-permeable inhibitor to trap Gaq proteins in the empty pocket conformation\nA.-L. Schmitz, R. Schrage, E. Gaffal, T. Carpentier, J. Wiest, G. Hiltensperger, J. Morschel, S. Hennen, D. H\u00e4u\u00dfler, V. Horn, D. Wenzel, M. Grundmann, K. M. B\u00fcllesbach, R. Schr\u00f6der, H. Brewitz, J. Schmidt, J. Gomeza, C. Gal\u00e9s, B. Fleischmann, T. T\u00fcting, D. Imhof, D. Tietze, M. G\u00fctschow, U. Holzgrabe, J. Sondek, T. Harden, K. Mohr, E. Kostenis, Chem. Biol. 21, 890-902 (2014)\n[doi: 10.1016/j.chembiol.2014.06.003](http://dx.doi.org/10.1016/j.chembiol.2014.06.003)\n- Development of simplified HPLC methods for the detection of counterfeit antimalarials in resource-restraint environments\nL. H\u00f6llein, U. Holzgrabe, J. Pharm. Biomed. Anal. 98, 434-445 (2014)\n[doi: 10.1016/j.jpba.2014.06.013](http://dx.doi.org/10.1016/j.jpba.2014.06.013)\n- Matrix-assisted laser desorption/ionization tandem mass spectrometry of N-glycans derivatized with isonicotinic hydrazide and its biotinylated form\nS. Bank, E. Heller, E, Memmel, J. Seibel, U. Holzgrabe, P. Kapkov\u00e1, Rapid Commun. Mass Spectrom. 28, 1745-1756 (2014)\n[doi: 10.1002/rcm.6955](http://dx.doi.org/10.1002/rcm.6955)\n- Quantitative determination of taurine in energy drinks by 1H NMR spectroscopy\nM. Hohmann, C. Felbinger, N. Christoph, H. Wachter, U. Holzgrabe, NewFood Magazine 17, 24-27 (2014)\n- Structure-activity relationships of strychnine analogs at glycine receptors\nA. Mohsen, E. Heller, U. Holzgrabe, A. Jensen, D. Zlotos, Chem. Biodivers. 11, 1256-1262 (2014)\n[doi: 10.1002/cbdv.201400110](http://dx.doi.org/10.1002/cbdv.201400110)\n- Dualsteric muscarinic antagonists-orthosteric binding pose controls allosteric subtype selectivity\nJ. Schmitz, D. van der Mey, M. Bermudez, J. Kl\u00f6ckner, D. Kaufel, R. Schrage, E. Kostenis, C. Tr\u00e4nkle, G. Wolber, K. Mohr, U. Holzgrabe, J. Med. Chem. 57, 6739-6750 (2014)\n[doi: 10.1021/jm500790x](http://dx.doi.org/10.1021/jm500790x)\n- 1H NMR profiling as an approach to differentiate conventionally and organically grown tomatoes\nM. Hohmann, N. Christoph, H. Wachter, U. Holzgrabe, J. Agric. Food Chem. 33, 8530-8540 (2014)\n[doi: 10.1021/jf502113r](http://dx.doi.org/10.1021/jf502113r)\n- Evaluation of enantiomeric purity of magnesium-L-aspartate dihydrate\nO. Wahl, U. Holzgrabe, J. Pharm. Biomed. Anal. 102, 100-109 (2015)\n[doi: 10.1016/j.jpba.2014.08.013](http://dx.doi.org/10.1016/j.jpba.2014.08.013)\n- Semisynthetic analogues of toxiferine I and their pharmacological properties at a7 nAChRs, muscle-Type nAChRs, and the allosteric binding site of muscarinic M2 receptors\nD. P. Zlotos, C. Tr\u00e4nkle, U. Holzgrabe, D. G\u00fcndisch, A. A. Jensen, J. Nat. Prod. 77, 2006-2013 (2014)\n[doi: 10.1021/np500259j](http://dx.doi.org/10.1021/np500259j)\n- Validation and application of an HPLC-CAD-TOF/MS method for identification and quantification of pharmaceutical counterions\nD. Ilko, C.-J Nap, U. Holzgrabe, S. Almeling, Pharmeuropa Bio & SN Sept. 2014, 81-91 (2014)\n- Protein release from electrospun nonwovens: Improving the release characteristics through rational combination of polyester blend matrices with polidocanol\nS. Puhl, D. Ilko, L. Li, U. Holzgrabe, L. Meinel, O. Germershaus, Int. J. Pharmaceutics 477, 273-281 (2014)\n[doi: 10.1016/j.ijpharm.2014.10.047](http://dx.doi.org/10.1016/j.ijpharm.2014.10.047)\n- Absolute Quantitative 1H NMR Spectroscopy for Compound Purity Determination\nM. Cushman, G.I. Georg, U. Holzgrabe, Wang. S., J. Med. Chem. 57, 9219 (2014)\n[doi: 10.1021/jm501683w](http://dx.doi.org/10.1021/jm501683w)\n- Search for dual function inhibitors for Alzheimer\u00b4s disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their A fibril formation inhibition capacity\nP. Kapkova, V. Alpt\u00fcz\u00fcn, P. Frey, E. Erciyas, U. Holzgrabe, Bioorg. Med. Chem., 14, 472-478 (2006)\n- Design, Synthesis and Action of Oxotremorine-related Hybrid-type Allosteric Modulators of Muscarinic Acetylcholine Receptors\nT. Desingrini, M. Muth, C. Dallanoce, E. Barocelli, S. Bertoni, K. Kellershohn, K. Mohr, M. De Amici, U. Holzgrabe, J. Med. Chem. 49, 366-372 (2006)\n- Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of the orthosteric agonist instead of an antagonist\nM. Gro\u00dfm\u00fcller, J. Anthony, C. Tr\u00e4nkle, U. Holzgrabe, K. Mohr, Naunyn-Schmiedeberg\u00b4s Archiv Pharmacol. 372, 267-276 (2006)\n- Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method\nA. Heinze, U. Holzgrabe, Int. J. Pharmaceutics 311, 108-112 (2006)\n- Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents\nR. Vicik, V. Hoerr, M. Glaser, M. Schultheis, E. Hansell, J.H. McKerrow, U. Holzgrabe, C. R. Caffrey, A. Ponte-Sucre, H. Moll, A. Stich, T. Schirmeister, Bioorg. Med. Chem. Lett. 16, 2753-2757 (2006)\n- Muscarinic Allosteric Modulators: Atypical Structure-Activity-Relationships in Bispyridinium-type compounds\nU. S\u00fcrig, K. Gaal, E. Kostenis, C. Tr\u00e4nkle, K. Mohr, U. Holzgrabe, Arch. Pharm. 339, 207-212 (2006)\n- Piperidones with activity against Plasmodium falciparum\nM. Saeftel, R. Sarite, S. Njuguna, U. Holzgrabe, D. Ulmer, A. H\u00f6rauf, A. Kaiser, Parasitology Res. 99, 281-286 (2006)\n- Characterization of Bacterial Growth and the Influence of Antibiotics by Means of UV Resonance Raman Spectroscopy\nU. Neugebauer, U. Schmidt, K. Baumann, W. Ziebuhr, S. Kozitskaya, U. Holzgrabe, W. Kiefer, M. Schmitt, J. Popp, Biopolymer 82, 306-311 (2006)\n- Interlaboratory study of a NACE method for the determination of R-timolol content in S-timolol maleate: Assessment of uncertainty\nR.D. Marini, C. Groom, F. Doucet, J. Hawari, Y. Bitar, U. Holzgrabe, R. Gotti, J. Schappler, S. Riudaz, R. Mol, G.W. Somsen, G.J. de Jong, H.T.T. Pham, J. Zhang, A. Van Schepdael, J. Hogmartens, A. Ceccato, B. Boulanger, M. Pedrini, A.-C. Servais, M. Fillet, J. Crommen, E. Rozet, P. Hubert, Electrophoresis 27, 2386-2399 (2006)\n- Why not using capillary electrophoresis in drug analysis ?\nU. Holzgrabe, D. Brinz, S. Kopec, C. Weber, Y. Bitar, Electrophoresis 27, 2283-2292 (2006)\n- Inhibition of hypusine biosynthesis in Plasmodium: a possible and new strategy in prevention and therapy of malaria\nA. Kaiser, D. Ulmer, T. Goebel, U. Holzgrabe, S. Saeftel, A. Hoerauf, Minireviews in Medicinal Chemistry 6, 1231-1241 (2006)\n- Allosteric Modulators and Selective Agonists of Muscarinic Receptors\nU. Holzgrabe, M. De Amici, K. Mohr, J. Mol. Neuroscience 30, 165-168 (2006)\n- Random chemistry as a new tool for the generation of small compound libraries\nP. Kapkov\u00e1, E. Heller, E. Kugelmann, J. Faber, G. Bringmann, U. Kessler, G. Folkers, U. Holzgrabe, Arch. Pharm. 339, 489-497 (2006)\n- Determination of Erythromycin and related substances in commercial samples using liquid chromatography/ion trap mass spectrometry\nA. Deubel, A.S. Fandino, F. S\u00f6rgel, U. Holzgrabe, J. Chromatogr. A 1136, 39-47 (2006)\n- Determination of the impurity profile of adenosine by means of ion-pair reversed phase chromatography\nS. Kopec, S. Almeling, U. Holzgrabe, Pharmeuropa Scientific Notes 2006-2, 17-21 (2006)\n- Effects of fluoroquinolones on HERG channels and on pancreatic \u00df-cell ATP-sensitive K+ channels\nB.J. Z\u00fcnkler, S. Claa\u00dfen, M. Wos-Maganga, C. Kriete, A. Pfl\u00f6ger, U. Holzgrabe, I. Rustenbeck, Toxicology 228, 239-241 (2006)\n- Assessment of inhibitory potency of antibiotics by MRI: Apparent T2 as a marker of cell growth\nV. Hoerr, K. Hoffmann, C. Schollmayer, U. Holzgrabe, A. Haase, P. Jacob, C. Faber, MAGMA 19, 247-255 (2006)\n- Development of an Evaluation Method of erythromycin and its related substances by liquid chromatography\nA. Deubel, U. Holzgrabe, J. Pharm. Biomed. Anal. 43, 493-498 (2007)\n- Micellar electrokinetic chromatography of aminoglycosides\nU. Holzgrabe, S. Laug, F. Wienen, Buchkapitel in \"Capillary electrophoresis - Methods and Protocols\" in der Serie \"Methods in Molecular Biology\", Editor: P. Schmitt-Kopplin, Humana Press 735-750 (2007)\n- A fast and efficient track to allosteric modulators of muscarinic receptors: microwave assisted synthesis\nJ. Schmitz, E. Heller, U. Holzgrabe, Monatsh. Chem. 138, 171-174 (2007)\n- Targeting acetylcholinesterase to treat neurodegeneration\nU. Holzgrabe, P. Kapkova, V. Alptuzun, J. Scheiber, E. Kugelmann, Expert Opin. Ther. Targets 11, 161-179 (2007)\n- Antitrypanosomal activity of quaternary naphthalimide derivatives\nM. Muth, V. Hoerr, A. Stich, U. Holzgrabe, Bioorg. Med. Chem. Lett. 17, 1590-1593 (2007)\n- 1H and 19F NMR relaxation studies of fleroxacin with Micrococcus luteus.\nB. Waibel, U. Holzgrabe, J. Pharm. Biomed. Anal. 43, 1595-1601 (2007)\n- The influence of fluoroquinolone drugs on the bacterial growth of S. epidermidis utilizing the unique potential of vibrational spectroscopy\nU. Neugebauer, U. Schmid, K. Baumann, W. Ziebuhr, S. Koziskaya, U. Holzgrabe, M. Schmitt, J. Popp, J. Phys. Chem. A 111, 2898-2906 (2007)\n- Impurity profiling of atropine sulfate by microemulsion electrokinetic chromatography\nY. Bitar, U. Holzgrabe, J. Pharm. Biomed. Anal. 44, 623-633 (2007)\n- Amino acids: aspects of impurity profiling by means of capillary electrophoresis\nS. Kopec, U. Holzgrabe, Electrophoresis 28, 2153-2167 (2007)\n- Comparison of cyclodextrin-dipeptide inclusion complexes in absence and presence of urea by means of capillary electrophoresis, nuclear magnetic resonance and molecular modelling\nB. Waibel, J. Scheiber, C. Meier, M. Hammitzsch, K. Baumann, G. K. E. Scriba, U. Holzgrabe, Eur. J. Org. Chem. 2007, 2921-2930 (2007) mit Titelbild\n- Population Pharmacokinetics and Pharmacodynamics of Piperacillin: Systematic Comparison of Cystic Fibrosis Patients and Healthy Volunteers\nJ. B. Bulitta, S. B. Duffull, M. Kinzig-Schippers, U. Holzgrabe, U. Stephan, G. L. Drusano, F. S\u00f6rgel, Antimicrob. Agents Chemother. 51, 2497-2507 (2007)\n- Enantioseparation of chiral tropa alkaloids by means of cyclodextrin-modified microemulsion electrokinetic chromatography\nY. Bitar, U. Holzgrabe, Electrophoresis 28, 2693-2700 (2007)\n- Population Pharmacokinetics at Two Dose Levels and Pharmacodynamic Profiling of Flucloxacillin\nC. B. Landersdorfer, C. M. J. Kirkpatrick, M. Kinzig-Schippers, J.B. Bulitta, U. Holzgrabe, G. L. Drusano, F. S\u00f6rgel, Antimicrob. Agents Chemother. 51, 3290-3297 (2007)\n- Toward an understanding of the mode of action of fluoroquinolone drugs\nU. Neugebauer, U. Schmid, K. Baumann, U. Holzgrabe, J. Popp, Proceedings of the International Society for Optical Engineering Band 6633, (2007) Biophotonics 2007: Optics in Life Science, J. Popp; G. von Bally (Herausgeber) 66331W, DOI: 10.1117/12.728137 (2007)\n- Laser-Induced Fluorescence-Capillary Electrophoresis and Fluorescence Microplate Reader Measurement: Two Methods to Quantify the Effect of Antibiotics\nV. Hoerr, W. Ziebuhr, S. Kozitskaya, E. Katzowitsch, U. Holzgrabe, Anal. Chem. 79, 7510-7518 (2007)\n; referiert: von D.L. Shenkenberg in Biophotonics International, Dec. 2007, 57-58\n- NMR-Spectroscopy in quality evaluation of drugs\nB. W. K. Diehl, F. Malz, U. Holzgrabe, Spectroscopy Europe 19 (5), 15-19 (2007)\n& Spectroscopy Asia, im Druck\n- Allosteric small molecules unveil a role of an extracellular E2/TM7 junction for GPCR activation\nD. J\u00e4ger, C. Schmalenbach, S. Prilla, A.Kebig, M. Sennwitz, J. Schrobang, E. Heller, C. Tr\u00e4nkle, U. Holzgrabe, H.-D. H\u00f6ltje & K. Mohr, J. Med. Chem. 51, 238-250 (2008)\n- In search of novel agents for therapy of tropical diseases and Human Immunodeficiency Virus\nT. Goebel, D. Ulmer, H. Projahn, J. Kl\u00f6ckner, E. Heller, M. Glaser, A. Ponte-Sucre, S. Specht, S. R. Sarite, M. Saeftel, A. Hoerauf, A. Kaiser, I. Hauber, J. Hauber, U. Holzgrabe, J. Med. Chem. 51, 238-250 (2008)\n- The Need for CE Methods in Pharmacopoeial Monographs\nU. Holzgrabe in: Capillary Electrophoresis Methods for Pharmaceutical Analysis, Hrsg. I. Jimidar & S. Ahuja, Elsevier Vol. 9, 245-258, (2008)\n- Generation of small-compound libraries via re-combinatorial chemistry by Fenton\u00b4s reagent\nE. Kugelmann, U. Holzgrabe, Arkivoc XI, 247-255 (2008)\n- Analysis of the molecular size distribution of polyethylene glycols by CE-UV versus HPLC with evaporative light scattering detection\nD. Brinz, U. Holzgrabe, Electrophoresis 29, 3605-3611 (2008)\n- Strategies for the development of new lead structures for the inhibition of the acetylcholinesterase\nP. Kapkova, V. Alptuzun, E. Heller, E. Kugelmann, G. Folkers, U. Holzgrabe, Chemistry and Molecular Aspects of Drug Design and Action (Eds. E. A. Rekka, P. N. Kouronakis) Taylor & Francis, Boca Raton, Florida, USA, (2008)\n- Enantioseparation of DOPA and related compounds by cyclodextrin-modified microemulsion electrokinetic chromatography\nC. Borst, U. Holzgrabe, J. Chromatogr. A 1024, 191-196 (2008)\n- Inhibition of Flucloxacin Tubular Renal Secretion by Piperacillin\nC.B. Landersdorfer, C.M.J. Kirkpatrick, M. Kinzig-Schippers, J.B. Bulitta, U. Holzgrabe, F. S\u00f6rgel, Br. J. Clin. Pharmacol. 66, 648-658 (2008)\n- Evaluation of the stability of gentamicin in different antibiotic carriers using a validated MEKC method\nK.-D. K\u00fchn, C. Weber, S. Kreis, U. Holzgrabe, J. Pharm. Biomed. Anal. 48, 612-618 (2008)\n- Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy\nT. Beyer, B. Diehl, G. Randel, E. Humpfer, H. Sch\u00e4fer, M. Spraul, C. Schollmayer, U. Holzgrabe, J. Pharm. Biomed. Anal. 48, 13-19 (2008)\n- Determination of Oversulfated Chondroitin Sulphate and Dermatan Sulphate in unfractionated Heparin by 1H NMR\nI. McEwen, B. Mulloy, E. Hellwig, L. Kozerski, T. Beyer, U. Holzgrabe, A. Rodomonte, R. Wanke, J.-M Speiser, Pharmeuropa Bio 2008-1, 31-39 (2008)\n- Prediction of the Oversulphated Chondroitin Sulphate Contamination of Unfractionated Heparin by ATR-IR Spectrophotometry\nJ. Norwig, T. Beyer, D. Brinz, U. Holzgrabe, M. Diller, D. Manns, Pharmeuropa Sci. Notes. 2009-1, 17-24 (2009)\n- Penetration of Antibacterials into Bones: Pharmacokinetic, Pharmacodynamic and Bioanalytical Considerations\nC.B. Landersdorfer, J.B. Bulitta, M. Kinzig, U. Holzgrabe, F. S\u00f6rgel, Clin. Pharmacokinetics 48, 89-124 (2009)\n- Dualsteric GPCR targeting: a novel route to binding and signalling pathway selectivity.\nJ. Antony, K. Kellershohn, M. Mohr-Andr\u00e4, A. Kebig, S. Prilla, M. Muth, E. Heller, T. Disingrini, C. Dallanoce, S. Bertoni, J. Schrobang, C. Tr\u00e4nkle, E. Kostenis, A. Christopoulos, H.-D. H\u00f6ltje, E. Barocelli, M. De Amici, U. Holzgrabe, K. Mohr, FASEB Journal 23, 442-450 (2009)\nvon der \"Faculty of 1000 Biology - the expert guide to the most important advances in biology\" als \"Must read\" eingestuft\n[doi: 10.1096/fj.08-114751](http://dx.doi.org/10.1096/fj.08-114751)\n- Cerulenin analogues as inhibitors of efflux pump in drug-resistant Candida albicans\nF. Diwischek, J. Morschh\u00e4user, U. Holzgrabe, Arch. Pharm. Chem. Life Sci. 342, 150-164 (2009)\n- Real time observation of microwave-enhanced reaction via fast FTIR-spectroscopy\nE. Heller, W. Lautenschl\u00e4ger, U. Holzgrabe, Tetrahedron Lett. 50, 1321-1323 (2009)\n- Structure-activity relationship and studies on the molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts\nA. Pontre-Sucre, T. Gulder, A. Wegehaupt, C. Albert, C. Rikanovic, L. Schaefflein, A. Frank, M. Schultheis, M. Unger, U. Holzgrabe, G. Bringmann, H. Moll, J. Med. Chem. 52, 626-636 (2009)\n- The insulinotropic effect of fluoroquinolones\nH. Gahaly, C. Kriete, S. Sahin, A. Pfl\u00f6ger, U. Holzgrabe, B.J. Z\u00fcnkler, I. Rustenbeck, Biochem. Pharmacol. 77, 1040-1052 (2009)\n- Evaluation of the extent of protein binding by means of NMR diffusion and relaxation experiments, and automated continuous ultrafiltration\nB. Waibel, C. Albert, U. Holzgrabe, Eur. J. Pharm. Sci. 37, 191-197 (2009)\n- Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo Simulation\nC. B. Landersdorfer, M. Kinzig, F. F. Hennig, J. B. Bulitta, U. Holzgrabe, G. L. Drusano, F. S\u00f6rgel, J. Gusinde, Antimicrob. Agents Chemother. 53, 2074-2081 (2009)\n- Bone Penetration of Amoxicillin and Clavulanic Acid Evaluated by Population Pharmacokinetics and Monte Carlo Simulation\nC. B. Landersdorfer, M. Kinzig, J. B. Bulitta, F. F. Hennig, U. Holzgrabe., F. S\u00f6rgel, J. Gusinde, Antimicrob. Agents Chemother. 53, 2569-2578 (2009)\n- Meropenem-Clavulanate - a new strategy fort he treatment of tuberculosis?\nU. Holzgrabe, ChemMedChem 4, 1051-1053 (2009)\n- O-glycoside sequence of pentacyclic triterpene saponins of Phytolacca bogotensis using LC/ESI multi-stage tandem mass spectrometry\nG. Montoya, G. J. Arango, M. Unger, U. Holzgrabe, Phytochem. Anal. 20, 465-474 (2009)\n- A small molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion\nS. Niedermeier, K. Singethan, S. G. Rohrer, M. Matz, M. Kossner, S. Diederich, A. Maisner, J. Schmitz, G. Hiltensperger, K. Baumann, U. Holzgrabe,* J. Schneider-Schaulies, J. Med. Chem. 52, 4257-4265 (2009)\n- New Semi-Physiological Absorption Model to Assess the Pharmacodynamic Profile of Cefuroxime Axetil using Nonparametric and Parametric Population Pharmacokinetics\nJ. B. Bulitta, C. B. Landersdorfer, M. Kinzig, U. Holzgrabe, F. S\u00f6rgel, Antimicrob. Agents Chemother. 53, 3462-3471 (2009)\n- Comparison of the Pharmacokinetic and Pharmacodynamic Profile of Carumonam in Cystic Fibrosis and Healthy Volunteers\nJ. Bulitta, S.B. Duffull, M. Kinzig-Schippers, U. Holzgrabe, U. Stephan, G.L. Drusano, F. S\u00f6rgel, Diagn. Microbiol. Inf. Dis. 65, 130-141 (2009)\n- Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid\nC. B. Landersdorfer, C. M. J. Kirkpatrick, M. Kinzig, J. B. Bulitta, U. Holzgrabe, G. L. Drusano, F. S\u00f6rgel. Antimicrob. Agents Chemother. 53, 3902-3907 (2009)\n- Quantitative Analysis in Pharmaceutical Analysis\nU. Holzgrabe, C. Borst, C. B\u00fcttner, Y. Bitar. in: Chiral Separations by Capillary Electrophoresis (Eds. A. Van Eckhaut, Y. Michotte), CRC PresBoca Raton, USA, 313-340 (2009)\n- Study on the Chiral Recognition of the Enantiomers of Ephedrine Derivatives with Neutral and Sulfated Heptakis(2,3-O-diacetyl)b-cyclodextrins Using Capillary Electrophoresis, UV, NMR and Mass Spectroscopy\nC. Hellriegel, H. H\u00e4ndel, M. Wedig, S. Steinhauer, F. S\u00f6rgel, K. Albert, U. Holzgrabe, J. Chromatogr. A 914, 315-324 (2001)\n- A sequence of aldol condensations and Michael addition giving a cyclohexenone ring system\nU. Kuhl, U. Holzgrabe, Monatsh.Chem. 132, 407-410 (2001)\n- A new Single-Isomer Chiral Selector for Capillary Electrophoresis: The Highly Water-Soluble Heptakis(2-N,N-dimethylcarbamoyl)-b-cyclodextrin\nT. Christians, U. Holzgrabe, J. Chromatogr. A 911, 249-257 (2001)\n- Hexamethonium-type allosteric modulators of muscarinic receptors havoing lateral dibenzoazepines\nR. Li, C. Tr\u00e4nkle, K. Mohr, U. Holzgrabe, Arch. Pharm. Pharm. Med. Chem. 334, 121-124 (2001)\n- Evaluation of the impurity profile of amino acids by means of capillary electrophoresis\nN. Novatchev, U. Holzgrabe, J. Pharm. Biomed. Anal. 26, 779-789 (2001)\n- Enantioseparation of linear and cyclic chiral phenethylamines by means of cyclodextrin-modified capillary electrophoresis\nM. Wedig, M. Thunhorst, S. Laug, M. Decker, J. Lehmann, U. Holzgrabe, Fresenius J. Anal. Chem. 371, 212-217 (2001)\n- Enantioseparation of chiral thiobarbiturates using cyclodextrin-modified capillary electrophoresis\nU. Schmitt, J. Bojarski, U. Holzgrabe, Electrophoresis 22, 3237-3242 (2001)\n- Lipophilicity and Membrane Interactions of Cationic-Amphiphilic Compounds: Lipophilic and Steric Effects\nC.D.P. Klein, G.F. Tabeteh, A. v. Laguna, U. Holzgrabe, K. Mohr, Eur. J. Pharm. Sci 14, 167-175 (2001)\n- N1-phenyl substituted 4-quinolones of tuberculostatic activity\nU. Holzgrabe, M. Steinert, Pharmazie 56, 850-851 (2001)\n- Stereochemical behaviour of k-agonistic 2,4-dipyridine 3,7-diazabicyclo[3.3.1]nonanones - influence of the substituent in position N3\nU. Kuhl, M. Graf v. Korff, K. Baumann, C. Burschka, U. Holzgrabe, J. Chem. Soc. Perkin 2, 2037-2042 (2001)\n- Stereocontrolled synthesis of enantiomers of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)-propyl]-pyrrolidin-2-one\nK. Kulig, U. Holzgrabe, B. Malawska, Tetrahedron Asym. 18, 2533-2536 (2001)\n- Indoles XIV. 4-Phenylpyrido[4,3-b]indoles and 5-phenyl-azepino[4,5-b]indoles by cyclisation of N-Indolylalkylephedrine derivatives - Scope and Stereoselectivity\nM. Wedig, S. Laug, T. Christians, M. Thunhorst, U. Holzgrabe, J. Pharm. Biomed. Anal. 27, 531-540 (2001)\n- Do We Know the Mechanism of Chiral Recognition between Cyclodextrins and Analytes?\nM. Decker, R. Faust, M. Wedig, M. Nieger, U. Holzgrabe, J. Lehmann, Heterocycles 55, 1455-1466 (2002)\n- The use of cyclodextrin modified capillary electrophoresis in the determination of the enantiomeric purity\nU. Holzgrabe, T. Christians, J. Capillary Electrophoresis 7, 23-29 (2002)\n- Evaluation of amino sugar, low molecular peptide and amino acid impurities of biotechnologically produced amino acids by means of capillary electrophoresis\nN. Novatchev, U. Holzgrabe, J. Pharm. Biomed. Anal 28, 475-486 (2002)\n- Characterization of paromomycin sulfate by means of capillary electophoresis with UV detection after pre-capillary derivatization\nF. Wienen, U. Holzgrabe, Chromatographia 55, 327-331 (2002)\n- N+/Si Replacement as a Tool for Probing the Pharmacophore of Allosteric Modulators of Muscarinic M2 Receptors: Synthesis, Allosteric Potency, and Positive Cooperativity of Silicon-based W84 Derivatives\nJ.O. Dai\u00df, S. Duda-Johner, C. Burschka, U. Holzgrabe, K. Mohr, R. Tacke, Organometallics 21, 803-811 (2002)\n- Quantitative Liquid Chromatography/Mass Spectrometry Determination of Isatin in Urine using Automated On Line Extraction\nM. Unger, W. Jacobsen, U. Holzgrabe, L.Z. Benet, J. Chromatogr. B 767, 245-253 (2002)\n- Evaluation of the impurity profile of alcuronium by means of capillary electrophoresis\nM. Wedig, N. Novatchev, T. Worch, S. Laug, U. Holzgrabe, J. Pharm. Biomed. Anal. 28, 983-990 (2002)\n- Studies on the chiral recognition of peptide enantiomers by neutral and sulfated b-cyclodextrin and heptakis-(2,3-di-O-acetyl)-b-cyclodextrin using capillary electrophoresis and nuclear magnetic resonance\nF. S\u00fc\u00df, C. Kahle, U. Holzgrabe, K.E. Scriba, Electrophoresis 23, 1301-1307 (2002)\n- The photocatalysed [2+2+2]-Cycloaddition of Nitriles with Acetylene: An Effective Method for the Synthesis of 2-Pyridines under Mild Conditions\nB. Heller, B. Sundermann, H. Buschmann, H.-J. Drexler, U. Holzgrabe, E. Heller, G. Oehme, J. Org. Chem. 67, 4414-4422 (2002)\n- Stereochemistry and opioid receptor affinity of 2,4-dipyridine 3,7-diazabicyclo[3.3.1]nonanones - influence of the substituent in position N7\nA. Cambareri, D. P. Zlotos, W. Englberger, M. Haurand, U. Holzgrabe, J. Heterocycl. Chem. 39, 789-798 (2002)\n- Elevation of ligand binding to muscarinic M2 acetylcholine receptors by alkane-bisammonium type allosteric modulators\nA. Raasch, O. Scharfenstein, C. Tr\u00e4nkle, U. Holzgrabe. K. Mohr, J. Med. Chem. 45, 3809-3812 (2002)\n- Diazabicyclononanones, a potent class of kappa analgesics\nU. Holzgrabe, A. Cambareri, U. Kuhl, T. Siener, W. Brandt, W. Stra\u00dfburger, E. Friderichs, W. Englberger, B. K\u00f6gel, Il Farmaco 57, 531-534 (2002)\n- Comparison of the Suitability of Capillary Electrophoresis and Thin Layer Chromatography for Determination of Impurities in Amino Acids\nN. Novatchev, U. Holzgrabe, Pharmeuropa 14.4, 640-647 (2002)\n- Quantitative 1H NMR Spectroscopy: Determination of the E/Z-isomer Ratio in the Antidepressant Drug Fluvoxamine For Usage in Pharmaceutical Analysis\nR. Deubner, U. Holzgrabe, Magn. Res. Chem. 40, 762-766 (2002)\n- Inhibition of Cytochrome P450 3A4 by Extracts and Kavapyrones of Piper methysticum (Kava-Kava)\nM. Unger, U. Holzgrabe, W. Jacobson, C. Cummins, L.Z. Benet, Planta Medica 68, 1055-1058 (2002)\n- Chiral separations by Cyclodextrin-modified Capillary Electrophoresis - Determination of the enantiomeric excess\nU. Schmitt, S.K. Branch, U. Holzgrabe, J. Separat. Sci. 25, 959-974 (2002)\n- Structure/activity-relationships of M2 muscarinic allosteric modulators\nK. Mohr, C. Tr\u00e4nkle, U. Holzgrabe, Receptor and Channels 9, 229-240 (2003)\n- Determination of clotrimazole in mice plasma by capillary electrophoresis\nF. Wienen, S. Laug, A. Schwab, S. Just, U. Holzgrabe, J. Pharm. Biomed. Anal. 30, 1879-1887 (2003)\n- Cooperative interactions at M2 muscarinic acetylcholine receptors: Structure/activity-relationships in stepwise shortened bispyridinium- and bis(ammonio)alkane-type allosteric modulators\nR. Gilsbach, M. Gro\u00dfm\u00fcller, V. Alpt\u00fcz\u00fcn, E. Erciyas, C. Tr\u00e4nkle, U. Holzgrabe, K. Mohr, Neurochemical Research 28, 667-673 (2003)\n- Antitrypanosomal naphthylisoquinoline alkaloids and related compounds\nG. Bringmann, V. Hoerr, U. Holzgrabe, A. Stich, Pharmazie 58, 343-346 (2003)\n- Capillary Electrophoresis Method for Determination of Related Substances in Glutathione Reduced Drug Substance\nN. Novatchev, U. Holzgrabe, Chromatographia 57, 345-349 (2003)\n- A new synthetic route to compounds of the AFDX-type with affinity to muscarinic M2-receptor\nU. Holzgrabe, E. Heller, Tetrahedron 59, 781-787 (2003)\n- Contribution of lateral substituents in symmetrical and nonsymmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptor\nM. Staudt, C. Tr\u00e4nkle, K. Mohr, U. Holzgrabe, Arch. Pharm. Pharm. Med. Chem. 336, 385-389 (2003)\n- Systematic development of high affinity bis(ammonio)alkane-type allosteric enhancers of muscarinic ligand binding\nM. Muth, O. Scharfenstein, W. Bender, E. Balatkova, C. Tr\u00e4nkle, K. Mohr, U. Holzgrabe, J. Med. Chem. 46, 1031-1040 (2003)\n- Comparison of Conventional and Microwave-assisted Reactions Giving Aromatic Oxazolidines\nF. Diwischek, E. Heller, U. Holzgrabe, Monatsh. Chem. 134, 1105-1110 (2003)\n- Composion and impurity profile of multisource bulkware of gentamicin - a comparison\nF. Wienen, R. Deubner, U. Holzgrabe, Pharmeuropa 15, 273-279 (2003)\n- Capillary Electrophoretic Resolution of 2,5-Dimethyl-4-hydroxy-3(2H)-furanone Enantiomers, the Key Flavour Compounds in Strawberry Fruit\nT. Raab, U. Schmitt, T. Hauck, A. Knecht, U. Holzgrabe, W. Schwab, Chromatographia 57, 501-504 (2003)\n- Mechanism of Action of the Diazabicyclononanone-type Kappa-Agonists\nU. Holzgrabe, W. Brandt, J. Med. Chem. 46, 1383-1389 (2003)\n- Bisquaternary Dimers of Strychnine and Brucine. A New Class of Potent Enhancers of Antagonist Binding to Muscarinic M2 Receptors\nD.P. Zlotos, S. Buller, U. Holzgrabe, K. Mohr, Bioorg. Med. Chem. 11, 2627-2634 (2003)\n- Tautomerism of 4-hydroxy-2,5-dimethyl-3(2H)-furanone: Evidence for its Enantioselective Biosynthesis\nT. Raab, T. Hauck, A. Knecht, U. Schmitt, U. Holzgrabe, W. Schwab, Chirality 15, 573-578 (2003)\n- Quantitation of Talinolol and other Beta-Blockers by Capillary Electrophoresis for in-vitro Drug Absorption Studies\nA. Bilal, P.C. Schmidt, U. Holzgrabe, M.A. Wahl, Electrophoresis 24, 2627-2632 (2003)\n- Kappa-receptor selective binding of opioid ligands with a heterocyclic bicycle[3.3.1]nonan-9-one structure\nS. Benyhe, A. Marki, C. Nachtsheim, U. Holzgrabe, A. Borsodi, Acta Biol. Hung. 54, 147-155 (2003)\n- Synthesis, biological activity and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type\nP. Kapkova, N. Stiefl, U. S\u00fcrig, B. Engels, K. Baumann, U. Holzgrabe, Arch. Pharm. Pharm. Med. Chem. 336, 523-540 (2003)\n- Assignment of the major and minor components of gentamicin for evaluation of batches\nR. Deubner, C. Schollmayer, F. Wienen, U. Holzgrabe, Magn. Res. Chem. 41, 589-598 (2003)\n- A new MEKC method for separation of the components of the aminoglycoside antibiotics\nF. Wienen, U. Holzgrabe, Electrophoresis 24, 2948-2957 (2003)\n- Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors\nV. Alpt\u00fcz\u00fcn, P. Kapkov\u00e1, E. Erciyas, U. Holzgrabe, J. Pharm. Pharmacol. 55, 1397-1404 (2003)\n- A novel class of allosteric modulators of the muscarinic M2 acetylcholine receptor: terphenylene derivatives\nJ. Teichgr\u00e4ber, U. Holzgrabe, Tetrahedron 59, 8697-8703 (2003)\n- Analytical Characterization of Crude Extracts from an African Ancistrocladus Species Using High Performance Liquid Chromatography and Capillary Electrophoresis Coupled to Tandem Mass Spectrometry\nM. Unger, M. Dreyer, S. Specker, S. Laug, M. Pelzing, C. Neus\u00fc\u00df, U. Holzgrabe, G. Bringmann, Phytochem. Anal. 15, 21-26 (2004)\n- Micellar Electrokinetic Chromatography, High Performance Liquid Chromatography and Nuclear Magnetic resonance - Three orthogonal methods for Characterization of Critical Drugs\nR. Deubner, U. Holzgrabe, J. Pharm. Biomed. Anal. 35, 459-467 (2004)\n- Chiral capillary electrophoresis: Facts and fiction on the reproducibility of resolution with randomly substituted cyclodextrins\nU. Schmitt, M. Ertan, U. Holzgrabe, Electrophoresis 25, 2801-2807 (2004)\n- Development of a New Type of Allosteric Modulators of Muscarinic Receptors. Hybrids of the antagonist AFDX384 and the Hexamethonium Derivative W84\nA. Atai, E. Heller, M. Mohr, K. Mohr, U. Holzgrabe, J. Med. Chem. 47, 3324-3327 (2004)\n- Quality of APIs - result of a research of different gentamicin products\nU. Holzgrabe, R. Deubner, F. Wienen, American Pharmaceutical Outsourcing 5, 24-28 (2004)\n- Allosteric modulators of tertiary alkanebisamino-type: variation of the substitution of the middle chain nitrogens\nR. Pick, S. Duda-Johner, C. Tr\u00e4nkle, K. Mohr, U. Holzgrabe, Monatsh. Chem. 135, 1539-1556 (2004)\n- Determination of binding constants of cyclodextrin inclusion complexes with amino acids and dipeptides by potentiometric titration\nC. Kahle, U. Holzgrabe, Chirality 16, 509-515 (2004)\n- Critical aspects of analysis of Micrococcus luteus, Neisseria cinerea and Pseudomonas fluorescens by means of capillary electrophoresis\nV. Hoerr, A. Stich, U. Holzgrabe, Electrophoresis 25, 3132-3138 (2004)\n- Analysis of atropine, its degradation products and related substances of natural origin by means of reversed phase high performance liquid chromatography\nC. Kirchoff, Y. Bitar, S. Ebel, U. Holzgrabe, J. Chromatogr. A 1046, 115-120 (2004)\n- Comparison of Pharmacological Activities of Salvinorin A, TRK-820 and 3FLB on the &[mu], &[delta] and &[kappa] Opioid and Nociceptin/orphanin FQ Receptors Expressed in CHO Cells and Their Antipruritic Activities in vivo\nY. Wang, K. Tang, S. Inan, D. Siebert, U. Holzgrabe, D. Lee, P. Huang, J.-G. Li, A. Cowan, L.-Y. Liu-Chen, J. Pharmacol. Exp. Therap. 312, 220-230 (2005)\n- Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents\nM. Muth, M. Sennwitz, K. Mohr, U. Holzgrabe, J. Med. Chem. 48, 2212-2217 (2005)\n- NMR spectroscopic and molecular modeling studies on cyclodextrin-dipeptide inclusion complexes\nC. Kahle, R. Deubner, Curd Schollmayer, Josef Scheiber, Knut Baumann, U. Holzgrabe, Eur. J. Org. Chem. 2005, 1578-1589 (2005)\n- Microwave-enhanced hydrogenation at medium pressure using a newly constructed reactor\nE. Heller, W. Lautenschl\u00e4ger, U. Holzgrabe, Tetrahedron Lett. 46, 1247-1249 (2005)\n- Analysis of the glucosinolate pattern of Arabidopsis thaliana seeds by capillary electrophoresis coupled to electrospray ionization mass spectrometry\nG. Bringmann, I. Kajahn, C. Neus\u00fc\u00df, M. Pelzing, S. Laug, M. Unger, U. Holzgrabe, Electrophoresis 26, 1513-1522 (2005)\n- Vibrational spectroscopic characterization of fluoroquinolones\nU. Neugebauer, A. Szeghalmi, M. Schmitt, W. Kiefer, J. Popp, U Holzgrabe, Spectrochimica Acta Part A 61, 1505-1517 (2005)\n- Development and Validation of a Separation Method for the Diastereomers and Enantiomers of Aziridine-type Protease Inhibitors\nY. Bitar, B. Degel, T. Schirmeister, U. Holzgrabe, Electrophoresis 26, 2313-2319 (2005)\n- Quantitative NMR spectroscopy - applications in drug analysis\nU. Holzgrabe, R. Deubner, C. Schollmayer, B. Waibel, J. Pharm. Biomed. Anal, 38, 806-812 (2005)\n- Proteinbindung von Arzneistoffen\nA. Heinze, U. Holzgrabe, Bioforum 6, 21-23 (2005)\n- Multivariate Analysis of Nuclear Magnetic Resonance Data - Characterization of Critical Drug Substance Quality of Gentamicin Sulfate\nW. Winter, R. Deubner, U. Holzgrabe, J. Pharm. Biomed. Anal., 38, 833-839 (2005)\n- Evaluation by Monte Carlo Simulation of the Pharmacokinetics at Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Normal Volunteers\nW. A. Kr\u00fcger, J. Bulitta, M. Kinzig-Schippers, C. Landersdorfer, U. Holzgrabe, K. G. Naber, G. L. Drusano, F. S\u00f6rgel, Antimicrob. Agents Chemother. 49, 1881-1889 (2005)\n- Anwendung der zweidimensionalen Isotachophorese\nD. Flottmann, J. Hins, C. Rettenmaier, N. Schnell, G. Bruchelt, U. Holzgrabe, CLB 56 (1), 14-17 (2005)\n- Capillary Zone Electrophoresis as a Tool for the Quality Control of Goldenseal Extracts\nM. Unger, S. Laug, U. Holzgrabe, Electrophoresis 26, 2430-2436 (2005)\n- Impurities in critical drugs\nU. Holzgrabe, Proceedings of the conference \"Quality on the move\" Budapest, 26, 63-67 (2004)\n- Studies on the stereochemistry of 1,2,6-trimethyl-4-piperidones\nF. Diwischek, B. Engels, U. Holzgrabe, Tetrahedron 61, 6993-7001 (2005)\n- Impurity profile of amino acids?\nS. Kopec, U. Holzgrabe, Pharmeuropa Scientific Note 2005-1, 39-45 (2005)\n- Comparison of the separation of aziridine isomers applying HDMS and HDAS in aqueous and non-aqueous systems\nY. Bitar, B. Degel, T. Schirmeister, U. Holzgrabe, Electrophoresis 26, 3897-3902 (2005)\n- Cytochrome P450 1A2 phenotyping for students laboratories\nS. Priller, M. Unger, U. Holzgrabe, Pharmacy Education 5, 157-168 (2005)\n- Batch Variability of Bacitracin - HPLC versus MEKC\nC. Weber, S. Matingen, U. Holzgrabe, Pharmeuropa Scientific Note, 2005-1, 47-51 (2005)\n- Random Chemistry as a New Tool for the Generation of Small Compound Libraries: Development fo a New Acetylcholinesterase Inhibitor\nP. Kapkova, E. Heller, M. Unger, G. Folkers, U. Holzgrabe, J. Med. Chem., 48, 7496-7499 (2005)\n- Atypical muscarinic allosteric modulation: Cooperativity among allosteric modulators and an atypical binding topology in muscarinic M2/M5 chimaeric receptors\nC. Tr\u00e4nkle, A. Dittmann, U. Schulz, O. Weyand, S. Buller, K. J\u00f6hren, N. Birdsall, U. Holzgrabe, J. Ellis, H.-D. H\u00f6ltje, K. Mohr, Mol. Pharmacol. 68, 1597-1610 (2005)\n- Synthesis and Biological Activity of New N1-Aryl substituted Quinolone Antibacterials\nJ. J\u00fcrgens,H. Schedletzky, P. Heisig, J.K. Seydel ,B. Wiedemann, U. Holzgrabe, Arch. Pharm. Pharm. Med. Chem. 329, 179-190 (1996)\n- Search for the Pharmacophore in Kappa-agonistic Diazabicyclo[3.3.1]nonan-9-one-1,5-diester and Arylacetamides\nW. Brandt, S. Drosihn, M. Haurand, U. Holzgrabe, C. Nachtsheim, Arch. Pharm. Pharm. Med. Chem. 329, 311-323 (1996)\n- Conformational Analysis, Molecular Shape Comparison, and Pharmacophore Identification of Different Allosteric Modulators of Muscarinic Receptors\nU. Holzgrabe, A. J. Hopfinger, J. Chem. Inf. Comp. Sci. 36, 1018-1024 (1996)\n- Comparison of Structurally Different Allosteric Modulators of Muscarinic Receptors by Self-Organizing Neural Networks\nU. Holzgrabe, M. Wagener, J. Gasteiger, J. Mol. Graph. 14, 185-193 (1996)\n- Evidence for a Multiple Binding Mode of Bispyridinium-type Allosteric Modulators of Muscarinic Receptors\nE. Kostenis, H. M. Botero Cid, U. Holzgrabe, K. Mohr, Eur. J. Pharmacol. 314, 385-392 (1996)\n- Chiral Discrimination of Ephedrine and Methylephedrine induced by b-Cyclodextrin, Heptakis(2,3-di-O-acetyl)b-cyclodextrin and Heptakis(6-O-acetyl)b-cyclodextrin\nU. Holzgrabe, H. Mallwitz, S. K. Branch, T. M. Jefferies, M. Wiese, Chirality 9, 211-219 (1997)\n- Effect of b-Cyclodextrin Acetylation on Resolution of Phenethylamines with CE and NMR Spectroscopy\nS. K. Branch, U. Holzgrabe, T. M. Jefferies, H. Mallwitz, F.J.R. Oxley, J. Chromatogr. A 758, 277-292 (1997)\n- Stability of Mono- and Bisbenzyl Ethers of the Acetylcholinesterase-reactivator TMB-4\nE. Inkmann, U. Holzgrabe, K.-F. Hesse, Pharmazie 52, 764-774 (1997)\n- Solid State Structure of 1\u00b4,1\u00b4-(1,3-propanediyl)bis(4-cyano)pyridinium Dibromide\nE. Inkmann, U. Holzgrabe, D. Schroeder, H. Reuter, Zt. Kristallogr. 212, 408 (1997)\n- Contributions of Lateral Substituents of Heptane-bisammonium Derivatives to the Allosteric Modulation of Antagonist Binding to Muscarinic M2-Receptors\nM. Staudt, C. Tr\u00e4nkle, K. Mohr, U. Holzgrabe, Life Sci. 62, 423-429 (1998)\n- Plasma Protein Binding of Gyrase Inhibitors</>\nG. Zlotos, A. B\u00fccker, U. Holzgrabe, M. Kinzig-Schippers, F. S\u00f6rgel, J. Pharm. Sci. 87, 215-220 (1998)\n- Utilizing NMR-Spectroscopy for Assessing Drug Enantiomeric Composition\nM. Thunhorst, U. Holzgrabe, Magn. Res. Chem. 36, 211-216 (1998)\n- Formation of a 1,6-Naphthyridine Derivative by a Double Mannich Reaction\nT. Siener, U. M\u00fcller, M. Jansen, U. Holzgrabe, Pharmazie 53, 442-445 (1998)\n- Defluorinated Sparfloxacin as a new photoproduct identified by liquid chromatography coupled with UV detection and tandem mass spectrometry\nM. Engler, G. R\u00fcsing, F. S\u00f6rgel, U. Holzgrabe, Antimicrobial Ag. Chemother. 42, 1151-1159 (1998)\n- Protein binding in a congeneric series of antibacterial quinolone derivatives\nG. Zlotos, A. B\u00fccker, U. Holzgrabe, Int. J. Pharmaceut. 169, 229-238 (1998)\n- Identification of a [3H]ligand for the common allosteric site of muscarinic acetylcholine M2-receptors\nC. Tr\u00e4nkle, E. Mies-Klomfa\u00df, H.M. Botero Cid, U. Holzgrabe, K. Mohr, Mol. Pharmacol. 54, 139-145 (1998)\n- Effects of various cyclodextrin derivatives on the resolution of fencamfamine isomers with CE and NMR\nM. Thunhorst, Y. Otte, T. Jefferies, S.K. Branch, U. Holzgrabe, J. Chromatogr. A 818, 239-249 (1998)\n- NMR spectroscopy in Pharmacy\nU. Holzgrabe, B. Diehl, I. Wawer, J. Pharm. Biomed. Anal. 17, 557-616 (1998)\n- The Use of Self-organizing Neural Networks in Drug Discovery\nS. Anzali, J. Gasteiger, U. Holzgrabe, J. Polanski, J. Sadowski, A. Teckentrup, M. Wagener\nin: H. Kubinyi, Y. Martin, G. Folkers, Perspectives in Drug Discovery and Design (Vol. 2)\nKluwer Acad. Publ. 9/19/11, 273-299 (1995)\n- HZ2, a selective kappa-agonist\nB. K\u00f6gel, T. Christoph, E. Friderichs, H.-H. Hennies, T. Matthiesen, J. Schneider, U. Holzgrabe, CNS Drug Reviews Perspectives in Drug Discovery and Design (Vol. 2), 54-70 (1998)\n- Determination of protein binding of gyrase inhibitors by means of continuous ultrafiltration\nG. Zlotos, M. Oehlmann, P. Nickel, U. Holzgrabe, J. Pharm. Biomed. Anal. 18, 847-858 (1998)\n- Allosteric Modulation of Antagonist Binding to Muscarinic Receptors\nU. Holzgrabe, K. Mohr, Drug Discovery Today 3, 216-222 (1998)\n- 1H and 13C Nuclear Magnetic Resonance Studies on Itraconazole in Neutral and Acid Solutions\nE. Inkmann, U. Holzgrabe, J. Pharm. Biomed. Anal. 20, 297-307 (1999)\n- Bisquaternary Ligands of the Common Allosteric Site of M2 Acetylcholine Receptors: Optimization of the Distances Between the Pharmacophoric Elements\nT. Nassif-Makki, C. Tr\u00e4nkle, G. Bejeuhr, A. Cambareri, C. Pfletschinger, E. Kostenis, K. Mohr, U. Holzgrabe, J. Med. Chem. 42, 849-858 (1999)\n- Enantioseparation of tropa alkaloids by means of anionic cyclodextrin modified capillary electrophoresis\nM. Wedig, U. Holzgrabe, Electrophoresis 20, 1555-1560 (1999)\n- Molecular hydropathicity index: Application to a series of allosteric modulators of the M2 receptors\nG. Vistoli, A. Pedretti, A.M. Villa, L. Villa, U. Holzgrabe, A. Cambareri, Analusis 27, 32-41 (1999)\n- Determination of the Enantiomeric Purity by Means of NMR Spectroscopy and Capillary Electrophoresis Using a Derivatized Cyclodextrin: A Comparison\nM. Thunhorst, B. Diehl, U. Holzgrabe, Pharmazie 54, 746-750 (1999)\n- Resolution of newly synthesized racemic dihydropyridines with different chiral selectors by means of capillary electrophoresis\nT. Christians, D. Diewald, C. We\u00dfler, Y. Otte, J. Lehmann, U. Holzgrabe, J. Chromatogr. A 853, 455-460 (1999)\n- Resolution of ephedrine derivatives by means of neutral and sulfated heptakis(2,3-di-O-acetyl)b-cyclodextrins using capillary electrophoresis and nuclear magnetic resonance spectroscopy\nM. Wedig, U. Holzgrabe, Electrophoresis 20, 2698-2704 (1999)\n- Muscarinic receptor agonists and antagonists\nD. P. Zlotos, W. Bender, U. Holzgrabe, Expert Opin. Ther. Pat. 9, 1029-1053 (1999)\n- Conformational and configurational behaviour of k-agonistic 3,7-diazabicyclo[3.3.1]nonan-9-ones-synthesis, nuclear magnetic resonance studies and semiempirical PM3 calculations\nT. Siener, U. Holzgrabe, S. Drosihn, W. Brandt, J. Chem. Soc. Perkin 2, 1827-1834 (1999)\n- Synthesis, X-ray analysis, and Spectroscopic Characterization of the Hemiaminal Cyclisation Product from 2,4-dipyridine Substituted 3,7-Diazabicyclo[3.3.1]nonanone 1,5-diester\nU. Kuhl, A. Cambareri, C. Sauber, F. S\u00f6rgel, H. Euler, R. Hartmann, A. Kirfel, U. Holzgrabe, J. Chem. Soc. Perkin 2, 2083-2088 (1999)\n- Probing the Size of a Hydrophobic Binding Pocket within the Allosteric Site of Muscarinic Acetylcholine M2-Receptors\nW. Bender, M. Staudt, K. Mohr, U. Holzgrabe, Life Science 66, 1675-82 (2000)\n- Ligands for the common allosteric site of acetylcholine M2-receptors: development and application\nU. Holzgrabe, W. Bender, H.M. Botero Cid, M. Staudt, R. Pick, C. Pfletschinger, E. Balatkova, C. Tr\u00e4nkle, K. Mohr, Pharm. Acta Helv. 74, 149-155 (2000)\n- Enantioseparation of dihydropyridine derivatives by means of neutral and negatively charged b-cyclodextrin derivatives using capillary electrophoresis\nT. Christians, U. Holzgrabe, Electrophoresis 21, 3609-3617 (2000)\n- Structure-activity Relationships in a Series of Bisquaternary Phthalimidine Derivatives Modulating the Muscarinic M2-Receptor Allosterically\nH. M. Botero Cid, C. Tr\u00e4nkle, R. Pick, E. Mies-Klomfa\u00df, E. Kostenis, K. Mohr, K. Baumann, U. Holzgrabe, J. Med. Chem. 43, 2155-2164 (2000)\n- Diazabicyclo[3.3.1]nonanone-type Ligands for the Opioid Receptors\nU. Kuhl, W. Englberger, U. Holzgrabe, Arch. Pharm. Pharm. Med. Chem. 333, 226-230 (2000)\n- Synthesis and Opioid affinity in a Series of Opioid-type analgesics: Diazabicyclo[3.3.1]nonan-9-ones\nT. Siener, A. Cambareri, U. Kuhl, W. Englberger, M. Haurand, B. K\u00f6gel U. Holzgrabe, J. Med. Chem. 43, 3746-3751 (2000)\n- Stereochemistry of 2,6-Dipyridine Substituted N-Benzyl-4-piperidone Mono- and Dicarboxylates and of the Corresponding Reduction Products\nU. Holzgrabe, B. Piening, K.-F. Hesse, H.-D. H\u00f6ltje, M. Worch, Z. Naturforsch. 44B, 565-574 (1991)\n- Keto-Enol-Tautomerism and Configurational Isomerism of 2,6-Disubstituted 4-Piperidone-3,5-dicarboxylates\nU. Holzgrabe, W. Friedrichsen, K.-F. Hesse, Z. Naturforsch. 46B, 1237-1250 (1991)\n- Synthese und Stereochemie potentiell stark analgetischer 2,4-m-diarylsubstituierter 3,7-Diazabicyclo[3.3.1]nonan-9-on-1,5-diester\nU. Holzgrabe, E. Erciyas, Arch. Pharm. (Weinheim) 325, 657-663 (1992)\n- 1H and 13C NMR Studies of Substituted Isoquinolines and Corresponding Isoquinolinium Derivatives in Different Solvents\nW. Werra, U. Holzgrabe, D. Heber, Magn. Res. Chem. 30, 640-644 (1992)\n- Molecular Modelling and Synthesis of Potent Stabilizers of Antagonist Binding to M2-Cholinoceptors\nG. Bejeuhr, U. Holzgrabe, K. Mohr, U. S\u00fcrig, A. v. Petersenn, Pharm. Pharmacol. Lett. 2, 100-103 (1992)\n- Cer(IV)oxidationen von b-Aminoketonen. 8. Mitt.: Synthese von im Piperidinteil verschieden substituierten 1,2,3,4-Tetrahydroisochinolinen\nU. Holzgrabe, E. Inkmann, Arch. Pharm. (Weinheim) 326, 209-215 (1993)\n- Synthesis and Nucleophilic Reactions of Cyano Substituted N-Methoxyisoquinolinium Salts\nD. Heber, U. Holzgrabe, W. Werra, Arch. Pharm. (Weinheim) 326, 785-790 (1993)\n- E/Z Isomerism of Anilinomethylenmalonic Acid Derivatives\nC. B\u00fcnz, D. Heber, U. Holzgrabe und U. S\u00fcrig, Magn. Res. Chem. 31, 371-374 (1993)\n- Cerium(IV) Oxidations. Part IX. Cyclization of Diethyl 4-phenylbutane-1,1-dicarboxylate\nU. Holzgrabe, J. Reinhardt, E. Stoll, Arch. Pharm. (Weinheim) 326, 985-987 (1993)\n- On a Stable and Highly Potent Hexamethonium Derivative Modulating Muscarinic Receptors Allosterically\nD. Bejeuhr, G. Blaschke, U. Holzgrabe, K. Mohr, U. S\u00fcrig, G. Terfloth, J. Pharm. Pharmacol. 46, 108-112 (1994)\n- 1H, 19F, and 13C NMR Spectral Data of fifteen Gyrase Inhibitors and some Metabolites\nU. Holzgrabe, S. K. Branch, Magn. Res. Chem. 32, 192-197 (1994)\n- Structurally Novel Group of Ligands selective for k-Opioid Receptors\nA. Borsodi, S. Benyhe, U. Holzgrabe, A. Marki, C. Nachtsheim, Regulatory Peptides 54, 27-28 (1994)\n- Cer(IV)oxidationen. Teil X. Oxidationen von w-Phenylalkyldicarbonyl- und dicarbonylanalogen Verbindungen\nU. Holzgrabe, J. Reinhardt, G. Zlotos, Arch. Pharm. (Weinheim) 327, 515-523 (1994)\n- Chiral Discrimination of Structurally Related Hydroxyphenylethylamines with b-Cyclodextrines and Heptakis(2,3-di-O-acetyl)b-cyclodextrin by Capillary Electrophoresis and NMR Spectroscopy\nS. K. Branch, U. Holzgrabe, T. M. Jefferies, M. W. Matchett, H. Mallwitz, J. Biomed. Pharm. Anal. 12, 1507-1517 (1994)\n- Search for the Pharmacophore of Bispyridinium-Type Allosteric Modulators of Muscarinic Receptors\nM. H. Botero Cid, U. Holzgrabe, E. Kostenis, K. Mohr, C. Tr\u00e4nkle, J. Med. Chem. 37, 1439-1445 (1994)\n- Allosteric effect on M2-cholinoceptors of derivatives of the alkane-bis-ammonium compound W84 - comparison with bispyridinium-type allosteric modulators\nE. Kostenis, U. Holzgrabe, K. Mohr, Eur. J. Med. Chem. 29, 947-953 (1994)\n- Variation of the Oxime function in Bispyridinium-type Allosteric Modulators of M2-Cholinoceptors\nJ. Gasteiger, U. Holzgrabe, E. Kostenis, K. Mohr, U. S\u00fcrig, M. Wagener, Pharmazie 50, 99-105 (1995)\n- Reduktionen substituierter 3,7-Diaza- und 3-Thia-7-azabicyclo[3.3.1]nonan-9-one mit Natriumborhydrid\nR. Haller, U. Ashauer, Arch. Pharm. (Weinheim) 318, 405-410 (1985)\n- Terti\u00e4re 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ole\nR. Haller, U. Ashauer, Arch. Pharm. (Weinheim) 318, 440-445 (1985)\n- Reduktionen heterocyclischer 9-Oxobicyclo[3.3.1]nonan-1,5-dicarbons\u00e4urealkylester mit komplexen Metallhydriden zu dreiwertigen Alkoholen\nR. Haller, U. Ashauer, Arch. Pharm. (Weinheim) 318, 525-531 (1985)\n- Konformere 3-Oxa-7-azabicyclo[3.3.1]nonanone und ihre Reaktionsprodukte\nR. Haller, U. Ashauer, Arch. Pharm. (Weinheim) 318, 700-707 (1985)\n- 1H- und 13C-NMR-spektroskopische Untersuchungen von 3-arylsubstituierten 2-Azaindolizinen\nU. Ashauer, C. Wolff, R. Haller, Arch. Pharm. (Weinheim) 319, 43-52 (1986)\n- Zur Umsetzung von N-benzylsubstituierten Piperidoncarbons\u00e4ureestern mit Cer(IV)sulfat\nU. Ashauer-Holzgrabe, R. Haller, Arch.Pharm. (Weinheim) 319, 1079-1083 (1986)\n- Stereochemistry of Substituted Isomeric 3-Oxa-7-azabicyclo[3.3.1]nonanones\nH. K\u00fcppers, K.-F. Hesse, U. Ashauer-Holzgrabe, R. Haller, Z. Naturforsch. 42B, 221-228 (1987)\n- 5-Oxo-1H-3,4,5,6-tetrahydro-2,6-methano-2-benzazocin und seine Reduktionsprodukte\nU. Ashauer-Holzgrabe, Arch. Pharm. (Weinheim) 320, 481-486 (1987)\n- Cer(IV)sulfat-Oxidationen: Intramolekulare Cyclisierung von N-Benzyl-b-aminoketonen zu 4-Benzoyl-1,2,3,4-tetrahydroisochinolinen\nU. Holzgrabe, Arch. Pharm. (Weinheim) 320, 647-654 (1987)\n- Cer(IV)oxidation von b-Aminoketonen. 3. Mitt.: Ein Syntheseweg zu 4-spirosubstituierten 1,2,3,4-Tetrahydroisochinolinen\nU. Holzgrabe, Arch. Pharm. (Weinheim) 321, 181 (1988)\n- Synthesis and X Ray Analysis of the (S) Enantiomer of Methyl 5-Hydroxy-3,11-di-2-pyridyl-4,5-dihydro-1H,3H-2,6-methano-6-benz[c]azocinecarboxylate C24H23N3O3 and of the Corresponding Camphanic Acid Ester C34H35N3O6\nK.-F. Hesse, U. Holzgrabe, B. Piening, Z. Naturforsch. 43B, 901-910 (1988)\n- Konformations- und Konfigurationsisomere substituierter 3-Oxa-7-azabicyclo[3.3.1]nonan-9-one\nU. Ashauer-Holzgrabe, T. Busch, Z. Naturforsch. 43B, 873-877 (1988)\n- Structure of Diethyl 9-Hydroxy-7-methyl-2,4-diphenyl-3-oxa-7-aza-1,5-bicyclo[3.3.1]- nonanedicarboxylate\nH. K\u00fcppers, U. Ashauer-Holzgrabe, Acta Cryst. C44, 1751-1754 (1988)\n- Cer(IV)-Oxidationen von b-Aminoketonen. Teil IV. Synthese isomerer Phenanthridinone\nU. Holzgrabe, C. Wolff, Arch. Pharm. (Weinheim) 321, 307-308 (1988)\n- Cer(IV)-Oxidationen von b-Aminoketonen. 5. Mitt.: Synthese verschieden substituierter 5-Oxo-2,6-methano-2-benzazocine\nU. Holzgrabe, B. Piening, R. Kohlmorgen, E. Stoll, Arch. Pharm. (Weinheim) 321, 917-920 (1988)\n- Cer(IV)-Oxidationen von b-Aminoketonen. 6. Mitt.: Untersuchungen zum Reaktionsverlauf\nU. Holzgrabe, Arch. Pharm. (Weinheim) 322, 137-140 (1989)\n- Cer(IV)-Oxidationen von b-Aminoketonen. 7. Mitt.: Synthese von 4-Benzoylisochinolin und des davon abgeleiteten Lactams\nU. Holzgrabe, Arch. Pharm. (Weinheim) 321, 767-768 (1988)\n- Reduktionen 3,11-dipyridylsubstituierter 5-Oxo-2,6-methano-2-benzazocin-6-carbon- s\u00e4ureester\nU. Holzgrabe, B. Piening, R. Haller, Arch. Pharm. (Weinheim) 322, 21-23 (1989)\n- Synthese, Stereochemie und analgetische Wirkung von 3,7-Diazabicyclo[3.3.1]nonan-9-onen und 1,3-Diazaadamantan-6-onen\nA. Samhammer, U. Holzgrabe, R. Haller, Arch. Pharm. (Weinheim) 322, 551-555 (1989)\n- Reduktionen an 3,7-Diazabicyclo[3.3.1]nonan-9-onen und davon abgeleiteten 1,3-Diazaadamantan-6-onen\nA. Samhammer, U. Holzgrabe, R. Haller, Arch. Pharm. (Weinheim) 322, 545-550 (1989)\n- Stereoselektive Synthese terti\u00e4rer 2,6-Methano-2-benzazocin-5-ole\nU. Holzgrabe, B. Piening, R. Haller, Arch. Pharm. (Weinheim) 323, 177-180 (1990)\n- Verfahren zur katalytischen Hydrierung von organischen Stoffen mit Mikrowellen\nU. Holzgrabe, E. Heller\nDE 10 2004 041 492 A1\n- Antitrypanosomale Aktivit\u00e4t quart\u00e4rer Naphthalimid-Derivate\nU. Holzgrabe, V. Hoerr, M. Muth, A. Ponte-Sucre, H. Moll, A. Stich\nDE 10 2006 060 707.4\n- Inhibitoren der zellul\u00e4ren Deoxyhypusin-Hydroxylase\nU. Holzgrabe, J. Kl\u00f6ckner, I. Hauber, J. Hauber\nEurop\u00e4isches Patent 07017891.8-2123\n- 4-Hydrazono-1,4-dihydropyridine Derivatives And their Medical Use\nU. Holzgrabe, V. Alptuezuen\nPCT/EP2010/057927; CODEN: PIXXD2 WO 2010/142642 A1\n- Tetrahydroisoquinolone derivatives and their use in the inhibition of HSP70 proteins\nU. Holzgrabe, C. Sotriffer, M. Chatterjee, E. M\u00fcller, A. Hartung, U. Peinz, D. Zilian\nPCT/EP2014/061495\n- Herstellung von Fluoreszenzfarbstoffen im Mikrowellenfeld und die Beobachtung des Reaktionsfortschrittes in Echtzeit mittels UV-Vis-Sensors\nU. Holzgrabe, E. Heller\n- Analgetika\nU. Holzgrabe, Dtsch. Apo. Ztg. 129, 1714-1718 (1989)\n- Neue Liganden am Benzodiazepinrezeptor\nU. Holzgrabe, Pharm.-Ztg. Wissenschaft 135, 45-52 (1990)\n- Phosphors\u00e4ureester: Vergiftung und Therapie aus molekularer Sicht\nU. Holzgrabe, G. Bejeuhr, Pharm. i. u. Z. 19, 247-256 (1990)\n- 2D-NMR-Spektroskopie zur Strukturaufkl\u00e4rung von Arzneistoffen\nU. Holzgrabe, S.K. Branch, Pharm.-Ztg. Wissenschaft 135, 211-214 (1990)\n- Gyrasehemmstoffe - Praktische Anwendung und theoretische Betrachtungen\nG. Bejeuhr, U. Holzgrabe, J. J\u00fcrgens, Pharm.-Ztg. Wissenschaft 137, 149-159 (1992)\n- Abschied von einem Modell - Struktur der Acetylcholinesterase\nU. Holzgrabe, Dtsch. Apo. Ztg. 133, 1901-1902 (1993)\n- Razemate - Kombinationspr\u00e4parate\nU. Holzgrabe, G. Bejeuhr, Dtsch. Apo. Ztg. 134, 2133 (1994)\n- Anatoxin-a(s) - ein bakterielles Organophosphat\nU. Holzgrabe, Pharm. i. u. Z. 23, 301-202 (1994)\n- Organophosphorus Insecticides: the Silent Killer\nU. Holzgrabe, TV-Sendung f\u00fcr \"undergraduate students\" an indischen Universit\u00e4ten und Schulen (1995)\n- K\u00f6nnen Arzneistoffe am Computer ma\u00dfgeschneidert werden?\nU. Holzgrabe, Pharm. i. u. Z. 25, 322-325 (1996)\n- Opioid-Agonisten und -Antagonisten - Opioidrezeptoren\nU. Holzgrabe, C. Nachtsheim, T. Siener, W. Brandt, S. Drosihn, Die Pharmazie 52, 4-22 (1997)\n- Antiepileptika im \u00dcberblick\nU. Holzgrabe, Pharm. i. u. Z. 26, 152-156 (1997)\n- ABT-594, ein nicht-opioides Analgetikum\nU. Holzgrabe, E. Inkmann, Pharm. i. u. Z. 27, 289-290 (1998)\n- Neue 4-Chinolonderivate im \u00dcberblick\nU. Holzgrabe, P. Heisig, Pharm. i. u. Z. 28, 30-35 (1999)\n- Paradigmenwechsel in der Entwicklung antiinfektiver Chemotherapeutika? Neue Methoden zur Entwicklung neuer Leitstrukturen\nU. Holzgrabe, A. Bechthold, Chemotherapiejournal 8, 69-78 (1999)\n- Antibiotische Chemotherapeutika\nU. Holzgrabe, A. Bechthold, Dtsch. Apo. Ztg. 140, 813-823 (2000)\n- Gyrasehemmstoffe im Abwind?\nU. Holzgrabe, Pharm. Ztg. 145, 3499-3504 (2000)\n- Medizinische Chemie und Analytik\nU. Holzgrabe, PZ Prisma 8, 15-23 (2001)\n- Wohin geht die Chinolonreise? Neue Wirkstoffe in der Entwicklung\nU. Holzgrabe, Pharm. i. u. Z. 30, 446-448 (2001)\n- In einer Formel lesen wie in einem Buch\nU. Holzgrabe, Med. Monatszeitschrift f. Pharmazeuten 24, 354-355 (2001)\n- Diazabicyclononanones, a new class of opioid-type analgesics\nU. Holzgrabe, E. Friderichs, W. Englberger, W. Strassburger, M. Haurand, B. K\u00f6gel, W. Brandt, A. Cambareri, U. Kuhl, T. Siener, Science and Culture 68, 11-18 (2002)\n- Ketolide und Oxazolidinone auf dem Pr\u00fcfstand\nU. Holzgrabe, Pharm. Ztg. 147, 1978-1983 (2002)\n- Stark wirksame Schmerzmittel ohne kritische Nebenwirkungen: Ist das m\u00f6glich?\nU. Holzgrabe, H. Projahn, D. Ulmer, Pharm. Ztg. 148, 1345-1351 (2003)\n- Verunreinigung von Arzneistoffen\nU. Holzgrabe, R. Deubner, N. Novatchev, F. Wienen, Dtsch. Apotheker-Zeitung 143, 3221-3228 (2003)\n- NMR Spectroscopy in Drug Analysis - Quantitative NMR spectroscopy\nPart 1: Determination of the Isomeric Composition of Drugs\nU. Holzgrabe, R. Deubner, C. Schollmayer, Bruker-Skripten (2003)\n- In der Pipeline, Ketolide und Oxazolidinone\nU. Holzgrabe, Pharm. i. u. Z. 33, (2003)\n- Antibiotikaentwicklung gestern und heute\nU. Holzgrabe, Chemotherapiejournal 13, 142-147 (2004)\n- Paul Ehrlich, seine Forschungsgebiete und ihre Wirkung auf die Gegenwart - Gedanken zu seinem 150. Geburtstag\nF.S\u00f6rgel, J. Bulitta, U. Holzgrabe, Pharm. Ztg. 149, 1038-1042 (2004)\n- Distributionswege - wie stabil sind Arzneimittel\nU. Holzgrabe, Pharm. Ztg. 149, 2190-2193 (2004)\n- Welche Berufsbezeichnung wird Ehrlichs Wirken gerecht? Bemerkungen zu seinem 150. Geburtstag\nF.S\u00f6rgel, J. Bulitta, U. Holzgrabe, Chemotherapiejournal 13, 157-165 (2004)\n- Neue selektive Estrogenrezeptore-Modulatoren - Me-too-SERMs?\nU. Holzgrabe, Pharm. i. u. Z. 33, 357-359 (2004)\n- Was tun gegen die zunehmende Resistenzentwicklung?\nU. Holzgrabe, Dtsch. Apotheker-Zeitung 145, 440-442 (2005)\n- Hase und Igel - der Wettlauf mit resistenten Bakterien\nP. Heisig, U. Holzgrabe, Pharm. Ztg. 150, 20-29 (2005)\n- Significance of capillary electrophoresis in the pharmaceutical industry\nU. Holzgrabe, Pharm. Ind. 67, 1209-1213 (2005)\n- T\u00f6dliche Bedrohung - Influenza und mehr\nU. Holzgrabe, E. Bennack, Pharm. Ztg. 150, 3065-74 (2005)\n- Die Natur als Wirkstofflieferant: Tropische Pflanzen als Produzenten neuartiger Wirkstoffe gegen Tropenkrankheiten\nGerhard Bringmann, Institut f\u00fcr Organische Chemie, und Ulrike Holzgrabe, Institut f\u00fcr Pharmazie und Lebensmittelchemie\nBericht in der Universit\u00e4tszeitung \"Blick\" (2005)\n- 200 Jahre Morphin und immer noch Neuigkeiten\nU. Holzgrabe, Pharm. Ztg. 150, 3626-3632 (2005)\n- Sprung- und Schrittinnovationen bei Antibiotika\nU. Holzgrabe, Dtsch. Apo. Ztg. 146, 251-257 (2006)\n- Katalytische Hydrierungen in der Mikrowelle bis 25 bar\nE. Heller, U. Holzgrabe, Nachrichten aus der Chemie 54, 29-33 (2006)\n- Glufosfamid - ein neues Lost-Derivat\nU. Holzgrabe, Pharm. i. u. Z. 35, 158-159 (2006)\n- Hydrierungen im Mikrowellenfeld unter Wasserstoffdruck\nE. Heller, U. Holzgrabe, W. Lautenschl\u00e4ger, Laborpraxis 30, M\u00e4rz 52-57 (2006)\n- Arzneimittel-R\u00fcckst\u00e4nde in Abwasser und Trinkwasser\nU. Holzgrabe, Technik in Bayern 10, 8-9 (2006)\n- Von Penicillin V zu tricyclischen \u00df-Lactamen - Struktur-Wirkungs-Beziehungen\nU. Holzgrabe, Pharm. i. u. Z. 35, 410-414 (2006)\n- Daptomycin\nU. Holzgrabe, Neue Arzneistoffe 1, 9-13 (2006)\n- Volkskrankheit COPD - eine \u00dcbersicht\nU. Holzgrabe, M. Muth, Med. Mo. Pharm. 30, 168-177 (2007)\n- Barbiturs\u00e4ure und -Derivate; Chloralhydrat, das \u00e4lteste Schlafmittel\nU. Holzgrabe, Pharm. i. u. Z. 36, 185, 195 (2007)\n[doi:10.1002/pauz.200790026](http://dx.doi.org/10.1002/pauz.200790026)\n[doi:10.1002/pauz.200790027](http://dx.doi.org/10.1002/pauz.200790027)\n- H1-Antihistaminika der ersten Generation\nE. Bennack, U. Holzgrabe, Pharm. i. u. Z. 36, 202-204 (2007)\n[doi:10.1002/pauz.200600218](http://dx.doi.org/10.1002/pauz.200600218)\n- Keine Second-Hand-Arzneimittel!\nU. Holzgrabe, Dtsch. Apotehker-Zeitung 147, 2270 (2007)\n- Quality of APIs - Gentamicin and others\nU. Holzgrabe, American Pharmaceutical Outsourcing, 5, 24-28 (2007)\n- Die neue Karriere des Thalidomids - ein altes Schlafmittel als Cancerostatikum\nU. Holzgrabe, Pharm. i. u. Z. 36, 446-449 (2007)\n[doi:10.1002/pauz.200700241](http://dx.doi.org/10.1002/pauz.200700241)\n- Gef\u00e4lschte Arzneimittel, auch in Deutschland ein Problem\nU. Holzgrabe, DZFK - Standpunkt 12 (3/4), 16-18 (2008)\n- Reduktase-Inhibitoren - Benigne Prostatahyperplasie und vieles mehr\nU. Holzgrabe, E. Bennack, Pharm. i. u. Z. 37, 310-313 (2008)\n[doi:10.1002/pauz.200700274](http://dx.doi.org/10.1002/pauz.200700274)\n- Heparin-Verunreinigungen - Die Spur f\u00fchrt nach China\nU. Holzgrabe, Pharm. Ztg. 153, 1036 (2008)\n- Vitamin E - alles im Fluss\nU. Holzgrabe, Pharm. i. u. Z. 38, 132-135 (2009)\n[doi:10.1002/pauz.200800304](http://dx.doi.org/10.1002/pauz.200800304)\n- Erkennung und Vermeidung von Arzneimittelf\u00e4lschungen durch Verwendung ad\u00e4quater Wirk- und Hilfsstoffe\nU. Holzgrabe, Pharm. Ind. 71, 2102-2108 (2009)\n- The light at the end of the tunnel? A hopeful beginning for a malaria vaccine\nU. Holzgrabe, International Pharmacy Journal 24, 31-34 (2009)\n- Problem Arzneimittelf\u00e4lschungen in Afrika und S\u00fcdostasien\nU. Holzgrabe, Pharm. i. u. Z. 38, 560-562 (2009)\n[doi:10.1002/pauz.200900345](http://dx.doi.org/10.1002/pauz.200900345)\n- Was gibt es Neues an der Heparinfront\nU. Holzgrabe, Pharm. Ztg. 154, 3147-3150 (2009)\n- Neue Antibiotika - den Vorsprung gegen\u00fcber resistenten Bakterien wahren?\nU. Holzgrabe, J. Schmitz, Pharm. Ztg. 154, 4780-4787 (2009)\n- Neue Strategien: Der Kampf gegen Arzneimittelf\u00e4lschungen\nC. B\u00fcttner-Merz, T. Beyer, U. Holzgrabe, GMP-Journal 16, 6-7 (2010)\n- Alte und neue Endothelin-Rezeptor-Antagonisten - PAH und viele andere Indikationen\nJ. Schmitz, U. Holzgrabe, Pharm. i. u. Z. 39(6), 430-435 (2010)\n[doi:10.1002/pauz.201000387](http://dx.doi.org/10.1002/pauz.201000387)\n- Wie sicher war die Oseltamivir-Versorgung in Zeiten der Grippe-Pandemie?\nU. Holzgrabe, Pharm. i. u. Z., 40(2), 151-154 (2011)\n[doi:10.1002/pauz.201100411](http://dx.doi.org/10.1002/pauz.201100411)\n- Multinationale Medikamente - Qualit\u00e4tssicherung im Zeitalter der Globalisierung - Kommentar\nU. Holzgrabe, Quantos Journal 01.2011, 2-3 (2011)\n- Schlankmacher, Potenzmittel und Co, Die Gefahr aus dem Netz - gef\u00e4lschte Medikamente in Deutschland\nU. Holzgrabe, Die Kriminalpolizei r\u00e4t: M\u00e4rz b2011, 4-5 (2011)\n- Antibiotika 2011 - Neue Wirkstoffe, aber kein Durchbruch\nJ. Schmitz, U. Holzgrabe, Pharm. Ztg. 156, 1030-1032 (2011)\n- Anabole Steroide - Gesundheitsgefahren im Web\nU. Holzgrabe, J. Schmitz, Pharm. Ztg. 156, 1650-1657 (2011)\n- Die Entwicklung selektiver a2-Rezeptor-Agonisten\nJ. Schmitz, U. Holzgrabe, Pharm. i. u. Z., 40(6), 496-502 (2011)\n[doi:10.1002/pauz.201100446](http://dx.doi.org/10.1002/pauz.201100446)\n- Die Fetts\u00e4uresynthese als Angriffspunkt - Von alten und neuen antimykobakteriellen Wirkstoffen\nC.M. Topf, J. Schiebel, C. Kisker, U. Holzgrabe, Pharm. i. u. Z., 41(1), 64-71 (2012)\n[doi:10.1002/pauz.201100454](http://dx.doi.org/10.1002/pauz.201100454)\n- MRSA - Entstehung, Verbreitung, Behandlung und Pr\u00e4vention\nU. Holzgrabe, M. Abele-Horn, Med. Mo. Pharm. 35(9), 319-328 (2012)\n- Conotoxine - vom Nervengift zum Analgetikum gegen Neuropathischen Schmerz\nU. Holzgrabe, J. Schmitz, Pharm. Ztg. 157, 4212-4218 (2012)\n- Arzneimittelf\u00e4lschungen - von wirkungslos bis gef\u00e4hrlich\nU. Holzgrabe, Pharm. Ztg. 158, 126-127 (2013)\n- Antibiotika in der Pipeline 2013\nU. Holzgrabe, Pharm. Ztg. 158, 1812-1820 (2013)\n- Antiarrhythmika - Taktgeber f\u00fcr ein unregelm\u00e4\u00dfig schlagendes Herz\nJ. Schmitz, U. Holzgrabe, Pharmakon 1, 326-335 (2013)\n- Renin-Inhibitoren - Irrungen und Wirrungen\nU. Holzgrabe, J. Schmitz, Pharmakon 1, 414-419 (2013)\n- Buchbespechung: Nina. C. Gonella: LC-NMR: expanding the limits of structure elucidation\nU. Holzgrabe, In: Bioanalytical Chemistry: 406, 1821-1822 (2014)\n- Conotoxine - Gifte der Kegelschnecken als hochpotente Anagetika\nU. Holzgrabe, J. Schmitz, Internistische Praxis 54, 427-435 (2014)\n- Wundermittel unter der Lupe\nU. Holzgrabe, J. Wiest, Pharm. Ztg. 159, 1484 (2014)\n- Arzneimittelf\u00e4lschungen - Biologika ohne Wirkstoff\nU. Holzgrabe, J. Wiest, Pharm. Ztg. 159, 2864-2865 (2014)\n- Bio oder nicht \u2013 lassen sich die Produkte durch 1H-NMR-Spektroskopie unterscheiden?\nM. Hohmann, N. Christoph, H. Wachter, U. Holzgrabe, Chemie in unserer Zeit 49, 8-9 (2015)\n- Alte Seuchen und neue Antibiotika\nU. Holzgrabe, Pharm. Ztg. 160, 1750-1757 (2015)\n- Farben als roter Faden\nU. Holzgrabe, J. Schmitz, F. S\u00f6rgel, Pharm. Ztg. 160, (2015)\n- Wirstoffe zur Therapie neuropathischer Schmerzen - Medizinische Chemie und Pipeline\nU. Holzgrabe, J. Schmitz, Pharmakon 3, 262-271 (2016)\n- Opioide in der palliativen Schmerztherapie\nJ. Schmitz, U. Holzgrabe, Pharmakon 3, 547-557 (2016)\n- Antibiotika-Entwicklung \u2013 Nachhaltigkeit kann Leben retten\nU. Holzgrabe, T. L\u00fchmann, L. Meinel, Pharm. Ztg. 161, 3864-3873 (2016)\n- Lieferengp\u00e4sse von Piperacillin-haltigen Arzneimitteln\nU. Holzgrabe, E. Bennack, H. Buschmann, L. H\u00f6llein, Deutsche Apothekerzeitung 157, 224-227 (2017)\n- Ein Lieferengpass und kein Mangel (Remifentanil)\nU. Holzgrabe, H. Buschmann,\nDeutsche Apotheker-Zeitung 157, 2102-2105 (2017)\n- Bronchialdilatation: LABA und LAMA\nU. Holzgrabe, P. H\u00f6gger, Med. Mo. Pharm. 40, 377-383 (2017)\n- Neue Antiinfektiva gegen Clostridium difficile\nU. Holzgrabe, Pharmakon 5, 446-450 (2018)\n- HPLC-CAD impurity profiling of carbocysteine using SCX-RP mixed-mode chromatography\nK. Schilling, R. Pawellek, U. Holzgrabe, Thermofisher Application Note (2018)\n- Gramnegative Keime: Wie gut sind die neuen Antibiotika?\nU. Holzgrabe, Pharm. Ztg. 163, 1480-1487 (2018)\n- Paradigmenwechsel vom Sondersammelgebiet zum Fachinformationsdienst Pharmazie\nU. Holzgrabe, ZfBB 65, 118-119 (2018)\n- Zu wenig Ibuprofen\nH. Buschmann, U. Holzgrabe, Deutsche Apotheker-Zeitung 158, 2767-2769 (2018)\n- NDMA in Valsartan\nH. Buschmann, U. Holzgrabe, Deutsche Apotheker-Zeitung 158, 2898-2902 (2018)\n- Pharmazeutische Qualit\u00e4tsanalytik in Entwicklungs- und Schwellenl\u00e4ndern: Vereinfachte HPLC-Analytik als Schnittstelle zwischen Minilab und den Arzneib\u00fcchern?\nL. H\u00f6llein, U. Holzgrabe, Pharmakon 6, 379-386 (2018)\n- HPLC-CAD impurity profiling of carbocisteine using SCX-RP mixed-mode chromatography\nK. Schilling, R. Pawellek, O. Wahl, U. Holzgrabe, Thermoscientific Application Note 72706 (2018)\n- Noch mehr Nitrosamine\nH. Buschmann, U. Holzgrabe, Deutsche Apotheker-Zeitung159, 50-54 (2019)\n- \u00dcberraschend stabil \u2013 Analyse von Altarzneien l\u00e4sst auf deutlich l\u00e4ngere Haltbarkeiten schlie\u00dfen\nM. Zilker, U- Holzgrabe, F. S\u00f6rgel, Deutsche Apotheker-Zeitung 159, 1646-1653 (2019)\n- \u201eUnerwartet\u201c verunreinigt\nH. Buschmann, U. Holzgrabe, D. Jung\nDeutsche Apotheker-Zeitung 159, 1866-1874 (2019)\n- Valsartan-Engpass \u2013 keine \u00dcberraschung (Gastkommentar)\nH. Buschmann, U. Holzgrabe, Deutsche Apotheker Zeitung 159, 1948 (2019)\n- Wof\u00fcr kann man SERM alles brauchen\nU. Holzgrabe, Pharm. Ztg. 164, 1800-1807 (2019)\n- Richtig lagern bei Hitze\nJ. Schmitz, S. Klapper, U. Holzgrabe, Deutsche Apotheker-Zeitung 159, 3234-3241 (2019)\n- Nitrosamine all \u00fcberall\nH. Buschmann, F. S\u00f6rgel, U. Holzgrabe, Deutsche Apotheker-Zeitung 159, 3632-3636 (2019)\n- Nitrosamine in Metformin\nH. Buschmann, F. S\u00f6rgel, U. Holzgrabe, Deutsche Apotheker-Zeitung 159, 4922-4925 (2019)\n- Ototoxizit\u00e4t von Arzneistoffen \u2013 ein Ph\u00e4nomen mit vielen Mechanismen\nE. Bennack, U. Holzgrabe, Pharmakon, 8, 38-43 (2020).\n- Lehren aus der Leere\nU. Holzgrabe, E. Bennack, F. S\u00f6rgel, D. Jung, H. Buschmann, Deutsche Apotheker-Zeitung 160, 1741-1745 (2020)\n- Gibt es wirklich neue Antibiotika in der Pipeline?\nUlrike Holzgrabe, Edith Bennack, Pharmakon, 8, 225-230 (2020)\n- Resistenzen durch Antibiotika im Abwasser\nUlrike Holzgrabe , Pharmakon, 8, 266-270 (2020)\n- Impurity Analysis of Aspartic acid and Glycine by HPLC-UV-CAD\nR. Pawellek, A. Leistner, U. Holzgrabe, ThermoFisher Scientific, Application Note (2020)\n- (K)ein \u00dcberraschungsbefund in Paracetamol \u2013 Synthesewege pr\u00e4destinieren f\u00fcr Verunreinigungen wie Chloranilin\nU. Holzgrabe, F. S\u00f6rgel, H. Buschmann, Deutsche Apotheker-Zeitung 160, 3224-3228 (2020)\n- Mit vereinten Kr\u00e4ften gegen Verunreinigungen \u2013 Komplement\u00e4re Detektoren in der Arzneibuchanalytik\nWith united forces against impurities, GIT-Labor-Fachzeitschrift eng. Fassung\nU. Holzgrabe, K. Schilling, R. Pawellek, O. Scherf-Clavel, GIT-Labor-Fachzeitschrift, 1-2/2021 24-26;\n[https://analyticalscience.wiley.com/do/10.1002/was.0018002/full/](https://analyticalscience.wiley.com/do/10.1002/was.0018002/full/)\n- Kein Chromophor \u2013 kein Problem; Fallstricke in der Analytik anspruchvoller Verbindungen\nU. Holzgrabe, K. Schilling, R. Pawellek, C. Theiss, O. Scherf-Clavel, GIT-Labor-Fachzeitschrift (online)\n- Impurity analysis of gabapentin by HPLC-UV-CAD\nR. Pawellek, A. Leistner, U. Holzgrabe, Thermofisher Scientific, Application Note 74011\n- Verunreinigungen - Wie gef\u00e4hrlich sind Nitrosamine?\nU. Holzgrabe. Pharm. Ztg. 166, 950-959 (2021)\n- Wie \u201esauber\u201c sind Sartane? Azido-Verunreinigungen nun auch in Losartan entdeckt\nH. Buschmann, U. Holzgrabe, Deutsche Apotheker-Zeitung 161, 3748-3756 (2021)\n- Heteroresistenz als m\u00f6gliche Ursache\nU. Holzgrabe, Pharm. Ztg. 166, 3224-3229 (2021)\n- Sartane \u2013 Qualit\u00e4tsprobleme sind nicht gel\u00f6st\nU. Holzgrabe, M. Schubert-Zsilavecz, Pharm. Ztg. 166, 3696-3697 (2021)\n- Topiramate impurity analysis: Method migration from a legacy HPLC system to modern instrumentation\nA. Leistner, U. Holzgrabe, Thermofisher Application Note No 572 (2022)\n- Sartane \u2013 Qualit\u00e4tsprobleme sind nicht gel\u00f6st\nU. Holzgrabe, M. Schubert-Zsilavecz, Pharm. Ztg. 166, 3696-7 (2021)\n- Mb. Crohn, Colitis und das Mikrobiom\nB.M. Gensthaler, U. Holzgrabe, Pharm. Ztg. 167, 444-447 (2022)\n- Evaluating LC methods for enhanced charged aerosol detector response; a case study using underivatized amino acids.\nA. Leistner, U. Holzgrabe, Thermofisher Application Note No 721 (2022)\n- \u00dcbelt\u00e4ter Hilfsstoffe\nU. Holzgrabe, Deutsche Apotheker-Zeitung 162, 2070-2075 (2022)\n- Paxlovid \u2013 wie stabil ist es eigentlich\nU. Holzgrabe, F. S\u00f6rgel, M. Kinzig, Deutsche Apotheker-Zeitung 162, 3708-09 (2022) & Pharm. Ztg. 167, 2830-31 (2022)\n- Resilienz f\u00fcr Lieferketten\nU. Weidenauer, U. Holzgrabe, R. Pebernik, A. Szczesny, Dtsch. Apothekerzeitung 163, 670-674 (2023)\n- Stuhl-Doping \u2013 eine neue Form des leistungssteigerung im Ausduersport?\nU. Holzgarbe, Pharmakon, im Druck\n- Acarbose impurity analysis: method migration from UV detection to universal charged aerosol detection\nA. Leistner, U. Holzgrabe, Thermofisher Application Note 1903 (2023)\n- Rebyota \u2013 das erste zugelassene f\u00e4kale Mikrobiota-Pr\u00e4parat\nU. Holzgrabe, Pharmakon, 11, 231-232 (2023)\n- Acarbose impurity analysis: method migration from UV detection to universal charged aerosol detection\nA. Leistner, U. Holzgrabe, Thermofisher Application Note 001903 (2023)\n- Stille Pandemie - Strategien gegen resistente Bakterien\nU. Holzgrabe, Pharm. Ztg. 168, 1672-1677 (2023)\n- Vom Wundermittel zum Ladenh\u00fcter (und zur\u00fcck)\nF. S\u00f6rgel, M. Kinzig, L. Kirchner, U. Holzgrabe, Dtsch. Apotheker-Ztg. 163, 2116-2119 (2023)\n- Beschleunigte Stabilit\u00e4tsuntersuchungen dank Mechanochemie\nU. Holzgrabe, Dtsch. Apotheker-Ztg. 163, 2106-2107 (2023)\n- Endlich eine saubere Sache? Ein R\u00fcckblick auf f\u00fcnf Jahre Nitrosamin-Skandal\nU. Holzgrabe, Dtsch. Apotheker-Ztg. 163, 2208-2212 (2023)\n- Mitherausgeberin von \"Hagers Handbuch der Pharmazeutischen Praxis\" bzw. \"Hagers Enzyklop\u00e4die der Arzneistoffe und Drogen\"\n5. Auflage: \"Stoffe\" E-O (1993) und P-Z (1994),\nFolgeb\u00e4nde \"Stoffe\" A-K (1998) und L-Z (1999)\n6. Auflage: \"Stoffe\" (2007)\nsowie Hager-ROM (2000-2014)\n- NMR spectroscopy in Drug Development and Drug Analysis\nU. Holzgrabe, B. Diehl, I. Wawer, VCH-Wiley, Weinheim, (1999)\n- <link file:152398 download file>NMR spectroscopy in Pharmaceutical Analysis\nU. Holzgrabe, B. Diehl, I. Wawer, Elsevier, Amsterdam, (2008)\n- Die Mistel in der Tumortherapie 2\nAktueller Stand der Forschung und klinischer Anwendung.\nHerausgeber: R. Scheer, S. Alban, H. Becker, U. Holzgrabe, F. H. Kemper, W. Kreis, H. Matthes, H. Schilcher, KVC-Verlag, (2009)\nPharmazie in unserer Zeit\n- Heft 5 (2001): Chinolone\n- Heft 1 (2002): Opioide\n- Heft 2 (2003): Antimykotika (mit M. Sch\u00e4fer-Korting)\n- Heft 1 (2004): Neue Antibiotika: Ketolide und Oxazolidinone (mit F. S\u00f6rgel)\n- Heft 5 (2004): Estrogene (mit. P.C. Schmidt)\n- Heft 2 (2005): Taxane (mit U- Jaehde)\n- Heft 6 (2005): Radiopharmaka (mit C. M\u00fcller)\n- Heft 2 (2006): Alkylantien (mit C. Kloft)\n- Heft 5 (2006): Beta-Lactame (mit F. S\u00f6rgel)\n- Heft 3 (2007): Schlafmittel (mit C. M\u00fcller)\n- Heft 6 (2007): Antiangiogenese (mit K. Mohr & G. Bendas)\n- Heft 2 (2008): Laxantien (mit M. Melzig)\n- Heft 4 (2008): Alphablocker (mit A. Sinz)\n- Heft 3 (2009): Vitamine (mit P. H\u00f6gger)\n- Heft 6 (2009): Tropenerkrankungen (mit M. Schlitzer und A. Stich)\n- Heft 1 (2010): Tropenerkrankungen (mit M. Schlitzer und A. Stich)\n- Heft 6 (2010): Endothelinrezeptor-Antagonisten (mit K. Mohr)\n- Heft 2 (2011): Grippe und Neuraminidase-Hemmer (mit M. Schlitzer und T. Steinmetzer)\n- Heft 6 (2011): Alpha-Agonisten (mit L. Hein)\n- Heft 1 (2012): Tuberkulose-Therapeutika (mit P. Imming und M. Schlitzer)\nPharmakon (ab 2013)\n- Heft 4 (2013): Antiarrhythmika (mit M. Schubert-Zsilavezc)\n- Heft 5 (2013): Antihypertensiva (mit M. Schubert-Zsilavezc)\n- Heft 4/5 (2014): HIV (mit T. Schirmeister/U.Dietrich)\n- Heft 6 (2014): MS-Therapeutika (mit S. K\u00fcrten)\n- Heft 1 (2015): Allergie (mit E. Martin)\n- Heft 6 (2015): Klimakterium (mit C. Lattrich)\n- Heft 3 (2016): Neuropathischer Schmerz (mit C. Sommer)\n- Heft 6 (2017): Palliativmedizin (mit B. van Oorschot)\n-\nHeft 3 (2017): Herzinsuffizient (mit L. Hein)\n-\nHeft 6 (2017): Durchfallerkrankungen (mit T. Weinke)\n-\nHeft 2 (2018): Z\u00f6liakie (mit G. Fuhrmann)\n-\nHeft 5 (2018): Pharmazie in der Entwicklungszusammenarbeit (mit L. Heide)\n-\nHeft 2 (2019): Vitamin D und E (mit G. Fuhrmann)\n-\nHeft 3 (2019): Hautschutz: Sonnenschutz, Wundheilung (mit R. Daniels & T. Dingermann)\n-\nHeft 6 (2019): Leber, Pankreas (mit E. Martin)\n- Quantitative NMR Spectroscopy - Principles and applications, J. Pharm. Biomed. Anal. 38, 797 - 923 (2005)\n- Mistletoe Symposium: Mistletoe in Tumour Therapy - Basic Research and Clinical Practice, Phytomedicine 14, Suppl. VII, 1-56 (2007)\n(mit R. Scheer, S. Alban, H. Becker, F. Kemper, W. Kreis, H. Matthes, H. Schilcher)\n- NMR spectroscopy in pharmaceutical and biomedical analysis, J. Pharm. Biomed. Anal. 93, (2014)\n- Neuer Nikotinmetabolit entdeckt\nPharm. i. u. Z. 30, 9 (2001)\n- Multivalente Arzneistoffe\nPharm. i. u. Z. 30, 102 (2001)\n- Hoffnung auf einen Impfstoff gegen Ebola-Viren\nPharm. i. u. Z. 30, 185-186 (2001)\n- Neue Waffen gegen multiresistente Bakterien?\nPharm. i. u. Z. 30, 187 (2001)\n- Ein Schnappschuss der Bakterienzellwand-Synthese - oder wie wirken b-Lactam-Antibiotika\nPharm. i. u. Z. 30, 370 (2001)\n- Die Natur, eine unersch\u00f6pfliche Fundgrube f\u00fcr Chemotherapeutika\nPharm. i. u. Z. 30, 371 (2001)\n- Polymorphismus verhindert die Wirkung von Fluoruracil\nPharm. i. u. Z. 30, 483 (2001)\n- Antimalariamittel zur Therapie der Creuzfeldt-Jakob-Krankheit?\nPharm. i. u. Z. 31, 8 (2002)\n- Ibuprofen gegen Alzheimer?\nPharm. i. u. Z. 31, 130 (2002)\n- Antimikrobielle Peptide als erste Verteidigungslinie\nPharm. i. u. Z. 31, 440 (2002)\n- Neue Waffen gegen Herpes-simplex-Viren\nPharm. i. u. Z. 31, 441 (2002)\n- Arrays \u00fcberall\nPharm. i. u. Z. 32, 91 (2003)\n- Ein Fett gegen Schmerzen\nPharm. i. u. Z. 32, 280 (2003)\n- Cytostatika aus dem Meer\nPharm. i. u. Z. 32, 281 (2003)\n- SARS bereits besiegt\nPharm. i. u. Z. 32, 280-281 (2003)\n- Wie kann man Resistenzen aufheben?\nPharm. i. u. Z. 32, 365 (2003)\n- Neuer Therapieansatz gegen AIDS: Fusionshemmstoffe\nPharm. i. u. Z. 33, 6 (2004)\n- Ein neuer Stern am Antibiotikahimmel - Daptomycin\nPharm. i. u. Z. 33, 270 (2004)\n- Protease-Inhibitor gegen Hepatitis C\nPharm. i. u. Z. 33, 160 (2004)\n- HIV-Therapie: und noch ein neuer Therapieansatz - PA-457\nPharm. i. u. Z. 33, 160 (2004)\n- Pilzinhaltsstoffe gegen Artheriosklerose\nPharm. i. u. Z. 33, 348-349 (2004)\n- R\u00e4tsel gel\u00f6st - warum Baldrian/Hopfen-Extrakte schl\u00e4frig machen\nPharm. i. u. Z. 33, 348 (2004)\n- Flexibilit\u00e4t zur Vermeidung von Resistenz\nPharm. i. u. Z. 33, 349 (2004)\n- Neues zum Metabolismus mit den Isoenzymen des Cytochroms P450\nPharm. i. u. Z. 33, 433 (2004)\n- Artemisinin und Nachfolger\nPharm. i. u. Z. 34, 95 (2005)\n- Paclitaxel zur Alzheimer-Behandlung\nPharm. i. u. Z. 34, 96 (2005)\n- Oral verf\u00fcgbarer Fusionshemmstoff gefunden (Co-Autorin E. Bennack)\nPharm. i. u. Z. 34, 182/3 (2005)\n- RANTES-Protein sch\u00fctzt Affen vor Infektion mit chim\u00e4ren AIDS-Viren (Co-Autorin E. Bennack)\nPharm. i. u. Z. 34, 182 (2005)\n- Diarylchinolon gegen Tuberkulose wirksam (Co-Autorin E. Bennack)\nPharm. i. u. Z. 34, 183/4 (2005)\n- Neue Wege zu hoch wirksamen Tetracyclinen\nPharm. i. u. Z. 34, 258-259 (2005)\n- Neue Wege zu selektiven Antiinfektiva\nPharm. i. u. Z. 34, 446-447 (2005)\n- Wie wirkt Paracetamol? Ein weiterer Mosaikstein zum Wirkmechanismus\nPharm. i. u. Z. 35, 100 (2006)\n- Neue Hoffung f\u00fcr Krebspatienten (Co-Autorin E. Bennack)\nPharm. i. u. Z. 35, 101 (2006)\n- Inhibition von Virulenzfaktoren, ein neuer Ansatz zur Entwicklung von Antibiotika\nPharm. i. u. Z. 35, 99 (2006)\n- Neue Waffe gegen \u00df-Lactamasen? (Co-Autorin E. Bennack)\nPharm. i. u. Z. 35, 387-388 (2006)\n- \u00df-Lactam-Antibiotika als Neuroprotektoren\nPharm. i. u. Z. 35, 387 (2006)\n- Ellagitannine als Topoisomerase- II- Hemmstoffe (Co-Autorin E. Bennack)\nPharm. i. u. Z. 35, 278 (2006)\n- Kleine \u00c4nderung, gro\u00dfe Wirkung - eine neues Vancomycin-Derivat gegen MRSA (Co-Autorin E. Bennack)\nPharm. i. u. Z. 35, 386 (2006)\n- Alte Wege zu neuen Antibiotika - Platensimycin\nU. Holzgarbe, T. Dingermann, I. Zuendorf, Pharm. i. u. Z. 35, 388-389 (2006)\n- Ein neues Target f\u00fcr neue Antibiotika - die Glycosyltransferase\nPharm. i. u. Z. 36, 334 (2007)\n- Zwei Fliegen mit einer Klappe - Platencin, ein neues Antibiotikum\nPharm. i. u. Z. 36, 418-419 (2007)\n- Lactivicin - ein Antibiotikum gegen Penicillin-resistente Pneumokokken\nPharm. i. u. Z. 36, 421-422 (2007)\n[doi:10.1002/pauz.200790103](http://dx.doi.org/10.1002/pauz.200790103)\n- Neue Antibiotika in Sicht?\nPharm. i. u. Z. 38, 106-108 (2009)\n- Neue Hoffnung auf eine Malaria-Impfung\nPharm. i. u. Z. 38, 486-487 (2009)\n[doi:10.1002/pauz.200990090](http://dx.doi.org/10.1002/pauz.200990090)\n- Wege aus der Malaria-Resistenz von Antibiotika?\nPharm. i. u. Z. 38, 487-488 (2009)\n[doi:10.1002/pauz.200990091](http://dx.doi.org/10.1002/pauz.200990091)\n- Notfallzulassung von Peramivir in den USA (Co-Autorin E. Bennack)\nPharm. i. u. Z. 39, 9-10 (2010)\n[doi:10.1002/pauz.200990126](http://dx.doi.org/10.1002/pauz.200990126)\n- Amadacyclin - ein neues Tetracyclin-Antibiotikum in der Pipeline (Co-Autor J. Schmitz)\nPharm. i. u. Z. 39, 94-95 (2010)\n[doi:10.1002/pauz.201090015](http://dx.doi.org/10.1002/pauz.201090015)\n- Zweifach Angriff auf die Gyrase durch Simocyclinon\nPharm. i. u. Z. 39, 95-96 (2010)\n[doi:10.1002/pauz.201090016](http://dx.doi.org/10.1002/pauz.201090016)\n- Alternative Wege zu \"Multidrug\"-resistenten Bakterien via reaktiver Sauerstoffspezies\nPharm. i. u. Z. 39, 260-261 (2010)\n- Trypanosomen im Fokus\nPharm. i. u. Z. 39, 261-262 (2010)\n[doi:10.1002/pauz.201090051](http://dx.doi.org/10.1002/pauz.201090051)\n- Gro\u00dfangriff gegen Plasmodien\nPharm. i. u. Z. 39, 334-335 (2010)\n[doi:10.1002/pauz.201090074](http://dx.doi.org/10.1002/pauz.201090074)\n- XF-73 - eine neue antibakterielle Leitstruktur (Co-Autor J. Schmitz)\nPharm. i. u. Z. 39, 335-336 (2010)\n[doi:10.1002/pauz.201090075](http://dx.doi.org/10.1002/pauz.201090075)\n- Plectasin ein neues Peptidantibiotikum mit hohem therapeutischem Potential (Co-Autor J. Schmitz)\nPharm. i. u. Z. 39, 336-338 (2010)\n[doi:10.1002/pauz.201090076](http://dx.doi.org/10.1002/pauz.201090076)\n- R\u00fcckkehr in das Vor-Semmelweis-Zeitalter MRSA, NDM-1 und was kommt noch?\nPharm. i. u. Z. 39, 426-427 (2010)\n[doi:10.1002/pauz.201090091](http://dx.doi.org/10.1002/pauz.201090091)\n- Die Natur als Apotheke gegen Tropenkrankheiten: Tirandamycin B gegen lymphatische Filariosen\nPharm. i. u. Z. 40, 450-451 (2011)\n[doi:10.1002/pauz.201190071](http://dx.doi.org/10.1002/pauz.201190071)\n- FRET zur Bestimmung der minimalen Hemmkonzentration von Antibiotika\nPharm. i. u. Z. 41, 6-7 (2012)\n[doi:10.1002/pauz.201290004](http://dx.doi.org/10.1002/pauz.201290004)\n- FimH-Inhibitoren - eine neue M\u00f6glichkeit chronische Harnwegsinfektionsinfektionen zu behandeln und zu verhindern\nPharm. i. u. Z. 41, 108-109 (2012)\n[doi:10.1002/pauz.201290023](http://dx.doi.org/10.1002/pauz.201290023)\n- Inhibitoren der New-Delhi-Metallolactamase\nPharm. i. u. Z. 41, 270 (2012)\n[doi:10.1002/pauz.201290066](http://dx.doi.org/10.1002/pauz.201290066)\n- 35 Jahre Resistenzen gegen Antibiotika\nPharm. i. u. Z. 41, 374-375 (2012)\n[doi:10.1002/pauz.201290081](http://dx.doi.org/10.1002/pauz.201290081)\n- Lys05 - en neuer Ansatz zur Tumortherapie?\nPharm. i. u. Z. 41, 375-376 (2012)\n[doi:10.1002/pauz.201290082](http://dx.doi.org/10.1002/pauz.201290082)\n- Mamba-Gift zur Behandlung starker Schmerzen\nPharmakon 1, 100 (2013)\n- Chinolon-3-arylether, die idealen Antimalariamittel\nPharmakon 1, 373-374 (2013)\n- KRAS-Inhibitoren f\u00fcr die Krebstherapie - neue Strategie, aber auch viele Fragen\nPharmakon 1, 375 (2013)\n- Ein neuer Stern am Antibiotikahimmel, Teixobactin?\nPharmakon 3, 181-182 (2015)\n- Griselimycin zur Therapie von Tuberkulose\nPharmakon 3, 436-437 (2015)\n- Cer(IV)-vermittelte Cyclisierung von N-Benzyl-b-aminoketonen als Synthesem\u00f6glichkeit f\u00fcr pharmakologisch interessante, rigidisierte Phenylethylaminderivate\nU. Holzgrabe, Symposium \"Naturstoffe als Leitsubstanzen f\u00fcr neue Arzneisubstanzen\", Bonn, 1988\nPharm. i. u. Z. 17, 91, 1988\n- Oxidative Cyclisation of N-Benzyl-b-aminoketones with Cerium(IV)sulphate leading to 1,2,3,4-Tetrahydroisoquinolines\nU. Holzgrabe, Pharmaceutical Science Seminar, University of Bath, 1988\n- Oxidative Cyclisierung von N-Benzyl-b-aminoketonen mit Cer(IV)sulfat zu 1,2,3,4-Tetrahydroisochinolinen\nU. Holzgrabe, Pharmazeutisches Kolloquium, Bonn, 1989\n- Allostere Beeinflussung des muscarinischen Rezeptors durch bisquart\u00e4re Ammonium- verbindungen\nU. Holzgrabe, Pharmazeutisches Kolloquium, Saarbr\u00fccken, 1991\n- Phosphors\u00e4ureestervergiftungen und ihre Therapiem\u00f6glichkeiten\nU. Holzgrabe, DPhG Landesgruppe Bremen, 1991\n- Neue Therapiem\u00f6glichkeiten bei Organophosphatvergiftungen: Beeinflussung des muscarinischen Rezeptors\nU. Holzgrabe, Pharmazeutisches Kolloquium, Universit\u00e4t D\u00fcsseldorf, 1991\n- New Ideas of the Treatment for Organophosphorus Poisoning: Allosteric Modulators of the Muscarinic Receptor\nU. Holzgrabe, Pharmaceutical Science Seminar, Bath, 1992\nU. Holzgrabe, Pharmaceutical Seminar, Warschau, 1992\n- Moderne Methoden der Arzneistoffindung - Therapeutika der Phosphors\u00e4ureestervergiftung\nU. Holzgrabe, Pharmazeutisches Seminar, Graz, 1992\n- Neue Wege bei der Suche nach Antidoten der Phosphors\u00e4ureestervergiftung\nU. Holzgrabe, DPhG-Tagung Plenarvortrag, Magdeburg, 1992\nDAZ 132, 2016, 1992\n- New Developments of the Treatment of Organophosphorous Poisoning\nU. Holzgrabe, Seminar Lecture, Jadavpur University, Chemistry Department, Calcutta, 1993\n- Organophosphorus Toxicity: Current Awareness\nU. Holzgrabe, Seminar Lecture, Calcutta University, Pharmacology Department, Calcutta, 1993\n- Gyrasehemmstoffe - Chemie, Pharmakokinetik und therapeutische Anwendung\nU. Holzgrabe, DPhG Bayern, Regionalgruppe W\u00fcrzburg, 1993\n- Allostere Modulatoren von muscarinischen Acetylcholinrezeptoren: Synthese, Struktur-Wirkungsbetrachtungen und Molecular Modelling\nU. Holzgrabe, Pharmazeutisch-lebensmittelchemisches Kolloquium, M\u00fcnster, 1994\n- Struktur-Wirkungsbetrachtungen an neuen, antibakteriell wirksamen N-Arylchinolonen\nU. Holzgrabe, 8. Symposium \"Chemotherapeutika\" im Rahmen der Fr\u00fchjahrstagung der DPhG, Mainz, 1994\nPharm i. u. Z. 23, 177, 1994\n- Molekulare Grundlagen der Therapie einer Organophosphatvergiftung\nU. Holzgrabe, Gastvorlesung im SS 94, Marburg, 1994 (DPhG)\n- Entwicklung von Verbindungen zur Subtypisierung von Opioidrezeptoren\nU. Holzgrabe, W. Brandt, Kolloquium bei der Firma Gr\u00fcnenthal, Aachen, 1994\n- Allosteric Modulation of Muscarinic Receptors\nU. Holzgrabe, Pharmaceutical Seminar, College of Pharmacy, University of Illinois at Chicago, 1995\n- Allostere Modulatoren muscarinerger Rezeptoren - Synthese und Struktur-Wirkungsbeziehungen\nU. Holzgrabe, Fachbereichskolloquium Biochemie/Biotechnologie, Universit\u00e4t Halle, 1995\n- Synthesis, Antibacterial Acitivity, and QSAR of N1-Aryl Substituted Fluoroquinolones\nU. Holzgrabe, Int. Symposium on Trends in Microbiology, Calcutta, 1995\n- Kohonen Maps - A Valuable Tool for Elucidation of Pharmacophores\nU. Holzgrabe, M. Wagener, J. Gasteiger, ACS-Conference, New Orleans 1996\nChem. Inf. Bull. 48, 35, (1996)\n- Allostere Modulation muscarinischer Rezeptoren - ein neues pharmakologisches Prinzip\nU. Holzgrabe, Pharmazeutisches Kolloquium, DPhG, Untergruppe Freiburg, 1997\n- Optimization of allosteric modulators of muscarinic receptors - molecular modelling, synthesis and pharmacology\nU. Holzgrabe, First International Symposium on Pharmaceutical Chemistry, Ankara, 1997\nU. Holzgrabe, Seminar an der Bornova University, Izmir, 1997\n- Compounds interacting with the Muscarinic Receptor Complex: Lead Finding and Optimization Utilizing QSAR and Molecular Modelling\nU. Holzgrabe, DuPont de Nemour, Newark, Delaware, 1998\n- Ligands for the Common Allosteric Site of the Acetylcholine M2-Receptors: Development and Application\nU. Holzgrabe, 12th Camerino-Noordwijkerhout Symposium: Receptor Chemistry Towards the third millenium, Camerino, 1999\n- Chiral Discrimination of Phenethylamines by Means of Neutral and Sulfated Heptakis(2,3-O-diacetyl)b-cyclodextrins using CE and NMR spectroscopy\nU. Holzgrabe, Second International Symposium on Pharmaceutical Chemistry, Ankara, 1999\n- Chirales Erkennen mit Cyclodextrinen\nU. Holzgrabe, GDCh-Ortsgruppe Aachen, 1999\n- k-Agonisten aus der Diazabicyclononanone-Reihe - Synthese, Pharmakologie und Struktur-Wirkungsbeziehungen\nU. Holzgrabe, Physiologisches Seminar, Universit\u00e4t W\u00fcrzburg, 1999\n- Liganden f\u00fcr die allostere Bindungsstelle an muscarinischen M2-Rezeptoren - Optimierung der Leitstruktur W84\nU. Holzgrabe, Pharmazeutisches Kolloquium, ETH Z\u00fcrich, 2000\n- Ligands of the muscarinic receptors - new therapeutic perspectives\nU. Holzgrabe, Akademie der Wissenschaften, Prag, Tschechien, 2000\n- Pharmazeutische Chemie im neuen Jahrtausend: Medizinische Chemie und Analytik - zwei Werkzeuge f\u00fcr die Arzneistoffsuche\nU. Holzgrabe, 3. Lesm\u00fcller-Vorlesung, W\u00fcrzburg, 2000\n- Ligands of the muscarinic receptors - new therapeutic perspectives\nU. Holzgrabe, Akademie der Wissenschaften, Prag, Tschechien, 2000\n- Neue Wege zur Therapie von Schmerz, Mb. Alzheimer und Organophosphatvergiftungen - Allostere Modulatoren muscarinischer Rezeptoren\nU. Holzgrabe, DPhG-Landesgruppe Schleswig-Holstein, Kiel, (2000\n- Stereochemie heterocyclischer Bicyclo[3.3.1]nonanone\nU. Holzgrabe, Institutsseminar, Anorganisches Institut, Universit\u00e4t Heidelberg, 2000\n- Allostere Modulation von muscarinischen Rezeptoren als neues pharmakologisches Konzept\nU. Holzgrabe, \"Tag der Chemie\", Gr\u00fcnenthal, Aachen, 2001\n- Diazabicyclononanones, A New Class of Opioid-type Analgesics - Synthesis, Pharmacology, and Structure-Activity-Relationships\nU. Holzgrabe, Vortragsreise durch USA: University of Florida at Gainesville, University of Illinios at Chicago, University of California at San Francisco, 2001\n- Diazabicyclononanone, eine strukturell neue Klasse opioidartiger Analgetika\nU. Holzgrabe, T. Siener, U. Kuhl, A. Cambareri, H. Buschmann, B. K\u00f6gel, E. Friderichs, GDCh-Hauptversammlung, W\u00fcrzburg, 2001\n- Bek\u00e4mpfung von starken Schmerzen mit alten und neuen Schmerzmitteln\nU. Holzgrabe, DPhG-Landesgruppe Mecklenburg-Vorpommern, Greifswald, 2002\n- Kennen wir den Mechanismus der chiralen Erkennung zwischen Cyclodextrinen und Analyten?\nU. Holzgrabe, DPhG-Landesgruppe Baden-W\u00fcrttemberg, T\u00fcbingen, 2002\n- Allosteric Modulation of Receptors: A Way to Enhance the Ligand binding to Muscarinic receptors\nU. Holzgrabe, 1st Conference on Pharmaceutical and Medicinal Chemistry, Ankara, 2002\n- Composition and Impurity Profile of Multisource Bulkware of gentamicin - A Comparision\nU. Holzgrabe, Vorsymposium der Fachgruppe Arzneimittelkontrolle der DPhG, Berlin, 2002\n- Characterization of cyclodextrins and their power to separate enantiomers\nU. Holzgrabe, Keynote Lecture, Separation and Characterization of Natural and Synthetic Macromolecules, Amsterdam, 2003\n- Zielgerichtete Entwicklung von hoch-affinen F\u00f6rderern der Ligandbindung an Muskarin-Rezeptoren\nU. Holzgrabe, Gastvortrag beim Symposium des Graduiertenkolleg 677, Pharmazie, Universit\u00e4t Bonn, 2003\n- Chiral recognition by means of CE and NMR spectroscopy - Mechanism and Application\nU. Holzgrabe, Symmetry Congress, Sassari, Italien, 2003\n- NMR Spectroscopy in Drug Analysis - Comparison of the Composition of Gentamicin Samples by Means of 1H NMR\nU. Holzgrabe, , Internationale Jahrestagung des \"Permanent Forum on International Pharmaceutical Crime (PFIPC)\", BfArM, Bonn, 2003\n- Der Tryptophan- und Gentamicinfall\nU. Holzgrabe, APV-Veranstaltung - Verunreinigungen von Ausgangsstoffen und Arzneimitteln, Erfurt, 2003\n- Allostere Modulation muscarinischer Rezeptoren - oder: Wie kann man die Ligandbindung an einen Rezeptor f\u00f6rdern?\nU. Holzgrabe, Vortrag im Rahmen der Forschergruppe 463, FU Berlin, 2003\n- Development of new lead structures fort he inhibition of the acetylcholinesterase\nU. Holzgrabe, 4th International Symposium on Pharmaceutical Chemistry, Istanbul 2003\n- Neue Antibiotika, neue \"Drug-Discovery\"-Methoden f\u00fcr Antibiotika\nU. Holzgrabe, Vorsymposium Klinische Pharmazie der DPhG-Tagung 2003, W\u00fcrzburg, 2003\n- Quality of APIs - Result of a research of different gentamicin products\nU. Holzgrabe, 6th CEFIC/APIC, European Conference on Active Ingredients, Budapest, 2003\n- Arzneimittelf\u00e4lschungen, Arzneimittelsicherheit\nU. Holzgrabe, 3. ZL-Expertentreffen \"Arzneimittelf\u00e4lschungen / Arzneimittelsicherheit\", Eschborn, 2003\n- Strategien zur Entwicklung neuer Antibiotika\nU. Holzgrabe, Forum-Veranstaltung \"Entwicklung und Zulassung von Antibiotika\", K\u00f6ln, 2003\n- Quantitative NMR in Drug Analysis and Drug Development\nU. Holzgrabe, 1st International meeting on NMR and Quantitative Analysis, Stockholm, 2004\n- Systematic development of enhancers of ligand binding to muscarinic acetylcholine receptors: bis(ammonio)alkane-type compounds\nU. Holzgrabe, Seminar an der Universit\u00e4t Mailand, Institut f\u00fcr Pharmazeutische Chemie und Technologie, 2004\n- Allosteric Modulation of Receptors - A Way to Enhance the Ligand Binding to Muscarinic Receptors\nU. Holzgrabe, 124th Annual Meeting of the Pharmaceutical Society of Japan, Osaka, 2004\n- Arzneimittelf\u00e4lschungen - Arzneimittelsicherheit\nU. Holzgrabe, DPhG-Symposium \"Arzneimittelf\u00e4lschungen\" auf der \"World Conference on Dosing of Antiinfectives\", N\u00fcrnberg, 2004\nVorsymposium \"Industriepharmazie\" auf der DPhG-Jahrestagung, Regensburg, 2004\n- The use of capillary electrophoresis to determine counterfeit drugs\nU. Holzgrabe, World Conference on Dosing of Antiinfectives, N\u00fcrnberg 2004\n- Impurities in Critical Drugs\nU. Holzgrabe, Quality on the move: Dynamics of the European Pharmacopoeia, Budapest, Ungarn, 2004\n- Development of New Lead Structures for the Inhibition of the Acetylcholinesterase\nU. Holzgrabe, Frontiers in Medicinal Chemistry, Annual Meeting of the GDCh and DPhG Section of Medicinal chemistry, Leipzig 2005\n- Reinheitsbestimmung von pflanzlichen Referenzsubstanzen f\u00fcr die pharmazeutische Analytik mittels quantitativer NMR-Spektroskopie\nH. Jancke, F. Malz, C. J\u00e4ger, Ulrike Holzgrabe, FAH-Sitzung, Bonn, 2005\n- Arzneimittelf\u00e4lschungen - Welche Gefahr besteht f\u00fcr Antibiotika?\nU. Holzgrabe, 8. Rostocker Antiinfektivatage - Klinik und Praxis, Rostock , 2005\n- From allosteric modulators to selective agonists of muscarinic receptors\nU. Holzgrabe, International Symposium on Medicinal Chemistry, Research and Development, Kusadasi, T\u00fcrkei, 2005\n- Allosteric Modulators and Selective Agonists of Muscarinic Receptors\nU. Holzgrabe, XII International Symposium on Cholinergic Mechanism, Alicante, Spanien, 2005\n- Arzneimittelf\u00e4lschungen: Gefahr f\u00fcr die deutsche Arzneimittelversorgung?\nU. Holzgrabe, Symposium \"Arzneimittelf\u00e4lschungen - ein untersch\u00e4tztes Problem\", DGRA, Bonn 2005\n- Why not using capillary electrophoresis in pharmaceutical analysis?\nU. Holzgrabe, MSB 2006, 20th International Symposium on Microscale Bioseparations, Amsterdam, 2006\n- Development of New Acetylcholine Inhibitors. Structure-based Drug Design and Random Chemistry\nU. Holzgrabe, 126th Annual Meeting of the Pharmaceutical Society of Japane, Sendai, 2006\n- Introduction to quantitative NMR spectroscopy - analysis of drugs\nU. Holzgrabe, FAH- & DPhG-Symposium \"Quantitative NMR in Pharmaceutical Analysis\", W\u00fcrzburg, 2006\n- Why not using capillary electrophoresis in pharmaceutical analysis?\nU. Holzgrabe, Analysdagarna, G\u00f6teborg, 2006\n- The piggy-back approach - bisnaphthalimides as muscarinic agonists, cancerostatics and trypanocidal drugs\nU. Holzgrabe, Molecular Processes in Health and Diseases, Microbiology and Microbial Bioinformatics, Tel Aviv, 2007\n- Random Chemistry as a new tool for the generation of small-compound libraries\nU. Holzgrabe, Pharmaceutical Sciences World Conference, Amsterdam, 2007\n- Strategies for the development of new lead structures for the inhibition of acetylcholinesterase\nU. Holzgrabe, 10th Conference in Advanced Medicinal Chemistry, Thessaloniki, 2007\n- Absch\u00e4tzung des Umweltrisikopotenzials\nU. Holzgrabe, FORUM-Veranstaltung \"Arzneimittel und Abwasser\", Frankfurt, 2007\n- Der Huckpack-Approach: Eine Methode zur Entwicklung von muskarinischen Wirkstoffen, Kanzerostatika und Antiinfektiva\nU. Holzgrabe, Seminar im Rahmen des Forschungsschwerpunkts, Neue Strategien in der pharmazeutischen Forschung, Wien, 2007\n- Piggy back approach: Bisnaphthalimides as muscarinic agonists, cancerostatics, and antiinfectives\nU. Holzgrabe, 1st International Conference on Drug Design & Discovery, Dubai, 2008\n- Der Rucksack-Approach - Bisnaphthalimide als Pharmakophor f\u00fcr muscarinische Wirkstoffe, Cancerostatica und Antiinfektiva\nU. Holzgrabe, GDCh-Ortsverband, Jena, 2008\n- NMR Spectroscopy in Pharmaceutical Analysis\nU. Holzgrabe, PBA 2008, Gdansk, 2008\n- NMR Spectroscopic Evaluation of Heparin for Pharmacopoeial Purposes\nU. Holzgrabe, B. Diehl, 2nd Workshop on the Characterization of Heparin Products, Stra\u00dfburg, 2008\n- Gefahren von Arzneimittelf\u00e4lschungen f\u00fcr Patienten\nU. Holzgrabe, Arzneimittelvertrieb, Euroforum-Konferenz, K\u00f6ln, 2008\n- The piggy back approach or how to find new lead structures for antiinfective or antiviral drugs\nU. Holzgrabe, M. Tischer, Ehrlich II - 2nd World Conference on Magic Bullets, N\u00fcrnberg, 2008\n- Unkonventionelle Therapiekonzepte: von orthosteren Antagonisten zu allosteren Modulatoren und Agonisten\nU. Holzgrabe, Jahresversammlung der DPhG, Bonn, 2008\n- NMR Spectroscopic Evaluation of Heparin and Beyond?\nU. Holzgrabe, International Laboratory Forum on Counterfeit Medicines, Berlin, 2008\n- Tryptophan, Gentamicin, Heparin - What happens next\nU. Holzgrabe, Sanofi-Aventis, Paris, (2009)\nU. Holzgrabe, 2nd Anticounterfeiting Pharma Conferencem IQOC, Wiesbaden, 2009\n- Quantitative NMR in Pharmaceutical Analysis\nU. Holzgrabe, 2nd International Meeting on NMR and Quantitative Analysis, Stockholm, Schweden, 2009\n- Past, Present and Future of Drug Discovery and Development\nU. Holzgrabe, PharmSciFair, Nizza, Frankreich, 2009\n- The piggy-back approach or how to use privileged skeletons for drug development\nU. Holzgrabe, Seminar an der Universit\u00e4t Bordeaux, Frankreich, 2009\n- Past, Present and Future of Drug Discovery and Development\nU. Holzgrabe, FIP-Kongress, Istanbul, T\u00fcrkei, 2009\n- Bisquart\u00e4re Bisnaphthalimde als Leitstrukturen f\u00fcr neue antiinfektive Substanzen\nU. Holzgrabe, M. Tischer, T. Menzel, L. Sologub, K. Olsen, G. Pradel, DPhG-Jahrestagung, Jena, 2009\n- Why not using (LC) NMR in drug Analysis?\nU. Holzgrabe, PBA2009USA, Orlando, USA, 2009\n- Quantum jumps in the development of antibiotics?\nU. Holzgrabe, Doktorandentagung der DPhG in Aigen, \u00d6sterreich, 2009\n- Strategies against Counterfeit Medicines - Introductory Remarks\nU. Holzgrabe, Congress-Leitung und Plenarvortrag, W\u00fcrzburg, 2010\n- qNMR Spectroscopy against Counterfeit Drugs\nU. Holzgrabe, XXXII Finnish NMR Symposium, Kuopio, Finland, 2010\n- Dualsteric GPCR Targeting: a Novel Route to Subtype-selective Agonists and Antagonists of the Muscarinic Receptor\nU. Holzgrabe, M. De Amici, E. Kostenis, K. Mohr; ISMC/EFMC Br\u00fcssel, 2010\n- Analysis strategies to uncover and avoid counterfeit drugs\nU. Holzgrabe, Drug Analysis, Antwerpen, 2010\n- Das Arzneibuch und orthogonale Methoden - NMR-Spektroskopie\nU. Holzgrabe, DPhG-Jahrestagung, Fachgruppe Arzneimittelkontrolle, Pharmazeutische Analytik, Braunschweig, 2010\n- Combating Alzheimer\u00b4s Disease by Multitarget Benzylidene-hydrozono-1,4-dihydropyridines\nU. Holzgrabe, Pr\u00e4sentation bei der Firma Merz, Frankfurt, 2010\n- 4-Quinolone-3-carboxamide - a lead structure for antiinfetcives\nU. Holzgrabe, G. Hiltensperger, M. Engstler, Frontiers in Medicinal Chemsitry, Saarbr\u00fccken, 2011\n- Small-molecule inhibitors of the legionella Mip protein\nU. Holzgrabe, C. Julo, Bayreuther Strukturtage, 2011\n- Outsourcing API production - boon and bane\nU. Holzgrabe, China Pharma Summit, APV Meeting, Berlin, 2011\n- Counterfeit Medicines - Introduction to the conference\nU. Holzgrabe, 3rd Anti-Counterfeit Conference - Strategies against Falsified/Counterfeit Medicines, Concept Heidelberg, W\u00fcrzburg, 2012\n- Pros and Cons of NMR Spectroscopy in Quality Assessment of Drugs\nU. Holzgrabe, J. Wiest, T. Beyer, B. Diehl, Analysdagarna, Uppsala, Schweden, 2012\n- Structure-based design versus serendipity -two case studies\nU. Holzgrabe, 2nd HIPS-Symposium, Saarbr\u00fccken, 2012\n- Aktuelle analytische Erkenntnisse zu weltweiten Arzneimittelf\u00e4lschungen\nU. Holzgrabe, DPhG-Jahrestagung, Fachgruppe Arzneimittelkontrolle, Pharmazeutische Analytik, Greifswald, 2012\n- Multitarget Drugs Design - Polypharmacology\nU. Holzgrabe, FIP-Meeting, Dublin, 2013\n- Dualsteric Ligands of GPCRs - a Tool for Biased Signalling and Partial Agonism\nU. Holzgrabe, M. De Amici, E. Kostenis, K. Mohr, DPhG-Jahrestagung, Freiburg, 2013\n- Inhibitors of the Macrophage Infectivity Potentiator Protein for the Treatment of Burkholderia, Yersinia, and Francisella Infectionsn\nF. Seufert, U.Holzgrabe, Biodefense Conference, M\u00fcnchen, 2013\n- Indian Plant Kingdom - A Rich Source for New Drugs Against Tropical Diseases\nU. Holzgrabe, 2nd Pharmaceutical Technology IAPST Conference 2014, Kolkata, India, 2014\n- Antibiotika-Forschung im Spannungsfeld zwischen wirtschaftlichen Zw\u00e4ngen und therapeutischen Notwendigkeiten\nU. Holzgrabe, Akad. Abschlussfeier, Frankfurt, 2014\n- Inhibitors of the Macrophage Infectivity Potentiator (MIP) Proetin fort he Treatment of Legionella, Burkholderia, Yersina and Franciscella Infections\nU. Holzgrabe, F. Seufert, C. Juli, C.A. Sotrifer, M. Hein, I. Norville, D. Jenner, M. Sarkar-Tyson, M. Weiwad, K. Schweimer, P. R\u00f6sch, R. Stacy, P. Myler, D. Begley, D. Fox, D. Lorimer, Frontiers in Medicinal Chemistry, T\u00fcbingen, 2014\n- Entwicklung neuer Antibiotika\nU. Holzgrabe, Institutsseminar, T\u00fcbingen, 2014\n- Neue Wirkstoffe gegen Infektionskrankheiten \u2013 der SFB\nU. Holzgrabe, GDCh-Vortrag, W\u00fcrzburg, 2015\n- Kleine Molek\u00fcle gegen kritische Infektionskrankheiten\nU. Holzgrabe, GDCh-Vortrag, M\u00fcnster, 2015\n- Small molecules for the treatment of Critical Infectious Diseases\nU. Holzgrabe, F. Seufert, J. Glaser, G. Hiltensperger, 5th HIPS-Symposium, Saarbr\u00fccken, 2015\n- High Performance Liquid Chromatography \u2013 Detection beyond UV/Vis\nU. Holzgrabe, A. Almeling, O. Wahl, D. Ilko, PBA, Tbilisi, Georgien, 2015\n- Small molecules for the treatment of Critical Infectious Diseases\nU. Holzgrabe, Workshop, Hoshi University, Tokyo, Japan, 2015\n- NMR in der Pharmazie\nU. Holzgrabe, Spectral Service, K\u00f6ln, 2015\n- Orthoster, Alloster, Dualster \u2013 Tools to switch the muscarinic receptor\nU. Holzgrabe, GLISTEN-Tagung, Erlangen, 2016\n- Concepts to simultaneously optimize activity, solubility, bioavailabilty, and toxicity\nU. Holzgrabe, J. Glaser, G. Hiltensperger, VI European workshop in drug synthesis, Siena, 2016\n- Small Molecules for Treatment of Critical Infectious Diseases\nU. Holzgrabe, Bazeley Oration, New Frontiers, ASM 2016, Perth, Australien\n- Amino acids analysis and impurity profiling for pharmacopoeial purposes\nU. Holzgrabe, R. K\u00fchnreich, O. Wahl, Pharmaceutical and Biomedical Analysis, Guangzhou, China, 2016\n- Dualsteric ligands of G protein-coupled receptors to study the activation and signaling of G proteins\nU. Holzgrabe, Receptor dynamics \u2013 emerging paradigms for novel drugs. International GPCR workshop, Montpellier, 2017\n- Purity Evaluation of White Waxes/Paraffines and Vaselines/Petrolatums\nU. Holzgrabe, qNMR Summit 2017, Berlin, 2017\n- HPLC detection beyond Ultraviolet and Visible\nU. Holzgrabe, Pharmaceutical and Biomedical Analysis, Plenarvortrag, Madrid 2017 sowie Vortrag bei ThermoFisher in Germering, 2017\n- Small Molecules for the Treatment of Critical Infectious Diseases\nU. Holzgrabe, Distinguished Seminar Lectureship, University of Minnesota, School of Pharmacy, 2017\n- How to develop small molecules for treatment of infections\nU. Holzgrabe, Confer\u00e8ncia de Recerca, Facultat de Farmacia i Ciencies de L\u00b4Alimentacio, Universitat de Barcelona, 2017\n- New Drugs against Old Bugs: Old Approaches and New Concepts\nU. Holzgrabe, Colloquium Monsoon 2017, Shiv Nadar University, New Delhi, Indien, 2017\n- Regulatory Analysis: impurity profiling\nU. Holzgrabe, Leibniz-Institut f\u00fcr Katalyse, Rostock, Seminar-Vortrag, 2018\n- NMR spectroscopy in Quality Analysis of Drugs and Excipients\nU. Holzgrabe, Advanced Pharmaceutical Analysis APA 2018, Lille 2018\n- The Future of Medicinal Chemistry\nU. Holzgrabe, JMC Editor\u00b4s Meeting, Boston, 2018\n-\nSearch for the \u201cKnown Unknowns\u201c and \u201cUnknown Unknowns\u201c in Drugs\nU. Holzgrabe, O. Scherf-Clavel, J. Wohlfart, F. S\u00f6rgel, AB-Sciex Darmstadt, 2019\n-\nNMR Spectroscopy in Quality Analysis of Drugs and Excipients\nU. Holzgrabe, B. Diehl, Y. Monakhova, E. Hafner, J. Urlaub, PBA2019, Tel Aviv, 2019\n-\nLead structures from nature for antiinfective drugs\nU. Holzgrabe, Kolloquium des GRK2158, D\u00fcsseldorf, 2019\n-\nAlloster \u2013 Dualster \u2013 Ago-Alloster \u2013 Muscarinic Receptors as a Workhorse for Studying the Activation\nU. Holzgrabe, Pharmazeutisches Kolloquium, Universit\u00e4t Erlangen, 2020\n-\nNitrosamines: Unexpected Impurities\nU. Holzgrabe; Seminra Instituto Chimica Farmaceutica, Universita degli Studi di Modena (2021)\n-\nNew Drugs against Old Bugs \u2013 Lead structure from Nature for Antiinfective Drugs\nU. Holzgrabe, Advances in Chemical Research 2021, keynote lecture, GITAM, Visakhapatnam, India (2021)\n-\nTreatment of Infections with Gram-negative Bacteria by Addressing Virulence Factors: the Macrophage Infectivity Potentiator\nU. Holzgrabe, HIPS-Meeting, Saarbr\u00fccken (2021)\n-\nLessons learnt form the Nitrosamine Case?\nU. Holzgrabe, O. Scherf-Clavel, F. S\u00f6rgel DPhG-Tagung Leipzig (virtual) 2021\n-\nAuf der Suche nach neuen Anti-Infektiva gegen alte Mikroben\nU. Holzgrabe, Challenge your Science; Entwicklung von Wirkstoffen & Medizinprodukten: Von der Grundidee bis zur Anwendung, Go-Bio initial 2021\n-\nWie gut ist die Qualit\u00e4tsanalytik der Arzneistoffe \u2013 die Nitrosamin-Story\nU. Holzgrabe, \u201e200 Jahre Archiv der Pharmazie \u2013 Vom Beginn bis heute\u201c, DPhG 2022\n-\nArzneimittelf\u00e4lschungen \u2013 was tun wir dagegen\nU. Holzgrabe, Berlin Brain Summit, 2022\n-\nJuggling analytes, column chemistry, and charged aerosol detection \u2013 HPLC analysis of weak chromophore drugs\nU. Holzgrabe, Drug Analysis, PBA, Mons, Belgien, 2022\n-\nLieferketten, Lieferengp\u00e4sse, Produktion, Innovation- der Versuch einer Analyse\nU. Holzgrabe, Landesapothekerkammer Th\u00fcringen, 2023\n-\nAddressing Virulence Factors \u2013 an Alternative Treatment of Infections\nU. Holzgrabe, Doktorandentagung der DPhG Bonn 2023\n-\nNo Chromophore, no HPLC analysis?\nU. Holzgrabe, Webinar ThermoFisher Scientific, 2023\n- Medikament\u00f6se Behandlung des Schnupfens\nSeminarkongre\u00df, Damp (1989)\n- Antacida - mehr als nur S\u00e4ureneutralisation\nFortbildungskongre\u00df, Malente, (1990)\n- Analgetika\nSeminarkongre\u00df, Damp, (1990)\n- Gyrasehemmstoffe - eine neue, alte Arzneistoffgruppe und ihre Probleme\nSeminarkongre\u00df, Damp, (1991)\n- S\u00e4ulenchromatographie und HPLC\nRegelweiterbildung zum Fachapotheker f\u00fcr Analytische Pharmazie, (1992, 1994, 1995, 1996, 1997, 1999, 2002)\n- NMR-Spektroskopie - Ein- und zweidimensionale Techniken\nRegelweiterbildung zum Fachapotheker f\u00fcr analytische Pharmazie, (1993, 1995, 1996, 1997, 1999, 2002)\n- Razemate und ihre Bedeutung f\u00fcr die Arzneimitteltherapie\nAkademie f\u00fcr Pharmazeutische Fortbildung der LAK Hessen, (1994)\nVortrag bei der DPhG-Landesgruppe Niedersachsen, Osnabr\u00fcck, (1996)\n- Gyrasehemmstoffe - Struktur-Wirkungsbeziehungen, Pharmakokinetik und therapeutische Anwendung\nDPhG-Landesgruppe Bayern, W\u00fcrzburg, (1993)\nDPhG-Landesgruppe Rheinland, Koblenz, (1996)\nBundeswehr, Koblenz (1997)\n- Einsatz der Kapillarelektrophorese in der Arzneistoffanalytik - Enantiomerentrennung am Beispiel eines Arzneistoffes\nBeteiligung an einem GDCh-Fortbildungskurs, M\u00fcnster, (1997) und W\u00fcrzburg, (1998)\n- Neue Antiepileptika im \u00dcberblick\nDPhG-Landesgruppe Rheinland, Aachen, (1997) und Krefeld (1999)\n- Neues auf dem Gebiet der Gyrasehemmstoffe\nDPhG Landesgruppe Bayern, M\u00fcnchen und W\u00fcrzburg, (1999)\nDPhG Landesgruppe Berlin/Brandenburg, Berlin, (1999)\nApothekerkammer Nordrhein, M\u00fclheim, (1999)\nTagung f\u00fcr Wehrmedizin, Koblenz,(1999)\n- Schmerzbek\u00e4mpfung\nInstitutskolloquium Bundeswehr Koblenz, (1999)\n- Gyrasehemmstoffe - schon im Abwind\nPharmacon, Meran, (2000)\nXXXVIII Internationaler Fortbildungskurs f\u00fcr praktische und wissenschaftliche Pharmazie der BAK, (2000)\nDPhG-Landesgruppe Nordrhein, Bonn, (2001)\nDPhG-Landesgruppe Bremen, (2002)\nDPhG-Landesgruppe Niedersachsen, Hannover, (2002)\n- Bek\u00e4mpfung multiresistenter Bakterien mit alten und neuen Antibiotika\nDPHG-Landesgruppe Niedersachsen, Osnabr\u00fcck, (2000) und Braunschweig, (2001)\nDPhG: Erlanger wissenschaftliche Winterfortbildung, (2003)\n- Bek\u00e4mpfung von Schmerzen mit alten und neuen Analgetika\nDPhG-Landesgruppe Hamburg, (2001)\nDPhG-Landesgruppe Th\u00fcringen, Erfurt, (2003)\nDPhG-Landesgruppe Bayern, Regensburg, (2004)\nDPhG-Landesgruppe Niedersachsen, G\u00f6ttingen, (2004)\n- Enantiomerentrennung in der CE: Methodenentwicklung und Reproduzierbarkeit, dargestellt an praktischen Arzneistoffbeispielen\nBeteiligung an einem GDCh-Fortbildungskurs, Braunschweig, (2001, 2002)\n- Alte Opioide in neuem Gewand\nW\u00fcrzburger wissenschaftliche Winterfortbildung (WwW), (2002)\nDPhG-Adventsfortbildung, M\u00fcnchen, (2002)\nBundesverbandstagung der Pharmaziestudierenden in W\u00fcrzburg, (2003)\n- Oxazolidinone, Ketolide und neue Chinolone - oder die Notwendigkeit, immer neue Antibiotika zu entwickeln\nPharmacon, Davos, (2002)\nZentrale Fortbildung der Landesapothekerkammer Westfalen-Lippe, (2002)\nADKA - drei L\u00e4nder, eine Krankenhauspharmazie, W\u00f6rlitz, (2002)\nDPhG-Landesgruppe Rheinland-Pfalz, Mainz, (2003)\n- Kann der Wettlauf gegen multiresistente Bakterien gewonnen werden?\nDPhG-Landesgruppe Bayern, M\u00fcnchen, (2003)\nApothekerkammer Konstanz, (2003)\n- Hase und Igel - der Wettlauf gegen multiresistente Keime\nVortragsveranstaltung des RCDS, W\u00fcrzburg, (2003)\nPharmaweekend des BPhD, M\u00fcnchen, (2004)\nJumax, W\u00fcrzburg, (2004)\n- Ketolide und Oxazolidinone - ein Quantensprung in der Entwicklung von Antibiotika?\nWorld Conference on Dosing of Antiinfectives, N\u00fcrnberg 2004\n- Capillary Electrophoresis - Principles and Applications\nWCDA-Workshop on Bioanalysis for graduate students, World Conference on Dosing of Antiinfectives, N\u00fcrnberg, (2004)\n- Schmerztherapie mit alten und neuen Analgetika\nDPhG-Regionalgruppe G\u00f6ttingen, (2004)\n- Arzneimittelf\u00e4lschungen, Gefahr f\u00fcr die Arzneimittelversorgung\nDPhG-Landesgruppe Rheinland, Koblenz, (2005),\nRegionale Fortbildung, LAK Nordrhein, Essen (2006)\nDPhG-Landesgruppe Bayern, W\u00fcrzburg, (2006)\n- Sprung-, Schritt- oder Scheininnovationen? Gibt es Neues auf dem Gebiet der Antiinfektiva?\nScheele-Tagung, Zinnowitz, (2005)\nLandegruppe Baden, Stuttgart, (2005)\nLandesgruppe Sachsen, Chemnitz, (2006)\n- Wie entstehen Resistenzen gegen Antibiotika?\nWorkshop Arzneimittelr\u00fcckstande im Abwasser, Forum Heidelberg, K\u00f6ln, (2005)\n- Kriterien f\u00fcr die Beurteilung von Arzneimittelinnovationen\nZwischenbilanz IQWiG, Euroforum Konferenz, K\u00f6ln, (2005)\n- Sprung-, Schritt- oder Scheininnovationen - ein Bewertungsversuch am Beispiel der Fluorchinolone\nKlinischer Abend - Therapie von Infektionen, Braunschweig, (2006)\n- Arzneimittelf\u00e4lschungen - (k)ein Problem f\u00fcr die Apotheke?\nArzneiform & Wirkung, LAK Baden-W\u00fcrttemberg, 34. Fortbildungsseminar in St. Blasien-Menzenschwand, (2006)\nLAK Baden-W\u00fcrttemberg, Tuttlingen, (2006)\nApothekerkammer Th\u00fcringen, Erfurt, (2007)\nLAK Baden-W\u00fcrttemberg, Freiburg, (2007)\nDeutscher \u00c4rztinnen und Apothekerinnen-Verband, Hannover, (2008)\n- Resistenzen - Motor f\u00fcr die Entwicklung neuer Antiinfektiva\nDPhG-Landesgruppe Bayern, Erlangen, (2006)\nLandesgruppe Bremen, (2006)\nLandesgruppe Th\u00fcringen, Jena, (2007)\n- Are quantum jumps possible in the development of antibiotics?\nFortbildung der BAK in Krakau, Polen, (2007)\n- Quantenspr\u00fcnge in der Entwicklung von Antibiotika\nDPhG: Regensburger wissenschaftliche Fortbildung f\u00fcr Apotheker, (2008)\n- Was gibt es Neues auf dem Markt der Antiinfektiva?\nFortbildung der Bayerischen Landesapothekerkammer im Rahmen von \"Ehrlich II\" in N\u00fcrnberg, (2008)\n- What do capillary electrophoresis and NMR spectrometry have to offer?\nWorkshop im Rahmen von \"Ehrlich II\" in N\u00fcrnberg, (2008)\n- Grundlagen der Antibiotikatherapie\nWorkshop des Zahn\u00e4rztlichen Arbeitskreises, Kempten, (2009)\n- Arzneimittelf\u00e4lschungen: Tryptophan, Gentamicin, Heparin - und was kommt noch?\nDPhG-Landesgruppe Bayern, Erlangen, (2009)\n- Neue Antibiotika\nBLAK-Fortbildungen in Regensburg, Erlangen, M\u00fcnchen, (2010)\nDPhG Mainz, (2010)\n- Gef\u00e4lschte Arzneimittel - wie gef\u00e4hrlich sind sie\nR\u00f6ntgengymnasium W\u00fcrzburg, (2010)\n- Wie entstehen Resistenzen gegen Antibiotika und Virustatika\nBLAK-Jahrestagung, W\u00fcrzburg, (2010)\n- Chiralit\u00e4t\nSch\u00fclertag, W\u00fcrzburg, (2010)\n- Neue Antibiotika auf dem Markt und in der Pipeline\nTag der Offizinpharmazie, DPhG-Jahrestagung, Braunschweig, (2010)\n- Resistenzen vermeiden - Antibiotika richtig dosieren\nDPhG-Landesgruppe Bayern, M\u00fcnchen, (2011)\n- Hormone aus dem Internet\nPharmacon, Davos (2011)\n- Arzneimittelf\u00e4lschungen\nDPhG-Landesgruppe Niedersachsen, Hannover, (2011)\nLandesapothekerkammer Hamburg, (2011)\nDPhG- Landesgruppe Hessen, Kassel, (2011)\nExamensfeier, Mainz, (2012)\nDPhG- Landesgruppe Westfalen, M\u00fcnster, (2012)\n- Neue Antibiotika in der Pipeline 2013\nPharmacon, Davos, (2013)\nLAK Rheinland-Pfalz, Mainz (2013)\nLAK Baden-W\u00fcrttemberg Stuttgart & Schw\u00e4bisch-Gem\u00fcnd, (2013)\nKiel, Jena & Heilbronn, (2014)\n- Antibiotika und Resistenzen - Wo stehen wir im Kampf gegen Viren und Bakterien?\nU. Holzgrabe, O. Germershaus\nMainfrankenmesse/Bayerischer Rundfunk, (2014)\n- Von \u201ealten\u201c Seuchen und \u201eneuen\u201c Antibiotika\nU. Holzgrabe, Pharmakon \u2013 BAK \u2013 Meran 2015; Herbstfortbildung Mainz, 2015, Heidelberg 2015, Bad Zwischenahn (2016)\n- Bakterielle Infektionskrankheiten \u2013 gestern und heute\n38. Heidelberger Herbstkongress f\u00fcr Apotheker, Heidelberg (2015)\n- Arzneimittelentwicklung und Qualit\u00e4tssicherung\nStudierendeninitiative globale Gesundheit: Pharmazeutisch, praktisch, gut? \u2013 Konzerne zwischen Mensch und Markt. W\u00fcrzburg (2015)\n- Wie gefuellt ist die Antibiotikapipeline\nU. Holzgrabe, 98. Zentrale Fortbildung, LAK Hessen, Gie\u00dfen (2018)\n- Antibiotic Production and Antibiotic Resistance: a Vicious Cycle\nU. Holzgrabe, Forster-Summer \u2013School, \u201cLet\u00b4s talk about changes\u201d Mainz, (2018)\n- Arzneimittelf\u00e4lschungen \u2013 Dank securPharm alles kein Problem?\nU. Holzgrabe, Fortbildung Landesapothekerkammer Th\u00fcringen, Jena (2018)\n- Lieferengp\u00e4sse, schlechte Arzneimittelqualit\u00e4t und F\u00e4lschungen \u2013 verschiedene Facetten des selben Problems?\nU. Holzgrabe, DPhG-Vortrag, Essen 2019, DPhG Magdeburg 2019, DPhG W\u00fcrzburg (2019)\n- Alte und Neue Antiinfektiva\nU. Holzgrabe, 47. Schwarzw\u00e4lder Fr\u00fchjahrskongress, Villingen/Schwenningen, (2019)\n- SERM und PhytoSERM\nHormontherapie, Brustkrebs und klimakterische Beschwerden\nPharmacon, Meran (2019)\n-\nSERM und in Ihre Anwendung bei Osteoporose und Mammakarzinom\nU. Holzgrabe, 42. Isnyer Fortbildungstage (2019)\n-\nqNMR in der Qualit\u00e4tsanalytik von Arzneistoffen und Hilfsstoffen\nU. Holzgrabe, Vorlesung in der Medizinischen Chemie in Erlangen (2020)\n-\nAntibiotika \u2013 R\u00fcckblick und Ausblick\nU. Holzgrabe, Pharmacon Schladming 2020, LAK Rheinland Pfalz (2020)\n-\nArzneimittelf\u00e4lschungen\nU. Holzgrabe, virtueller Kongress der Deutschen Interdisziplin\u00e4ren Vereinigung f\u00fcr Intensiv- und Notfallmedizin (DIVI) (2020)\n-\nNitrosamines \u2013 Unexpected Impurities in Drugs?\nU. Holzgrabe, Gastvorlesung - Webinar, Modena (2021)\n-\nAntibiotika und Resistenzen\nU. Holzgrabe, BLAK-Fortbildung, Webinar (2021)\n- Gibt es ein BSE-bedingtes Risiko f\u00fcr Arzneimittel?\nT. Dingermann, U. Holzgrabe, M. Schubert-Zsilavecz, DAZ 140, 5645 (2000), PZ 145, 4218 (2000)\n- Wie sicher sind Arzneimittel?\nT. Dingermann, U. Holzgrabe, H. W\u00e4tzig, D. Schn\u00e4delbach, M. Schubert-Zsilavecz, F. Stanislaus, A. Ritter, DAZ 142, 3538 (2002), PZ 147, 3102 (2002)\n- Stellungnahme der DPhG zum Eckpunktepapier der Konsensverhandlungen zur Gesundheitsreform\nT. Dingermann, U. Holzgrabe, M. Schubert-Zsilavecz, A. Ritter, F. Stanislaus, K. Michel, DAZ 142, 3538 (2002), PZ 147, 3102 (2002)\n- Pharmazeutische Forschung an den Universit\u00e4ten\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, T. Dingermann, H.-H. Borchert, DAZ 144, 694 (2004); PZ, 149, 523 (2004)\n- Die Liste muss ver\u00e4nderbar sein\nU. Holzgrabe, K. Mohr, Interview zur Erstattungsf\u00e4higkeit von OTC-Arzneimitteln, PZ 149, 969-970 (2004)\n- Bewertung m\u00f6glicher pharmakokinetischer Arzneimittel-Interaktionen mit Phytopharmaka\nU. Holzgrabe, S. Alban, T. Dingermann, PZ 149, 1474 (2004)\n- DPhG diskutiert Bachelor- und Masterstudieng\u00e4nge\nU. Holzgrabe, K. Mohr, M. Schubert-Zsilavecz, A. Link, F. Stanislaus, A. Ritter, PZ 149, 2339 (2004)\n- Festbetragsgruppen leisten unangemessener Therapie Vorschub\nU. Holzgrabe, T. Dingermann, E. Mutschler, F. S\u00f6rgel, DAZ 144, 3774 (2004), PZ 149, 2955 (2004)\n- Statement der DPhG zur Offenlegung aller klinischen Studien\nU. Holzgrabe, M. Schubert-Zsilavecz, F. Stanislaus, E. Mutschler, T. Dingermann, PZ 149, 3194 (2004); DAZ 144, 4992 (2004)\n- Werden wir in zehn Jahren wieder an einfachen Infektionen sterben?\nU. Holzgrabe, H. Derendorf, F. S\u00f6rgel, PZ 149, 3620 (2004), DAZ 144, 4748 (2004)\n- Zweitverwertung von Arzneimitteln\nU. Holzgrabe, M. Schubert-Zsilavecz, F. Stanislaus, K. Mohr, P. Kleinebudde, A. G\u00f6pferich, G. Hanke, DAZ 144, 4866 (2004), PZ 149, 3852 (2004)\n- DPhG-Statement zum Vermarktungsverzicht von Rofecoxib\nU. Holzgrabe, T. Dingermann, M. Schubert-Zsilavecz, K. Mohr, E. Mutschler, DAZ 144, 5098-5101 (2004), PZ 149, 4008-4010 (2004)\n- Zukunftsorientierte Versorgungsstrukturen in deutschen Krankenh\u00e4usern - patientenorientierte Dienstleistungen durch Apotheker in der Arzneimitteltherapie\nU. Holzgrabe, G. Hempel, C. Kloft, U. Warnke, DAZ 145, 554-5 (2005), PZ 150, 534/5(2005)\n- Studiengeb\u00fchren - Pro und Contra\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, DAZ 145, 681/2 (2005)\n- Pharmazie-Institute mit positiven Indikatoren\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, T.Dingermann, PZ 150, 1020 (2005), DAZ 145, 1267 (2005)\n- Kriterien f\u00fcr die Beurteilung von Arzneimittelinnovationen - Positionspapier der DPhG und der APV\nH. Blume, K. Brauer, T. Dingermann, U. Holzgrabe, P. Kleinebudde, K. Mohr, H. Morck, E. Mutschler, M. Schubert-Zsilavecz, W. Schunack, M. Weiser, I. Z\u00fcndorf, DAZ 145, 1513-1525 (2005); PZ Suppl. 14/05\n- Statement der DPhG zur Stammzellforschung\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, T. Dingermann, A. Vollmar, E. Mutschler, M. H. Zenk, DAZ 145, 3859 (2005), PZ 150, 2481 (2005)\n- Ma\u00dfnahmen zum Schutz vor einer Influenza-Pandemie\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, T. Dingermann, PZ 150, 3450-3451 (2005)\n- Hom\u00f6opathie wirkt, aber nicht die hom\u00f6opathischen Arzneimittel\nU. Holzgrabe, T. Dingermann, M. Schubert-Zsilavecz, K. Mohr, DAZ 145, 5824 (2005); PZ 150, 4226 (2005)\n- Stellungnahme der DDG und DPhG zur Verwendung von Zimt und anderen pflanzlichen Produkten als Antidiabetika bei Typ II Diabetes\nH.P.T. Ammon, U. Holzgrabe, T. Dingermann, M. Schubert-Zsilavecz, DAZ 145, 6064 (2005); PZ 150, 4228 (2005)\n- Sicherer Zugang zu Drogen der Traditionellen Chinesischen Medizin (TCM)\nGemeinsames Statement der Arzneimittelkommission der Deutschen Apotheker und der Deutschen Pharmazeutischen Gesellschaft\nUlrike Holzgrabe, .M. Schubert-Zsilavecz, K. Mohr, T. Dingermann\n- Deutsche Pharmazeutische Gesellschaft fordert eine zeitnahe Aktualisierung von Fachinformationen zur Vermeidung von Arzneimittelinteraktionen\nU. Holzgrabe, M. Schubert-Zsilavecz, T. Dingermann, K. Mohr, DAZ 146 (2006); PZ 151, 2351 (2006)\n- Pharmazie forschungsstark (Exzellenzinitiative)\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, PZ 151, 3832 (2006)\n- Pharmazie ist in Deutschland weiterhin forschungsstark (CHE-Ranking)\nU. Holzgrabe, M. Schubert-Zsilavecz, T. Dingermann, K. Mohr, DAZ 146, 4387 (2006); PZ 151, 3920 (2006)\n- Stellungnahme der Deutschen Pharmazeutischen Gesellschaft zur Aussendung der AOK Hessen zum Thema \"Bestm\u00f6gliche Behandlung\"\nU. Holzgrabe, M. Schubert-Zsilavecz, K. Mohr, H. Stark, T. Dingermann\n- Fortbildung ist die beste Investition in die Zukunft\nU. Holzgrabe, M. Schubert-Zsilavecz, F. Stanislaus, A. Ritter, K. Mohr, M. Stein, PZ 152, 884 (2007); DAZ 147, 894 (2007)\n- Anspruch und Wirklichkeit der individualisierten Therapie\nU. Holzgrabe, U. Jaehde, C. Kloft, M. Schubert-Zsilavecz, K. Mohr, DAZ 147, 2273 (2007); PZ 152, 2004 (2007)\n- Gemeinsames Statement von DPhG und APV zur Teilbarkeit von Tabletten\nJ. Breitkreutz, U. Holzgrabe, P. Kleinebudde; K. Michel, A. Ritter, F. Stieneker, DAZ 147, 2854-2855 (2007); PZ 152, 2457 (2007)\n- Gemeinsames Ziel: Arzneimittelsicherheit\nU. Holzgrabe, R. Bauer, DAZ 147, 2959 (2007)\n- Gegen die Banalisierung von Arzneimitteln am Beispiel der Phytopharmaka\nU. Holzgrabe, H. Stuppner, R. Bauer, DAZ 147, 4682 (2007); PZ 152, 3925 (2007)\n- Gefahr durch Arzneimittelf\u00e4lschungen\nU. Holzgrabe, M. Schubert-Zsilavecz, PZ 153, 1005-1006 (2008); DAZ 148, 1228-1229 (2008)\n- DPhG-Statement zur Austauschbarkeit von wirkstoffgleichen Fertigarzneimitteln\nH. Blume, K. Brauer, T. Dingermann, U. Holzgrabe, E. Mutschler, M. Schubert-Zsilavecz, W. Weitschies, I. Z\u00fcndorf, DAZ 148, 1902-1903 (2008); PZ 153, 1683-1684 (2008)\n- Arzneimittelf\u00e4lschungen und Arzneistoffe minderer Qualit\u00e4t\nU. Holzgrabe, PZ 155, 1514 (2010); DAZ 150, 1776 (2010)\n- Multinationale Medikamente - Qualit\u00e4tssicherung im Zeitalter der Globalisierung\nM. Tawab, U. Holzgrabe, E. Fink, R. Kl\u00e4mbt, M. Stein, M. Schubert-Zsilavecz, PZ 156, 103-104 (2011), DAZ 151, 178-9 (2011)\n- Neue EU-Direktive zu Arzneimittelf\u00e4lschungen - wichtiger Schritt f\u00fcr mehr Patientensicherheit\nM. Tawab, U. Holzgrabe, M. Stein, E. Fink, R. Kl\u00e4mbt, M. Schubert-Zsilavecz, PZ 156, 791 (2011), DAZ 151, 1062-3 (2011)\n- DPhG unterst\u00fctzt aktuelle Positionspapiere der DFG und des Wissenschaftsrat zur Zukunft und zu Perspektiven des deutschen Wissenschaftssystems\nM. Schubert-Zsilavecz, U. Holzgrabe, T. Dingermann, D. Steinhilber, PZ 158, 2872 (2013), DAZ 153, 3365 (2013)\n- Apotheke vor Ort bietet gr\u00f6\u00dfte Sicherheit\nArzneimittel und Medizinprodukte aus dem Internet - Gesundheitsrisiken f\u00fcr Patienten\nU. Holzgrabe, K. M\u00fcller, M. Stein, D. Steinhilber, M. Schubert-Zsilavecz, R. Kl\u00e4mbt, PZ 158, 4011-4012 (2013), DAZ 153, 4716 (2013)\n- Pharmazie-Professoren wenden sich an die BAK / Pharmazieprofessoren in Sorge\nB. Clement, T. Dingermann, U. Holzgrabe, E. Mutschler, M. Schubert-Zsilavecz, D. Steinhilber, A. Vollmar. W. Weitschies, PZ 158, (2013), DAZ 153, (2013)\n- Stellungnahme der Altpr\u00e4sidenten der DPhG zum EuGH-Urteil\nPZ 161, 3407 (2016)\n- \"Erkennung, Gewinnung und funktionale Analyse von Wirkstoffen gegen Infektionskrankheiten\"\nGerhard Bringmann, Lehrstuhl f\u00fcr Organische Chemie I, August Stich, Missions\u00e4rztliches Institut und Ulrike Holzgrabe, Lehrstuhl f\u00fcr Pharmazeutische Chemie\nBericht in der Universit\u00e4tszeitung \"Blick\" 2005\n- \"Die Natur als Wirkstofflieferant: Tropische Pflanzen als Produzenten neuartiger Wirkstoffe gegen Tropenkrankheiten\"\nGerhard Bringmann, Institut f\u00fcr Organisch Chemie, Ulrike Holzgrabe, Institut f\u00fcr Pharmazie und Lebensmittelchemie\nBericht in der Universit\u00e4tszeitung \"Blick\" 2005:", "language": null, "image": null, "pagetype": null, "links": ["https://www.chemie.uni-wuerzburg.de/en/", "/en/institute/", "/en/institute/equipment/", "/en/institute/medicinal-chemistry/", "/en/institute/pharmaceutical-biology/", "/en/institute/pharm-technology/", "/en/institute/clinical-pharmacy/", "/en/institute/training/", "/en/institute/cooperation/", "/en/research-groups/", "/en/forschung/prof-brunschweiger/", "/en/forschung/prof-brunschweiger/research-topics/", "/en/forschung/prof-brunschweiger/publications/", "/en/forschung/prof-brunschweiger/group-members/", "/en/drugdelivery/", "https://www.chemie.uni-wuerzburg.de/en/lmc/", "https://www.decker-lab.de", "/en/aksotriffer/", "/en/research-groups/prof-petra-hoegger/", "/en/research-groups/prof-petra-hoegger/publications/", "/en/research-groups/prof-petra-hoegger/group-members/", "/en/forschung/prof-hoegger/ba-klin-pharm/", "/en/forschung/prof-holzgrabe/", "/en/forschung/prof-holzgrabe/research-topics/", "/en/forschung/prof-holzgrabe/publications/", "/en/students/", "/en/students/student-advice/", "/en/students/pharmacy-studies/", "/en/studium/pharmazie/informationen-zum-wintersemester-2023-24-und-studienverlauf/", "/en/studium/pharmazie/informationen-zum-wintersemester-2023-24-und-studienverlauf/grundstudium/", "/en/studium/pharmazie/informationen-zum-wintersemester-2023-24-und-studienverlauf/hauptstudium/", "/en/studium/pharmazie/stundenplaene-ws-23/", "/en/studium/pharmazie/studienanfaengerinnen/", "/en/studium/pharmazie/studienwechsel-und-leistungsanerkennung/", "/en/studium/pharmazie/verhalten-bei-krankheit/", "/en/studium/pharmazie/wahlpflichtfach/", "/en/studium/pharmazie/rechtliches/", "/en/studium/pharmazie/bafoeg/", "/en/students/pharmacy-studies/faq-pharmacy/", "https://www.chemie.uni-wuerzburg.de/en/lmc/students/", "https://www.chemie.uni-wuerzburg.de/en/studium/fachschaften/", "/en/erasmus/", "/en/erasmus/outgoing-students/", "/en/erasmus/incoming-students/", "/en/alumni/", "/en/events/", "/en/veranstaltungen/archiv-dphg-vortraege/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2023/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2022-23/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2022/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2021-22/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2021/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2020-21/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2020/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2019-20/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2019/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2018-19/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2018/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2017-18/", "/en/veranstaltungen/dphg-vortraege-wintersemester-2020-21/archiv/dphg-lectures/", "/en/veranstaltungen/dphg-vortraege-wintersemester-2020-21/archiv/dphg-lectures-1/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2016/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2015-16/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2015/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2014-15/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2014/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2013-14/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2013/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2012-13/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2012/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2011-12/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2011/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2010-11/", "/en/veranstaltungen/archiv-dphg-vortraege/sommersemester-2010/", "/en/veranstaltungen/archiv-dphg-vortraege/wintersem-2009-10/", "/en/veranstaltungen/archiv-www/", "/en/veranstaltungen/archiv-www/2022/", "/en/veranstaltungen/archiv-www/2021/", "/en/veranstaltungen/archiv-www/2020/", "/en/veranstaltungen/archiv-www/2019/", "/en/veranstaltungen/archiv-www/2018/", "/en/veranstaltungen/archiv-www/2017/", "/en/veranstaltungen/archiv-www/2016/", "/en/veranstaltungen/archiv-www/2015/", "/en/veranstaltungen/archiv-www/2014/", "/en/veranstaltungen/archiv-www/2013/", "/en/veranstaltungen/archiv-www/2012/", "/en/veranstaltungen/archiv-www/2011/", "/en/veranstaltungen/archiv-www/2010/", "/en/veranstaltungen/archiv-www/2009/", "/en/veranstaltungen/archiv-www/2008/", "/en/veranstaltungen/archiv-www/2007/", "/en/veranstaltungen/archiv-www/2006/", "/en/veranstaltungen/archiv-www/2005/", "/en/contact-and-services/", "/en/contact-and-services/team-and-contact/", "/en/contact-and-services/work-safety/", "/en/kontakt-und-services/stellenausschreibungen/", "/en/contact-and-services/technical-department/", "/en/kontakt-und-services/technikum/feinmechanik/", "/en/kontakt-und-services/technikum/fertigung/", "/en/kontakt-und-services/technikum/ausbildung/", "/en/kontakt-und-services/technikum/auftrag-technikum/", "https://www.chemie.uni-wuerzburg.de/en/services/central-services/chemicals-and-materials/", "https://www.uni-wuerzburg.de/en/verwaltung/agtu/aufgaben/abfallentsorgung/", "/en/contact-and-services/special-assignments/", "/en/contact-and-services/authorities/", "/en/contact-and-services/travel-information/", "#page-wrapper", "/forschung/prof-holzgrabe/publications/", "https://www.uni-wuerzburg.de/en/sonstiges/login/", "https://www.uni-wuerzburg.de/en/sonstiges/barrierefreiheit/leichte-sprache/", "https://www.uni-wuerzburg.de/en/sonstiges/barrierefreiheit/gebaerdenvideos/", "#mobile-mega-navigation", "https://www.uni-wuerzburg.de/en/", "https://www.uni-wuerzburg.de/en/sonstiges/login/", "https://www.uni-wuerzburg.de/en/sonstiges/barrierefreiheit/leichte-sprache/", "https://www.uni-wuerzburg.de/en/sonstiges/barrierefreiheit/gebaerdenvideos/", "/forschung/prof-holzgrabe/publications/", "https://www.chemie.uni-wuerzburg.de/en/", "/en/institute/", "/en/institute/equipment/", "/en/institute/medicinal-chemistry/", "/en/institute/pharmaceutical-biology/", "/en/institute/pharm-technology/", "/en/institute/clinical-pharmacy/", "/en/institute/training/", "/en/institute/cooperation/", "/en/research-groups/", "/en/forschung/prof-brunschweiger/", "/en/drugdelivery/", "https://www.chemie.uni-wuerzburg.de/en/lmc/", "https://www.decker-lab.de", "/en/aksotriffer/", "/en/research-groups/prof-petra-hoegger/", "/en/forschung/prof-holzgrabe/", "/en/students/", "/en/students/student-advice/", "/en/students/pharmacy-studies/", "https://www.chemie.uni-wuerzburg.de/en/lmc/students/", "https://www.chemie.uni-wuerzburg.de/en/studium/fachschaften/", "/en/erasmus/", "/en/erasmus/outgoing-students/", "/en/erasmus/incoming-students/", "/en/alumni/", "/en/events/", "/en/veranstaltungen/archiv-dphg-vortraege/", "/en/veranstaltungen/archiv-www/", "/en/contact-and-services/", "/en/contact-and-services/team-and-contact/", "/en/contact-and-services/work-safety/", "/en/kontakt-und-services/stellenausschreibungen/", "/en/contact-and-services/technical-department/", "https://www.chemie.uni-wuerzburg.de/en/services/central-services/chemicals-and-materials/", "https://www.uni-wuerzburg.de/en/verwaltung/agtu/aufgaben/abfallentsorgung/", "/en/contact-and-services/special-assignments/", "/en/contact-and-services/authorities/", "/en/contact-and-services/travel-information/", "/en/", "https://www.chemie.uni-wuerzburg.de/en/", "/en/institute/", "/en/research-groups/", "/en/forschung/prof-brunschweiger/", "/en/drugdelivery/", "https://www.chemie.uni-wuerzburg.de/en/lmc/", "https://www.decker-lab.de", "/en/aksotriffer/", "/en/research-groups/prof-petra-hoegger/", "/en/forschung/prof-holzgrabe/", "/en/forschung/prof-holzgrabe/research-topics/", "/en/forschung/prof-holzgrabe/publications/", "/en/students/", "/en/erasmus/", "/en/alumni/", "/en/events/", "/en/contact-and-services/", "https://www.uni-wuerzburg.de/en/", "https://www.chemie.uni-wuerzburg.de/en/", "/en/", "/en/research-groups/", "/en/forschung/prof-holzgrabe/", "/en/forschung/prof-holzgrabe/publications/", "http://orcid.org/0000-0002-0364-7278", "https://www.ncbi.nlm.nih.gov/pubmed/?term=holzgrabe+u", "https://doi.org/10.1007/978-1-4939-9438-0_20", "https://doi.org/10.1016/j.ejps.2018.10.027", "https://doi.org/10.1016/j.bioorg.2018.11.051", "https://doi.org/doi:\u00a010.14499/indonesianjcanchemoprev10iss2pp60-70", "https://doi.org/10.1016/j.jpba.2018.09.020", "https://doi.org/10.1016/j.bioorg.2018.11.051", "https://doi.org/10.1016/j.jpba.2019.01.016", "https://doi.org/10.1016/B978-0-12-409547-2.14081-8", "https://doi.org/10.1016/j.jpba.2018.12.010", "https://doi.org/10.1016/j.jpba.2019.01.036", "https://doi.org/10.1016/j.jpba.2019.04.020", "https://doi.org/10.1021/acs.jmedchem.8b01822", "https://doi.org/doi:\u00a010.1021/jacs.9b03505", "https://doi.org/10.1007/s00216-019-01744-y", "https://doi.org/10.1002/dta.2593", "https://doi.org/10.1016/j.jpba.2019.05.022", "https://doi.org/10.1016/j.jpba.2019.04.035", "https://doi.org/10.1124/mol.119.116202", "https://doi.org/10.3390/pharmaceutics11070323.", "https://doi.org/10.1021/acs.jnatprod.9b00180", "https://doi.org/10.1016/j.jpba.2019.112847", "https://doi.org/10.1016/j.jpba.2019.112839", "https://doi.org/10.3389/fphar.2019.01284", "https://doi.org/10.3324/haematol.2019.223024", "https://doi.org/10.3390/cosmetics6040070", "https://doi.org/doi:", "https://doi.org/10.1016/j.bioorg.2020.103633", "https://doi.org/10.1016/j.chroma.2020.460911", "https://doi.org/10.1016/j.jpba.2020.113149", "https://doi.org/10.1002/mrc.5009", "https://doi.org/10.1002/ejlt.201900442", "https://doi.org/10.3390/molecules25071486", "https://doi.org/10.1016/j.jpba.2020.113425", "https://doi.org/10.1021/acsinfecdis.9b00378", "https://doi.org/10.1021/acsomega.0c02630", "https://doi.org/10.1016/j.jpba.2020.113457", "https://doi.org/10.1016/j.ibror.2020.07.004", "https://doi.org/10.1021/acs.jmedchem.0c00911", "https://doi.org/10.1002/ardp.202000147", "https://doi.org/10.3390/md18090457", "https://doi.org/10.1021/acsptsci.0c00069", "https://doi.org/10.1089/ars.2019.7957", "https://doi.org/10.1021/acs.molpharmaceut.0c00720", "https://doi.org/10.3389/fncel.2020.573950", "https://doi.org/10.1021/acsomega.0c04220", "https://doi.org/10.1101/2020.09.16.299537", "https://doi.org/10.1016/j.jpba.2020.113711", "https://doi.org/10.1007/s00216-021-03249-z", "https://doi.org/10.1016/j.jpba.2021.113982", "https://doi.org/10.1002/elps.202000307", "https://doi.org/10.1021/acs.jnatprod.0c01030", "https://doi.org/10.1016/j.jpba.2021.113982", "https://doi.org/10.1007/s00216-021-03249-z", "https://doi.org/10.1016/j.chroma.2021.462120", "https://doi.org/10.1016/j.jpba.2021.114110", "https://doi.org/10.1016/j.jpba.2021.114205", "https://doi.org/10.1186/s13321-021-00532-0", "https://doi.org/10.1371/journal.pone.0255437", "https://doi.org/10.1007/s10337-021-04079-y", "https://doi.org/10.1002/ardp.202100260", "https://doi.org/10.1016/j.chroma.2021.462613", "https://doi.org/10.1039/D1CC04716G", "http://dx.doi.org/10.1016/j.jpba.2014.08.013", "http://dx.doi.org/10.1016/j.jpba.2014.11.012", "http://dx.doi.org/10.1007/s00436-014-4210-4", "http://dx.doi.org/10.1021/jm500860w", "http://dx.doi.org/10.1007/s11095-014-1607-9", "http://dx.doi.org/10.3390/molecules20045740", "http://dx.doi.org/10.1107/S2056989015006817", "http://dx.doi.org/10.1021/acs.jafc.5b00940", "http://dx.doi.org/10.1016/j.jpba.2015.04.042", "http://dx.doi.org/10.1016/j.ejpb.2015.04.034", "http://dx.doi.org/10.1016/j.ejpb.2014.11.018", "http://dx.doi.org/10.1016/j.ejpb.2014.12.015", "http://dx.doi.org/10.1016/j.ejpb.2015.05.027", "http://dx.doi.org/10.1016/j.jpba.2015.06.002", "http://dx.doi.org/10.3390/molecules200610873", "http://dx.doi.org/10.1002/elps.201500025", "http://dx.doi.org/10.1016/j.chembiol.2015.08.002", "http://dx.doi.org/10.1021/acs.jafc.5b03853", "http://dx.doi.org/10.1371/journal.pone.0142386", "http://dx.doi.org/10.1039/C5MD00481K", "http://dx.doi.org/10.1016/j.trac.2015.11.009", "http://dx.doi.org/10.1016/j.ejpb.2015.11.009", "http://dx.doi.org/10.1016/j.jpba.2016.01.057", "http://dx.doi.org/10.1016/j.talanta.2016.03.071", "http://dx.doi.org/10.1002/nadc.20164046023", "http://dx.doi.org/10.1016/j.talanta.2016.03.071", "http://dx.doi.org/10.1016/j.bmc.2016.06.003", "http://dx.doi.org/10.1128/AAC.01757-15", "http://dx.doi.org/10.1074/jbc.M116.735431", "http://dx.doi.org/10.1016/j.ijantimicag.2016.06.020", "http://dx.doi.org/10.1016/j.jpba.2016.07.044", "http://10.1016/j.bmc.2016.08.025", "http://dx.doi.org/10.1016/j.jpba.2016.08.035", "http://dx.doi.org/10.1007/s00063-016-0185-5", "http://doi.org/10.1080/13543776.2017.1272577", "http://doi.org/10.1124/jpet.116.237149", "http://doi.org/10.1002/ange.201701524", "http://doi.org/10.1039/c7md00149e", "https://doi.org/10.1021/acs.jmedchem.6b01613", "http://doi.org/10.1016/j.jpba.2017.05.034", "http://doi.org/10.1021/acschembio.7b00275", "http://doi.org/doi:", "http://doi.org/10.1080/01480545.2017.1366504", "https://10.1016/j.jpba.2017", "http://iucrdata.iucr.org/x/issues/2017/04/00/", "https://10.1016/j.jconrel.2017", "https://10.1016/j.fitote.2017", "https://doi.org/10.1016/j.jpba.2017.07.064", "https://doi.org/10.1016/j.jpba.2017.05.034", "https://doi.org/10.1159/000480091", "https://doi.org/10.1128/AAC.01510-17", "https://doi.org/10.5414/CP203106", "https://doi.org/10.1016/j.jpba.2017.11.078", "https://doi.org/10.1186/s12906-017-2009-4", "https://doi.org/10.1016/j.jpba.2017.10.010", "https://doi.org/10.1016/j.jpba.2017.12.019", "https://doi.org/10.1021/acsphotonics.8b00072", "https://doi.org/10.1556/1006.2018.31.4.4", "https://doi.org/10.1016/j.ejmech.2018.04.055", "https://doi.org/10.1080/00304948.2018.1525990", "https://doi.org/10.1016/j.ejpb.2018.05.012.", "https://doi.org/10.1080/00397911.2018.1476889", "https://doi.org/10.1159/000489999", "https://doi.org/10.1002/elps.201800170", "https://doi.org/10.1002/dta.2420", "https://doi.org/10.3389/fmicb.2018.01473", "https://doi.org/10.1016/j.jpba.2018.07.043", "https://doi.org10.1016/j.ejps.2018.07.054", "https://doi.org/10.3389/fphar.2018.00995", "https://doi.org/10.1021/acs.molpharmaceut.8b00469", "https://Doi.org/10.1016/j.chroma.2018.09.031", "https://doi.org/10.1016/j.ejps.2018.10.027", "https://doi.org/10.3390/molecules23123230", "http://dx.doi.org/10.1016/j.chroma.2009.11.036", "http://dx.doi.org/10.1111/j.1365-2125.2009.03564.x", "http://dx.doi.org/10.1016/j.jpba.2009.12.007", "http://dx.doi.org/10.1016/j.bmc.2010.01.002", "http://dx.doi.org/10.1002/med.20166", "http://dx.doi.org/10.1016/j.chroma.2010.02.017", "http://dx.doi.org/10.1111/j.1476-5381.2009.00601.x", "http://dx.doi.org/10.1128/AAC.00936-09", "http://dx.doi.org/10.1016/j.bmc.2010.03.067", "http://dx.doi.org/10.1016/j.tetlet.2010.04.130", "http://dx.doi.org/10.1016/j.ejps.2010.04.002", "http://dx.doi.org/10.1016/j.pnmrs.2010.05.001", "http://dx.doi.org/10.1002/ejoc.201000441", "http://dx.doi.org/10.1016/j.jpba.2010.06.025", "http://dx.doi.org/10.1002/jssc.201000141", "http://dx.doi.org/10.1111/j.1365-2125.2010.03750.x", "http://dx.doi.org/10.1007/s12566-010-0016-8", "http://dx.doi.org/10.1099/vir.0.025650-0", "http://dx.doi.org/10.1007/s00216-010-4169-7", "http://dx.doi.org/10.1128/AAC.00586-10", "http://dx.doi.org/10.1007/s00436-010-2127-0", "http://dx.doi.org/10.1021/jm101156y", "http://dx.doi.org/10.1016/j.jpba.2010.12.016", "http://dx.doi.org/10.1016/j.jpba.2010.12.017", "http://dx.doi.org/10.1016/j.jpba.2010.12.023", "http://dx.doi.org/10.1128/AAC.01484-10", "http://dx.doi.org/10.1186/gb-2011-12-3-r24", "http://dx.doi.org/10.1016/j.jpba.2011.03.031", "http://dx.doi.org/10.1016/j.jchromb.2011.04.012", "http://dx.doi.org/10.1016/j.jpba.2011.05.027", "http://dx.doi.org/10.1039/9781849732994-00124", "http://dx.doi.org/10.3987/COM-11-12340", "http://dx.doi.org/10.1002/cmdc.201100404", "http://dx.doi.org/10.1016/j.ejps.2011.11.004", "http://dx.doi.org/10.1128/AAC.00437-11", "http://dx.doi.org/10.1021/jm101439s", "http://dx.doi.org/10.1002/elps.201100575", "http://dx.doi.org/10.1002/ardp.201100423", "http://dx.doi.org/10.1039/C2MD20025B", "http://dx.doi.org/10.1007/s11746-012-2051-9", "http://dx.doi.org/10.1016/j.jpba.2012.03.019", "http://dx.doi.org/10.1016/j.ijpharm.2012.05.017", "http://dx.doi.org/10.1038/ncomms2028", "http://dx.doi.org/10.1128/AAC.00937-12", "http://dx.doi.org/10.3390/molecules171214685", "http://dx.doi.org/10.1002/lite.201200241", "http://dx.doi.org/10.1007/978-1-62703-263-6_23", "http://dx.doi.org/10.1002/ange.201205315", "http://dx.doi.org/10.1002/anie.201205315", "http://dx.doi.org/10.1111/bph.12003", "http://dx.doi.org/10.1691/ph.2013.6501", "http://dx.doi.org/10.1002/ange.201210006", "http://dx.doi.org/10.1002/anie.201210006", "http://dx.doi.org/10.1016/j.ejps.2013.04.024", "http://dx.doi.org/10.1016/S1473-3099(13)70191-9", "https://doi.org/10.13170/aijst.2.3.1063", "https://doi.org/10.14499/indonesianjpharm25iss2pp68", "http://dx.doi.org/10.1038/nchembio.1384", "http://dx.doi.org/10.1016/j.jpba.2013.08.046", "http://dx.doi.org/10.1016/j.jpba.2013.04.010", "http://dx.doi.org/10.1128/AAC.01875-13", "http://dx.doi.org/10.3390/molecules19021394", "http://dx.doi.org/10.1016/j.ejmech.2014.01.032", "http://dx.doi.org/10.1016/j.jpba.2014.02.012", "http://dx.doi.org/10.1021/cn500016p", "http://dx.doi.org/10.1016/j.jpba.2014.04.013", "http://dx.doi.org/10.1016/j.bcp.2014.05.012", "http://dx.doi.org/10.1016/j.chembiol.2014.06.003", "http://dx.doi.org/10.1016/j.jpba.2014.06.013", "http://dx.doi.org/10.1002/rcm.6955", "http://dx.doi.org/10.1002/cbdv.201400110", "http://dx.doi.org/10.1021/jm500790x", "http://dx.doi.org/10.1021/jf502113r", "http://dx.doi.org/10.1016/j.jpba.2014.08.013", "http://dx.doi.org/10.1021/np500259j", "http://dx.doi.org/10.1016/j.ijpharm.2014.10.047", "http://dx.doi.org/10.1021/jm501683w", "http://dx.doi.org/10.1096/fj.08-114751", "http://dx.doi.org/10.1002/pauz.200790026", "http://dx.doi.org/10.1002/pauz.200790027", "http://dx.doi.org/10.1002/pauz.200600218", "http://dx.doi.org/10.1002/pauz.200700241", "http://dx.doi.org/10.1002/pauz.200700274", "http://dx.doi.org/10.1002/pauz.200800304", "http://dx.doi.org/10.1002/pauz.200900345", "http://dx.doi.org/10.1002/pauz.201000387", "http://dx.doi.org/10.1002/pauz.201100411", "http://dx.doi.org/10.1002/pauz.201100446", "http://dx.doi.org/10.1002/pauz.201100454", "https://analyticalscience.wiley.com/do/10.1002/was.0018002/full/", "http://dx.doi.org/10.1002/pauz.200790103", "http://dx.doi.org/10.1002/pauz.200990090", "http://dx.doi.org/10.1002/pauz.200990091", "http://dx.doi.org/10.1002/pauz.200990126", "http://dx.doi.org/10.1002/pauz.201090015", "http://dx.doi.org/10.1002/pauz.201090016", "http://dx.doi.org/10.1002/pauz.201090051", "http://dx.doi.org/10.1002/pauz.201090074", "http://dx.doi.org/10.1002/pauz.201090075", "http://dx.doi.org/10.1002/pauz.201090076", "http://dx.doi.org/10.1002/pauz.201090091", "http://dx.doi.org/10.1002/pauz.201190071", "http://dx.doi.org/10.1002/pauz.201290004", "http://dx.doi.org/10.1002/pauz.201290023", "http://dx.doi.org/10.1002/pauz.201290066", "http://dx.doi.org/10.1002/pauz.201290081", "http://dx.doi.org/10.1002/pauz.201290082", "https://www.uni-wuerzburg.de/en/sonstiges/kontakt/", "mailto:i-pharm-lmc@uni-wuerzburg.de", "https://wueaddress.uni-wuerzburg.de/", "/en/contact-and-services/travel-information/", "#", "https://wueaddress.uni-wuerzburg.de/building/3316", "https://www.uni-wuerzburg.de/en/", "https://www.uni-wuerzburg.de/en/university/", "https://www.uni-wuerzburg.de/en/studying-at-jmu/", "https://www.uni-wuerzburg.de/en/research/", "https://www.uni-wuerzburg.de/en/teaching/", "https://www.uni-wuerzburg.de/en/institutions/overview/", "https://www.uni-wuerzburg.de/en/international/", "https://www.uni-wuerzburg.de/en/", "https://www.uni-wuerzburg.de/en/studying-at-jmu/studienangelegenheiten/dates-and-deadlines/", "https://www.uni-wuerzburg.de/en/studium/angebot/", "https://www.uni-wuerzburg.de/en/news-and-events/news/archive/", "https://www.uni-wuerzburg.de/en/news-and-events/jobs-and-apprenticeship/", "https://www.uni-wuerzburg.de/en/university-employees/", "https://www.uni-wuerzburg.de/en/amtl-veroeffentlichungen/", "https://www.uni-wuerzburg.de/en/institutions/overview/", "https://www.bibliothek.uni-wuerzburg.de/en/", "https://www.rz.uni-wuerzburg.de/en/", "https://www.hochschulsport-wuerzburg.de/", "https://www.uni-wuerzburg.de/en/studying-at-jmu/zsb/", "https://www.uni-wuerzburg.de/en/studium/pruefungsamt/", "https://www.uni-wuerzburg.de/en/studying-at-jmu/studienangelegenheiten/", "https://www.uni-wuerzburg.de/en/stuv/", "https://www.uni-wuerzburg.de/en/career-centre/", "https://www.uni-wuerzburg.de/en/studium/online-service/", "http://wuestudy.uni-wuerzburg.de/", "https://wuecampus.uni-wuerzburg.de", "https://www.uni-wuerzburg.de/en/studium/vorlesungsverzeichnis/", "https://www.uni-wuerzburg.de/en/studying-at-jmu/studienangelegenheiten/application-and-enrollment/daten-online/start-onlineservice/", "https://katalog.bibliothek.uni-wuerzburg.de/TouchPoint/start.do?View=sunrise&Language=de", "https://www.uni-wuerzburg.de/en/sonstiges/kontakt/", "https://wueaddress.uni-wuerzburg.de/", "https://www.uni-wuerzburg.de/en/verwaltung/personal/lageplan/", "https://www.uni-wuerzburg.de/en/presse/", "https://www.uni-wuerzburg.de/en/studium/zsb/s/telefonservice/", "https://www.uni-wuerzburg.de/en/administration/breakdown-acceptance/", "https://www.uni-wuerzburg.de/en/administration/technischer-betrieb/", "https://www.uni-wuerzburg.de/en/verwaltung/agtu/aufgaben/gesundheitsschutz/emergency-contacts/", "#js-picture-credits", "#top", "/index.php?id=167869", "https://www.uni-wuerzburg.de/en/sonstiges/imprint-privacy-policy/", "https://www.uni-wuerzburg.de/en/sonstiges/privacy-disclaimer/", "https://www.uni-wuerzburg.de/en/sonstiges/barrierefreiheit/barrierefreiheit/"]}